Document:

Guaranty and Collateral Agreement

 Exhibit 10.35 
  

 GUARANTY AND COLLATERAL AGREEMENT 
 dated as of 
 April 5, 2007 
 among 
 NIGHTHAWK RADIOLOGY HOLDINGS, INC., 
 THE SUBSIDIARIES OF NIGHTHAWK RADIOLOGY 
 HOLDINGS, INC. IDENTIFIED HEREIN 
 and 
 MORGAN STANLEY & CO. INCORPORATED, 
 as COLLATERAL AGENT 
  

 TABLE OF CONTENTS 
  

			
	 	  	Page
	 ARTICLE I Definitions
	  	1
		
	 Section 1.01. Credit Agreement; UCC
	  	1
	 Section 1.02. Other Defined Terms
	  	1
		
	 ARTICLE II Guaranty
	  	5
		
	 Section 2.01. Guaranty
	  	5
	 Section 2.02. Amendments, etc. with respect to the Obligations
	  	5
	 Section 2.03. Guaranty Absolute and Unconditional
	  	5
	 Section 2.04. Reinstatement
	  	7
	 Section 2.05. Payments
	  	7
	 Section 2.06. Information
	  	7
		
	 ARTICLE III Pledge of Securities
	  	7
		
	 Section 3.01. Pledge
	  	7
	 Section 3.02. Delivery of the Pledged Collateral
	  	8
	 Section 3.03. Representations, Warranties and Covenants
	  	8
	 Section 3.04. Registration in Nominee Name; Denominations
	  	9
	 Section 3.05. Voting Rights; Dividends and Interest
	  	9
		
	 ARTICLE IV Security Interests in Personal Property
	  	10
		
	 Section 4.01. Security Interest
	  	10
	 Section 4.02. Representations and Warranties
	  	12
	 Section 4.03. Covenants
	  	14
	 Section 4.04. Other Actions
	  	16
	 Section 4.05. Covenants Regarding Patent, Trademark and Copyright Collateral
	  	17
	 Section 4.06. Cash Management System and Securities Accounts
	  	18
	 Section 4.07. Certain Uncertificated Securities
	  	19
		
	 ARTICLE V Remedies
	  	19
		
	 Section 5.01. Remedies upon Default
	  	19
	 Section 5.02. Application of Proceeds
	  	20
	 Section 5.03. Grant of License To Use Intellectual Property
	  	22
	 Section 5.04. Securities Act
	  	22
	 Section 5.05. Medicare/Medicaid
	  	22
		
	 ARTICLE VI Indemnity, Subrogation and Subordination
	  	22
		
	 Section 6.01. Indemnity and Subrogation
	  	22
	 Section 6.02. Contribution and Subrogation
	  	23
	 Section 6.03. Subordination
	  	23
		
	 ARTICLE VII Miscellaneous
	  	23
		
	 Section 7.01. Notices
	  	23
	 Section 7.02. Waivers; Amendment
	  	23
	 Section 7.03. Collateral Agent’s Fees and Expenses; Indemnification
	  	24
	 Section 7.04. Successors and Assigns
	  	24
	 Section 7.05. Survival of Agreement
	  	24
	 Section 7.06. Counterparts; Effectiveness; Several Agreement
	  	25
	 Section 7.07. Severability
	  	25
	 Section 7.08. Right of Set-Off
	  	25
	 Section 7.09. Governing Law; Jurisdiction; Consent to Service of Process
	  	25
	 Section 7.10. WAIVER OF JURY TRIAL
	  	26

  

 -i- 

			
	 Section 7.11. Headings
	  	26
	 Section 7.12. Security Interest Absolute
	  	26
	 Section 7.13. Termination or Release
	  	26
	 Section 7.14. Additional Subsidiaries
	  	27
	 Section 7.15. Collateral Agent Appointed Attorney-in-Fact
	  	27
	 Section 7.16. Further Assurances
	  	27
	 Section 7.17. Collateral Agent
	  	27

  

			
	Exhibits	  	
		
	Exhibit I	  	Form of Supplement
	Exhibit II	  	Form of Deposit Account Control Agreement
	Exhibit III	  	Form of Securities Account Control Agreement
	Exhibit IV	  	Form of Grant of Security Interest in United States Trademarks
	Exhibit V	  	Form of Grant of Security Interest in United States Patents
	Exhibit VI	  	Form of Grant of Security Interest in United States Copyrights
	Exhibit VII	  	Form of Uncertificated Securities Control Agreement

  

 -ii- 

 GUARANTY AND COLLATERAL AGREEMENT (this “Agreement”) dated as of April 5, 2007, among NIGHTHAWK
RADIOLOGY HOLDINGS, INC., a Delaware corporation (the “Borrower”), the Subsidiaries of the Borrower from time to time party hereto (whether as original signatories or as additional parties as contemplated by Section 7.14 hereof) identified
herein and MORGAN STANLEY & CO. INCORPORATED, as Collateral Agent. 
 Reference is made to the Credit Agreement dated as of April 5,
2007 (as amended, amended and restated, waived, supplemented or otherwise modified from time to time, the “Credit Agreement”), among the Borrower, the Lenders party thereto from time to time and Morgan Stanley Senior Funding, Inc.,
as Administrative Agent. The Lenders have agreed to extend credit to the Borrower subject to the terms and conditions set forth in the Credit Agreement. The obligations of the Lenders to extend such credit are conditioned upon, among other things,
the execution and delivery of this Agreement. The Subsidiary Credit Parties are affiliates of the Borrower, will derive substantial benefits from the extension of credit to the Borrower pursuant to the Credit Agreement and are willing to execute and
deliver this Agreement in order to induce the Lenders to extend such credit. Accordingly, the parties hereto agree as follows: 
 ARTICLE I

 Definitions 
 Section 1.01. Credit Agreement; UCC. Except as provided in the immediately succeeding sentence, capitalized terms used in this Agreement and not otherwise defined in this Agreement have the meanings specified in the Credit
Agreement. All terms defined in the New York UCC (as defined in this Agreement) and not defined in this Agreement have the meanings specified therein. 
 Section 1.02. Other Defined Terms. As used in this Agreement, the following terms have the meanings specified below: 
 “Account Debtor” means any Person who is or who may become obligated to any Grantor under, with respect to or on account of an Account. 
 “Adjusted Net Worth” of any Guarantor at any time, shall mean the greater of (x) $0 and (y) the amount by which the fair
saleable value of such Guarantor’s assets on the date of the respective payment hereunder exceeds its debts and other liabilities (including contingent liabilities, but without giving effect to any of its obligations under this Agreement or any
other Credit Document). 
 “Agreement” means this Guaranty and Collateral Agreement, as the same may be amended, modified,
restated and/or supplemented from time to time in accordance with its terms. 
 “Article 9 Collateral” has the meaning
assigned to such term in Section 4.01. 
 “Australian Cap Amount” means, initially, $1,000,000; provided that at
the end of each fiscal year following the Initial Borrowing Date, the Australian Cap Amount shall be increased by $250,000. 
 “Closing Date Pledged Collateral” has the meaning assigned to such term in Section 3.02. 
 “Collateral” means Article 9 Collateral and Pledged Collateral. 
 “Contract Rights” shall
mean all rights of any Grantor under each Contract, including, without limitation, (i) any and all rights to receive and demand payments under any or all Contracts, (ii) any and all rights to receive and compel performance under any or all
Contracts and (iii) any and all other rights, interests and claims now existing or in the future arising in connection with any or all Contracts. 
 “Contracts” with respect to any Grantor, all contracts, agreements, instruments and indentures in any form and portions thereof, to which such Grantor is a party or under which such Grantor or any
property of such 

 Grantor is subject, as the same may from time to time be amended, supplemented, waived or otherwise modified, including,
without limitation, (i) all rights of such Grantor to receive moneys due and to become due to it thereunder or in connection therewith, (ii) all rights of such Grantor to damages arising thereunder and (iii) all rights of such Grantor
to perform and to exercise all remedies thereunder. Without limiting the foregoing, “Contracts” shall include the Initial Borrowing Date Acquisition Agreement, all other Initial Borrowing Date Acquisition Documents and all
Designated Permitted Acquisition Documents and the rights of each Grantor thereunder. 
 “Contributing Party” has the
meaning assigned to such term in Section 6.02. 
 “Control” shall mean (i) in the case of each Deposit
Account, “control”, as such term is defined in Section 9-104 of the New York UCC, (ii) in the case of any Securities Account, “control” as such term is defined in Section 8-106 of the New York UCC, and
(iii) in the case of any Commodity Account, “control”, as such term is defined in section 9-106 of the New York UCC. 
 “Control Agreements” means, collectively, the Deposit Account Control Agreements and the Securities Account Control Agreements. 
 “Copyright License” means any written agreement, now or hereafter in effect, granting any right to any third party under any Copyright now or hereafter owned by any Grantor or that such Grantor
otherwise has the right to license, or granting any right to any Grantor under any Copyright now or hereafter owned by any third party, and all rights of any Grantor under any such agreement. 
 “Copyrights” means all of the following now owned or hereafter acquired by any Grantor: (a) all copyright rights in any work
subject to the copyright laws of the United States or any other country, whether as author, assignee, transferee or otherwise and (b) all registrations and applications for registration of any such copyright in the United States or any other
country, including registrations, recordings, supplemental registrations and pending applications for registration in the United States Copyright Office, including those listed on Schedule III of the GCA Disclosure Letter. 
 “Credit Agreement” has the meaning assigned to such term in the preliminary statement in this Agreement. 
 “Credit Document Obligations” means (a) the due and punctual payment by the Borrower of (i) the principal of and interest
(including interest accruing during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) on the Loans, when and as due, whether at maturity, by
acceleration, upon one or more dates set for prepayment or otherwise, and (ii) all other monetary obligations of the Borrower to any of the Secured Creditors under the Credit Agreement and each other Credit Document, including obligations to
pay fees, expense reimbursement obligations and indemnification obligations, whether primary, secondary, direct, contingent, fixed or otherwise (including monetary obligations incurred during the pendency of any bankruptcy, insolvency, receivership
or other similar proceeding, regardless of whether allowed or allowable in such proceeding), (b) the due and punctual performance of all other obligations of the Borrower under or pursuant to the Credit Agreement and each other Credit Document,
and (c) the due and punctual payment and performance in full of all the obligations of each other Credit Party under or pursuant to this Agreement and each other Credit Document. 
 “Deposit Account Control Agreement” means an agreement substantially in the form annexed hereto as Exhibit II or such other form as is
reasonably satisfactory to the Collateral Agent and the Borrower establishing Collateral Agent’s Control with respect to any Deposit Account. 
 “Deposit Accounts” means, collectively, with respect to each Grantor, (i) all “deposit accounts” as such term is defined in the New York UCC and in any event shall include all accounts and sub-accounts
relating to any of the foregoing accounts and (ii) all cash, funds, checks, notes and instruments from time to time on deposit in any of the accounts or sub-accounts described in clause (i) of this definition. 
  

 -2- 

 “Excess Exempted Foreign Entity Voting Equity Interests” means the Voting Equity
Interests of an Exempted Foreign Entity in excess of 65% of the total combined voting power of all classes of Voting Equity Interests of such Exempted Foreign Entity. 
 “Exempted Foreign Entity” means any corporation or any limited liability company, in each case, organized under the laws of a jurisdiction other than the United Sates or any State or territory thereof
that, in any such case, is treated as a corporation or an association taxable as a corporation for U.S. Federal income tax purposes. 
 “Federal Securities Laws” has the meaning assigned to such term in Section 5.04. 
 “Grantors” means the Borrower and the Subsidiary Credit Parties. 
 “Guaranteed Party” shall mean
the Borrower and each Subsidiary of the Borrower party to any Interest Rate Protection Agreement or Other Hedging Agreement with one or more Lenders or any affiliate thereof. 
 “Guarantors” means the Subsidiary Credit Parties. 
 “Indemnitee” shall have the meaning assigned to such term in Section 7.03(b). 
 “Intellectual Property” means all intellectual and similar property of any Grantor of every kind and nature now owned or hereafter acquired by any Grantor, including Patents, Copyrights, Licenses, Trademarks, trade secrets,
confidential or proprietary technical and business information, software and databases and all embodiments or fixations thereof and related documentation, registrations and franchises, and all additions, improvements and accessions to, and books and
records describing or used in connection with, any of the foregoing. 
 “Investment Property” means a security, whether
certificated or uncertificated, Security Entitlement, Securities Account, Commodity Contract or Commodity Account. 
 “License” means any Patent License, Trademark License, Copyright License or other license or sublicense agreement pertaining to Intellectual Property to which any Grantor is a party, including those listed on
Schedule III of the GCA Disclosure Letter. 
 “Medicare Deposit Account” means any Deposit Account into which Medicare
and/or Medicaid receivables are paid. 
 “New York UCC” means the Uniform Commercial Code as from time to time in effect in
the State of New York. 
 “Obligations” means (a) Credit Document Obligations and (b) the due and punctual payment
and performance in full of all obligations of each Credit Party under each Interest Rate Protection Agreement and Other Hedging Agreement that is entered into with an Other Creditor. 
 “Other Creditor” means any Lender or any affiliate thereof, together with such Lender’s or affiliate’s successors and assigns
(even if the respective Lender subsequently ceases to be a Lender under the Credit Agreement for any reason), who has from time to time entered into one or more Interest Rate Protection Agreements and/or Other Hedging Agreements with a Credit Party

 “Patent License” means any written agreement, now or hereafter in effect, granting to any third party any right to make,
use or sell any invention on which a Patent, now or hereafter owned by any Grantor or that any Grantor otherwise has the right to license, is in existence, or granting to any Grantor any right to make, use or sell any invention on which a Patent,
now or hereafter owned by any third party, is in existence, and all rights of any Grantor under any such agreement. 
 “Patents” means all of the following now owned or hereafter acquired by any Grantor: (a) all letters patent of the United States or the equivalent thereof in any other country, all registrations and recordings

  

 -3- 

 thereof, and all applications for letters patent of the United States or the equivalent thereof in any other country,
including registrations, recordings and pending applications in the United States Patent and Trademark Office or any similar offices in any other country, including those listed on Schedule III of the GCA Disclosure Letter, and (b) all
reissues, continuations, divisions, continuations-in-part, renewals or extensions thereof. 
 “Permits” shall mean, to the
extent permitted to be assigned by the terms thereof or by applicable law, all licenses, permits, rights, orders, variances, franchises or authorizations of or from any Governmental Authority. 
 “Pledged Collateral” has the meaning assigned to such term in Section 3.01. 
 “Pledged Debt” has the meaning assigned to such term in Section 3.01. 
 “Pledged Securities” means any promissory notes, stock certificates or other securities now or hereafter included in the Pledged
Collateral, including all certificates, instruments or other documents representing or evidencing any Pledged Collateral. 
 “Pledged
Stock” has the meaning assigned to such term in Section 3.01. 
 “Proceeds” has the meaning specified in
Section 9-102 of the New York UCC. 
 “Secured Creditors” means (a) the Lenders, (b) the Collateral Agent,
(c) the Administrative Agent and each other Agent, (d) each Other Creditor and (e) the successors and permitted assigns of each of the foregoing. 
 “Securities Account Control Agreement” means an agreement substantially in the form annexed hereto as Exhibit III or an agreement in a form that is reasonably satisfactory to the Collateral Agent and
the Borrower establishing the Collateral Agent’s Control with respect to any Securities Account. 
 “Security Interest”
has the meaning assigned to such term in Section 4.01(a). 
 “Subsidiary Credit Parties” means (a) the
Subsidiaries identified on Schedule I and (b) each other Subsidiary of Borrower that becomes a party to this Agreement as a Subsidiary Credit Party after the Effective Date. 
 “Trademark License” means any written agreement, now or hereafter in effect, granting to any third party any right to use any Trademark
now or hereafter owned by any Grantor or that any Grantor otherwise has the right to license, or granting to any Grantor any right to use any Trademark now or hereafter owned by any third party, and all rights of any Grantor under any such
agreement. 
 “Trademarks” means all of the following now owned or hereafter acquired by any Grantor: (a) all
trademarks, service marks, trade names, domain names, corporate names, company names, business names, fictitious business names, trade styles, trade dress, logos, other source indicators or business identifiers, designs and general intangibles of
like nature, now existing or hereafter adopted or acquired, all registrations and recordings thereof, and all registration and recording applications filed in connection therewith, including registrations and registration applications in the United
States Patent and Trademark Office or any similar offices in any State of the United States or any other country or any political subdivision thereof, and all extensions or renewals thereof, including those listed on Schedule III of the GCA
Disclosure Letter and (b) all goodwill associated therewith or symbolized thereby. 
 “Voting Equity Interests” of any
Person shall mean all classes of Equity Interests of such Person entitled to vote. 
  

 -4- 

 ARTICLE II 
 Guaranty 
 Section 2.01. Guaranty. (a) Each of the Guarantors hereby, jointly and
severally, unconditionally and irrevocably, guarantees to the Collateral Agent, for the ratable benefit of the Secured Creditors, and to the Secured Creditors the prompt and complete payment and performance when due and payable (whether at the
stated maturity, by acceleration or otherwise) of all Obligations of the Borrower and each other Credit Party. 
 (b) Each Guarantor and each
Secured Creditor (by its acceptance of the benefits of this Agreement) hereby confirms that it is its intention that the guaranty made by the Guarantors not constitute a fraudulent transfer or conveyance for purposes of the Bankruptcy Code, the
Uniform Fraudulent Conveyance Act or any similar Federal or state law. To effectuate the foregoing intention, each Guarantor and each Secured Creditor (by its acceptance of the benefits of this Agreement) hereby irrevocably agrees that the
Obligations guaranteed by such Guarantor shall be limited to such amount as will, after giving effect to such maximum amount and all other (contingent or otherwise) liabilities of such Guarantor that are relevant under such laws, not constitute a
fraudulent transfer or conveyance for purposes of such laws. 
 (c) Each Guarantor agrees that the Obligations guaranteed by it hereunder may
at any time and from time to time exceed the amount of the liability of such Guarantor hereunder without impairing the guaranty contained in this Article II or affecting the rights and remedies of the Collateral Agent or any other Secured Creditor
hereunder. 
 (d) No payment made by the Borrower, any of the Guarantors, any other guarantor or any other Person or received or collected by
the Collateral Agent or any other Secured Creditor from the Borrower, any of the Guarantors, any other guarantor or any other Person by virtue of any action or proceeding or any set-off or appropriation or application at any time or from time to
time in reduction of or in payment of any of the Obligations shall be deemed to modify, reduce, release or otherwise affect the liability of any Guarantor hereunder which shall, notwithstanding any such payment (other than any payment made by such
Guarantor in respect of the Obligations or any payment received or collected from such Guarantor in respect of any of the Obligations), remain liable for the Obligations guaranteed by it hereunder up to the maximum liability of such Guarantor
hereunder until (but subject to Section 2.04 in the case of following clause (i)) the earlier to occur of (i) the first date on which all the Loans and all other Obligations then due and owing, are paid in full in cash and the Total
Commitment has been terminated or (ii) the release of such Guarantor from this Agreement in accordance with the express provisions of Section 7.13(b) hereof. 
 Section 2.02. Amendments, etc. with respect to the Obligations. To the maximum extent permitted by law, each Guarantor shall remain obligated hereunder notwithstanding that, without any reservation of
rights against any Guarantor and without notice to or further assent by any Guarantor, any demand for payment of any of the Obligations made by the Collateral Agent or any other Secured Creditor may be rescinded by the Collateral Agent or such other
Secured Creditor and any of the Obligations continued, and the Obligations, or the liability of any other Person upon or for any part thereof, or any collateral security or guaranty therefor or right of offset with respect thereto, may, from time to
time, in whole or in part, be renewed, extended, amended, modified, accelerated, compromised, subordinated, waived, surrendered or released by the Collateral Agent or any other Secured Creditor, and the Credit Agreement and the other Credit
Documents and any other documents executed and delivered in connection therewith may be amended, waived, modified, supplemented or terminated, in whole or in part, in accordance with their respective terms, as the Collateral Agent (or the Required
Lenders under the Credit Agreement, or the applicable Lenders(s), as the case may be) may deem advisable from time to time, and any collateral security, guaranty or right of offset at any time held by the Collateral Agent or any other Secured
Creditor for the payment of any of the Obligations may be sold, exchanged, waived, surrendered or released. Neither the Collateral Agent nor any other Secured Creditor shall have any obligation to protect, secure, perfect or insure any Lien at any
time held by it as security for any of the Obligations or for the guaranty contained in this Article II or any property subject thereto, except to the extent required by applicable law. 
 Section 2.03. Guaranty Absolute and Unconditional. (a) Each Guarantor waives, to the maximum extent permitted by applicable law, any and
all notice of the creation, renewal, extension or accrual of any 
  

 -5- 

 of the Obligations and notice of or proof of reliance by the Collateral Agent or any other Secured Creditor upon the
guaranty contained in this Article II or acceptance of the guaranty contained in this Article II; each of the Obligations, and any obligation contained therein, shall conclusively be deemed to have been created, contracted or incurred, or renewed,
extended, amended or waived, in reliance upon the guaranty contained in this Article II; and all dealings between the Borrower and any of the other Credit Parties, on the one hand, and the Collateral Agent and the other Secured Creditors, on the
other hand, likewise shall be conclusively presumed to have been had or consummated in reliance upon the guaranty contained in this Article II. Each Guarantor waives, to the maximum extent permitted by applicable law, diligence, presentment,
protest, demand for payment and notice of default or nonpayment to or upon any of the Borrower or any of the other Credit Parties with respect to any of the Obligations. Each Guarantor understands and agrees, to the extent permitted by law, that the
guaranty contained in this Article II shall be construed as a continuing, absolute and unconditional guaranty of payment and not of collection. Each Guarantor hereby waives, to the maximum extent permitted by applicable law, any and all defenses
that it may have arising out of or in connection with any and all of the following: (a) the validity or enforceability of the Credit Agreement or any other Credit Document, any of the Obligations or any other collateral security therefor or
guaranty or right of offset with respect thereto at any time or from time to time held by the Collateral Agent or any other Secured Creditor, (b) any defense, set-off or counterclaim (other than a defense of payment or performance) that may at
any time be available to or be asserted by the Borrower against the Collateral Agent or any other Secured Creditor, (c) any change in the time, place, manner or place of payment or any amendment, waiver or increase in any of the Obligations in
accordance with the terms of the documentation evidencing the same, (d) any exchange, taking, or release of Collateral, (e) any change in the structure or existence of any of the Borrower or any of its Subsidiaries (except in connection
with any release permitted by Section 7.13 hereof or any other liquidation, merger or dissolution permitted by the Credit Agreement), (f) any application of Collateral to any of the Obligations, (g) any law, regulation or order of any
jurisdiction, or any other event, affecting any term of any Obligation or the rights of the Collateral Agent or any other Secured Creditor with respect thereto, including, without limitation: (i) the application of any such law, regulation,
decree or order, including any prior approval, which would prevent the exchange of any currency (other than Dollars) for Dollars or the remittance of funds outside of such jurisdiction or the unavailability of Dollars in any legal exchange market in
such jurisdiction in accordance with normal commercial practice, (ii) a declaration of banking moratorium or any suspension of payments by banks in such jurisdiction or the imposition by such jurisdiction or any Governmental Authority thereof
of any moratorium on, the required rescheduling or restructuring of, or required approval of payments on, any indebtedness in such jurisdiction, (iii) any expropriation, confiscation, nationalization or requisition by such country or any
Governmental Authority that directly or indirectly deprives the Borrower or any other Credit Party of any assets or their use, or of the ability to operate its business or a material part thereof, or (iv) any war (whether or not declared),
insurrection, revolution, hostile act, civil strife or similar events occurring in such jurisdiction which has the same effect as the events described in clause (i), (ii) or (iii) above (in each of the cases contemplated in clauses
(i) through (iv) above, to the extent occurring or existing on or at any time after the date of this Agreement), or (h) any other circumstance whatsoever (other than payment in full in cash of the Obligations (other than inchoate
indemnity obligations) guaranteed by it hereunder) (with or without notice to or knowledge of the Borrower or any other Credit Party) that constitutes, or might be construed to constitute, an equitable or legal discharge of the Borrower or any other
Credit Party for its Obligations, or of such Guarantor under the guaranty contained in this Article II, in bankruptcy or in any other instance. When making any demand hereunder or otherwise pursuing its rights and remedies hereunder against any
Guarantor, the Collateral Agent or any other Secured Creditor may, but shall be under no obligation to, make a similar demand on or otherwise pursue such rights and remedies as it may have against the Borrower, any other Guarantor or any other
Person or against any collateral security or guaranty for the Obligations guaranteed by such Guarantor hereunder or any right of offset with respect thereto, and any failure by the Collateral Agent or any other Secured Creditor to make any such
demand, to pursue such other rights or remedies or to collect any payments from the Borrower, any other Guarantor or any other Person or to realize upon any such collateral security or guaranty or to exercise any such right of offset, or any release
of the Borrower, any other Guarantor or any other Person or any such collateral security, guaranty or right of offset, shall not relieve any Guarantor of any obligation or liability hereunder, and shall not impair or affect the rights and remedies,
whether express, implied or available as a matter of law, of the Collateral Agent or any other Secured Creditor against any Guarantor. For the purposes hereof “demand” shall include the commencement and continuance of any legal
proceedings. 
 (b) Each Guarantor hereby acknowledges and affirms that it understands that to the extent the Obligations are secured by Real
Property located in the State of California, such Guarantor shall be liable for the full amount of the liability hereunder notwithstanding foreclosure on such Real Property by trustee sale or any other reason impairing such Guarantor’s or any
Secured Creditors’ right to proceed against any Borrower, any other Guaranteed Party or any other guarantor of the Obligations. 
  

 -6- 

 (c) Each Guarantor hereby waives (to the fullest extent permitted by applicable law) all rights and
benefits under Section 580a, 580b, 580d and 726 of the California Code of Civil Procedure. Each Guarantor hereby further waives (to the fullest extent permitted by applicable law), without limiting the generality of the foregoing or any other
provision hereof, all rights and benefits which might otherwise be available to such Guarantor under Sections 2809, 2810, 2815, 2819, 2821, 2839, 2845, 2848, 2849, 2850, 2899 and 3433 of the California Civil Code. 
 (d) Until the Obligations (other than inchoate indemnity obligations) have been paid in full in cash, each Guarantor waives its rights of subrogation and
reimbursement and any other rights and defenses available to such Guarantor by reason of Sections 2787 to 2855, inclusive, of the California Civil Code, including, without limitation, (1) any defenses such Guarantor may have to this Guaranty by
reason of an election of remedies by the Secured Creditors and (2) any rights or defenses such Guarantor may have by reason of protection afforded to the Borrower or any Guaranteed Party pursuant to the antideficiency or other laws of
California limiting or discharging such Borrower’s or such other Guaranteed Party’s indebtedness, including, without limitation, Section 580a, 580b, 580d or 726 of the California Code of Civil Procedure. In furtherance of such
provisions, each Guarantor hereby waives all rights and defenses arising out of an election of remedies by the Secured Creditors, even though that election of remedies, such as a nonjudicial foreclosure, destroys such Guarantor’s rights of
subrogation and reimbursement against any Borrower or any other Guaranteed Party by the operation of Section 580d of the California Code of Civil Procedure or otherwise. 
 Section 2.04. Reinstatement. The guaranty of any Guarantor contained in this Article II shall continue to be effective, or be reinstated, as
the case may be, if at any time payment, or any part thereof, of any of the Obligations guaranteed by such Guarantor hereunder is rescinded or must otherwise be restored or returned by the Collateral Agent or any other Secured Creditor upon the
insolvency, bankruptcy, dissolution, liquidation or reorganization of any Borrower or any other Credit Party, or upon or as a result of the appointment of a receiver, intervenor or conservator of, or trustee or similar officer for, any Borrower or
any other Credit Party or any substantial part of its property, or otherwise, all as though such payments had not been made. 
 Section 2.05. Payments. Each Guarantor hereby guarantees that payments hereunder will be paid to the Administrative Agent, for the benefit of the Secured Creditors, without set-off, counterclaim or other defense and on the same
basis as payments are made by the Borrower under Sections 4.03 and 4.04 of the Credit Agreement. 
 Section 2.06. Information.
Each Guarantor assumes all responsibility for being and keeping itself informed of the Borrower’s and each other Credit Party’s financial condition and assets and of all other circumstances bearing upon the risk of nonpayment of the
Obligations and the nature, scope and extent of the risks that such Guarantor assumes and incurs hereunder and agrees that none of the Collateral Agent or the other Secured Creditors will have any duty to advise such Guarantor of information known
to it or any of them regarding such circumstances or risks. 
 ARTICLE III 
 Pledge of Securities 
 Section 3.01. Pledge. As security for the
payment or performance, as applicable, in full of the Obligations, each Grantor hereby grants to the Collateral Agent, its successors and assigns, for the ratable benefit of the Secured Creditors, a security interest in, all of such Grantor’s
right, title and interest in, to and under (a) the Equity Interests of any Person (including, without limitation, the Borrower and each Subsidiary) owned by it on the date hereof or at any time thereafter acquired by it, and in all certificates
at any time representing any such Equity Interests, and any other shares, stock certificates, options or rights of any nature whatsoever in respect of the Equity Interests of any Person that may be issued or granted to, or held by, such Grantor
while this Agreement is in effect (collectively, the “Pledged Stock”); provided that the Pledged Stock shall not include Excess Exempted Foreign Entity Voting Equity; (b) all debt securities and promissory notes held by,
or owed to, such Grantor (whether the respective issuer or obligor is the Borrower, any of its Subsidiaries or any other Person) on the Effective Date or at 
  

 -7- 

 any time thereafter, and all securities, promissory notes and any other instruments evidencing the debt securities or
promissory notes described above (collectively, the “Pledged Debt”); (c) all other property that may be delivered to and held by the Collateral Agent pursuant to the terms of this Section 3.01; (d) subject to
Section 3.05, all payments of principal or interest, dividends, cash, instruments and other property from time to time received, receivable or otherwise distributed in respect of, in exchange for or upon the conversion of, and all other
Proceeds received in respect of, the securities referred to in clauses (a), (b) and (c) above; (e) subject to Section 3.05, all rights and privileges of such Grantor with respect to the securities and other property referred
to in clauses (a), (b), (c) and (d) above; and (f) all Proceeds of any of the foregoing (the items referred to in clauses (a) through (f) above being collectively referred to as the “Pledged
Collateral”). 
 TO HAVE AND TO HOLD the Pledged Collateral, together with all right, title, interest, powers, privileges and
preferences pertaining or incidental thereto, unto the Collateral Agent, its successors and assigns, for the ratable benefit of the Secured Creditors, forever, subject, however, to the terms, covenants and conditions hereinafter set
forth. 
 Section 3.02. Delivery of the Pledged Collateral. (a) Each Grantor represents and warrants that all certificates,
agreements or instruments representing or evidencing the Pledged Stock (the “Closing Date Pledged Collateral”) and the Pledged Debt in existence on the date hereof have been delivered to the Collateral Agent in suitable form for
transfer by delivery or accompanied by duly executed instruments of transfer or assignment in blank. Each Grantor agrees promptly to deliver or cause to be delivered to the Collateral Agent any and all Pledged Stock and all debt securities
constituting Pledged Collateral now owned or hereafter acquired by such Grantor. 
 (b) In addition to the requirements of preceding clause
(a), each Grantor will cause (i) each note issued by the Borrower or any of its Subsidiaries and (ii) each promissory note evidencing any Indebtedness for borrowed money owed to such Grantor by any Person which is in excess of
$250,000 to be delivered to the Collateral Agent. 
 (c) Upon delivery to the Collateral Agent, (i) any Pledged Securities shall be
accompanied by undated stock powers duly executed in blank or other undated instruments of transfer reasonably satisfactory to the Collateral Agent and by such other instruments and documents as the Collateral Agent may reasonably request and
(ii) all other property comprising part of the Pledged Collateral shall be accompanied by proper instruments of assignment duly executed by the applicable Grantor and such other instruments or documents as the Collateral Agent may reasonably
request. Each delivery of Pledged Securities shall be accompanied by a schedule describing such Pledged Securities, which schedule shall be attached as a supplement to Schedule II of the GCA Disclosure Letter and made a part thereof,
provided that failure to attach any such schedule hereto shall not affect the validity of such pledge of such Pledged Securities. Each schedule so delivered shall supplement any prior schedules so delivered. 
 Section 3.03. Representations, Warranties and Covenants. The Grantors jointly and severally represent, warrant and covenant to and with the
Collateral Agent, for the benefit of the Secured Creditors, that: 
 (a) Schedule II of the GCA Disclosure Letter correctly sets forth
the percentage of the issued and outstanding shares (or units or other comparable measure) of each class of the Equity Interests of the issuer thereof represented by the Pledged Stock and includes all Pledged Stock and Pledged Debt; 
 (b) to the knowledge of such Grantor (unless such Pledged Stock and Pledged Debt has been issued by the Borrower or any of its Subsidiaries, in which
case this representation and warranty shall not be qualified by knowledge), the Pledged Stock and Pledged Debt have been duly and validly authorized and issued by the issuers thereof and (i) in the case of Pledged Stock, are fully paid and
nonassessable and (ii) in the case of Pledged Debt, are legal, valid and binding obligations of the issuers thereof, except to the extent that the enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium or other similar laws generally affecting creditors’ rights and by equitable principles (regardless of whether enforcement is sought in equity or at law); 
 (c) except for the security interests granted hereunder, each of the Grantors (i) is and, subject to any transfers made in compliance with the Credit Agreement, will continue to be the direct owner, beneficially

  

 -8- 

 and of record, of the Pledged Securities indicated on Schedule II of the GCA Disclosure Letter as owned by such Grantor,
(ii) holds the same free and clear of all Liens, other than Permitted Liens, (iii) except for transfers permitted under the Credit Agreement, will make no assignment, pledge, hypothecation or transfer of, or create or permit to exist any
security interest in or other Lien on, the Pledged Collateral, other than Permitted Liens, and (iv) will defend its title or interest thereto or therein against any and all Liens (other than Permitted Liens), however arising, of all Persons
whomsoever; 
 (d) except for restrictions and limitations imposed by (i) the Credit Documents, (ii) securities laws generally or
(iii) customary provisions in joint venture agreements relating to purchase options, rights for first refusal, tag, drag, call or similar rights of a third party that owns Equity Interests in such joint venture, the Pledged Collateral is and
will continue to be freely transferable and assignable, and, except as otherwise expressly permitted by the Credit Agreement, none of the Pledged Collateral is or will be subject to any option, right of first refusal, shareholders agreement, charter
or by-law provision or contractual restriction of any nature that might prohibit, impair, delay or otherwise affect the pledge of such Pledged Collateral hereunder, the sale or disposition thereof pursuant hereto or the exercise by the Collateral
Agent of rights and remedies hereunder; 
 (e) each of the Grantors has the power and authority to pledge the Pledged Collateral pledged by
it hereunder in the manner hereby done or contemplated; 
 (f) no consent or approval of any Governmental Authority, any securities exchange
or any other Person was or is necessary to the validity of the pledge effected hereby (other than such as have been obtained and are in full force and effect); 
 (g) by virtue of the execution and delivery by the Grantors of this Agreement, when (x) any Pledged Securities are delivered to the Collateral Agent in accordance with this Agreement or (y) the filing of the
Uniform Commercial Code financing statements with respect to the respective Grantor are made as described in Section 4.02(a), the Collateral Agent will obtain, for the benefit of the Secured Creditors, a legal, valid and perfected lien upon and
security interest in such Pledged Securities as security for the payment and performance of the Obligations to the extent such security interest may be perfected by possession or filing of a Uniform Commercial Code financing statement. 

Section 3.04. Registration in Nominee Name; Denominations. The Collateral Agent, on behalf of the Secured Creditors, shall have the right
(in its sole and absolute discretion) to hold the Pledged Securities in the name of the applicable Grantor, endorsed or assigned in blank or in favor of the Collateral Agent or, upon the occurrence and during the continuation of an Event of Default,
in its own name as pledgee or the name of its nominee (as pledgee or as sub-agent). Each Grantor will promptly give to the Collateral Agent copies of any notices or other communications received by it with respect to Pledged Securities registered in
the name of such Grantor. The Collateral Agent shall at all times upon the occurrence and during the continuation of an Event of Default have the right to exchange the certificates representing Pledged Securities for certificates of smaller or
larger denominations for any purpose consistent with this Agreement. 
 Section 3.05. Voting Rights; Dividends and Interest.
(a) Unless and until an Event of Default shall have occurred and be continuing and the Collateral Agent shall have notified the Grantors that their rights under this Section 3.05 are being suspended: 
 (i) Each Grantor shall be entitled to exercise any and all voting and other consensual rights and powers inuring to an owner of Pledged
Securities or any part thereof for any purpose consistent with the terms in this Agreement, the Credit Agreement and the other Credit Documents, provided that, except as expressly permitted under the Credit Agreement, such rights and powers
shall not be exercised in any manner that would reasonably be expected to materially and adversely affect the rights inuring to a holder of any Pledged Securities or the rights and remedies of any of the Collateral Agent or the other Secured
Creditors under this Agreement or the Credit Agreement or any other Credit Document or the ability of the Secured Creditors to exercise the same. 
 (ii) Each Grantor shall be entitled to receive and retain any and all dividends, interest, principal and other distributions paid on or distributed in respect of the Pledged Securities to the extent and 
  

 -9- 

 only to the extent that such dividends, interest, principal and other distributions are not prohibited by
the terms and conditions of the Credit Agreement, the other Credit Documents and applicable laws, provided that (x) any noncash dividends, interest, principal or other distributions that would constitute Pledged Stock or Pledged Debt,
whether resulting from a subdivision, combination or reclassification of the outstanding Equity Interests of the issuer of any Pledged Securities or received in exchange for Pledged Securities or any part thereof, or in redemption thereof, or as a
result of any merger, consolidation, acquisition or other exchange of assets to which such issuer may be a party or otherwise, shall be and become part of the Pledged Collateral, and, if received by any Grantor, shall not be commingled by such
Grantor with any of its other funds or property but shall be held separate and apart therefrom, shall be held in trust for the benefit of the Collateral Agent and the other Secured Creditors and shall be forthwith delivered to the Collateral Agent
in the same form as so received (with any necessary endorsement as described in Section 3.03(c) or otherwise) and (y) any Article 9 Collateral so received shall be subject to the applicable provisions of Article IV hereof. 
 (b) Upon the occurrence and during the continuation of an Event of Default, after the Collateral Agent shall have notified the Grantors in writing of the
suspension of their rights under paragraph (a)(ii) of this Section 3.05, all rights of any Grantor to dividends, interest, principal or other distributions that such Grantor is authorized to receive pursuant to paragraph (a)(ii) of
this Section 3.05 shall cease, and all such rights shall thereupon become vested in the Collateral Agent, which shall have the sole and exclusive right and authority to receive and retain such dividends, interest, principal or other
distributions. All dividends, interest, principal or other distributions received by any Grantor contrary to the provisions of this Section 3.05 shall be held in trust for the benefit of the Collateral Agent and the other Secured Creditors,
shall be segregated from other property or funds of such Grantor and shall be forthwith delivered to the Collateral Agent upon written demand in the same form as so received (with any necessary endorsement). Any and all money and other property paid
over to or received by the Collateral Agent pursuant to the provisions of this paragraph (b) shall be retained by the Collateral Agent in an account to be established by the Collateral Agent upon receipt of such money or other property and
shall be applied in accordance with the provisions of Section 5.02. 
 (c) Upon the occurrence and during the continuation of an Event
of Default, after the Collateral Agent shall have notified in writing the Grantors of the suspension of their rights under paragraph (a)(i) of this Section 3.05, all rights of any Grantor to exercise the voting and other consensual rights and
powers it is entitled to exercise pursuant to paragraph (a)(i) of this Section 3.05 shall cease, and all such rights shall thereupon become vested in the Collateral Agent, which shall have the sole and exclusive right and authority to
exercise such voting and other consensual rights and powers, provided that, unless otherwise directed by the Required Lenders, the Collateral Agent shall have the right from time to time following and during the continuation of an Event of
Default to permit the Grantors to exercise such rights. After all Events of Default have been cured or waived, the Grantors shall have the right to exercise the voting and consensual rights and powers that they would otherwise be entitled to
exercise pursuant to the terms of paragraph (a)(i) above. 
 (d) Any notice given by the Collateral Agent to the Grantors suspending their
rights under paragraph (a) of this Section 3.05 (i) may be given by telephone if promptly confirmed in writing, (ii) may be given to one or more of the Grantors at the same or different times and (iii) may suspend the rights
of the Grantors under paragraph (a)(i) or paragraph (a)(ii) of this Section 3.05 in part without suspending all such rights (as specified by the Collateral Agent in its sole and absolute discretion) and without waiving or otherwise affecting
the Collateral Agent’s rights to give additional notices from time to time suspending other rights so long as an Event of Default has occurred and is continuing. 
 ARTICLE IV 
 Security Interests in Personal Property 
 Section 4.01. Security Interest. (a) As security for the payment or performance, as applicable, in full of the Obligations, each Grantor
hereby grants to the Collateral Agent, its successors and permitted assigns, for the ratable benefit of the Secured Creditors, a security interest (the “Security Interest”) in all right, title or interest in or to any and all of the
following assets and properties now owned or at any time hereafter acquired by such Grantor 
  

 -10- 

 or in which such Grantor now has or at any time in the future may acquire any right, title or interest (collectively, the
“Article 9 Collateral”): 
 (i) all Accounts; 
 (ii) all Chattel Paper; 
 (iii) all cash and Deposit Accounts; 
 (iv) all Documents; 
 (v) all Goods; 
 (vi) all Equipment; 
 (vii) all General Intangibles; 
 (viii) all Instruments; 
 (ix) all Inventory; 
 (x) all Investment Property; 
 (xi) all Letter of Credit Rights; 
 (xii) all Intellectual Property; 
 (xiii) all Permits; 
 (xiv) all Contracts and all Contract Rights; 
 (xv) the commercial tort claims specified on Schedule IV of the GCA Disclosure Letter or otherwise specified by a Grantor to the Collateral Agent pursuant to Section 4.04(d); 
 (xvi) all books and records pertaining to the Article 9 Collateral; and 
 (xvii) to the extent not otherwise included, all Proceeds and products of any and all of the foregoing and all collateral security,
supporting obligations and guarantees given by any Person with respect to any of the foregoing. 
 Notwithstanding the foregoing, the Article 9 Collateral
shall not include (i) any Equipment that is subject to a purchase money lien or capital lease permitted under the Credit Agreement to the extent the documents relating to such purchase money lien or capital lease would not permit such Equipment
to be subject to the Security Interests created hereby, (ii) any general intangibles or other rights arising under any joint venture agreements to the extent that customary provisions in such agreements governing or entered into by such joint
ventures would not permit such general intangibles or other rights to be subject to the Security Interests created hereby, (iii) any lease, license or other contract if the grant of a security interest therein in the manner contemplated by this
Security Agreement, under the terms thereof or under applicable law, is prohibited or would give any other party thereto (other than a Grantor) the right to terminate such lease, license or other contract; provided that the exclusions in
clauses (ii) and (iii) shall (x) not apply to exclude any rights to receive payments and (y) only apply to the extent that, and for so long as, any such prohibition or termination right would not be rendered ineffective pursuant
to the New York UCC or any other applicable law, (iv) any Deposit Accounts (and the cash and Cash Equivalents therein) specifically and exclusively used for (x) payroll, payroll taxes, and other employee wage and benefit payments to or for
the benefit of any Grantor’s employees and accrued and unpaid employee compensation (including salaries, wages, benefits and expense reimbursements) and (y) all taxes required to be collected or withheld (including, without limitation,
federal 
  

 -11- 

 and state withholding taxes (including the employer’s share thereof), taxes owing to any governmental unit thereof,
sales, use and excise taxes, customs duties, import duties and independent customs brokers’ charges), other taxes for which any Grantor may become liable, (v) any Deposit Accounts (and the cash and Cash Equivalents therein) or Securities
Accounts (and the financial assets therein) specifically and exclusively used as security for standby letters of credit to the extent permitted under Section 9.01(s) of the Credit Agreement; and (vi) any Excess Exempted Foreign Entity
Voting Equity. 
 (b) Each Grantor hereby irrevocably authorizes the Collateral Agent at any time and from time to time to file in any
relevant jurisdiction any financing statements (including fixture filings) with respect to the Collateral or any part thereof and amendments thereto that (i) indicate the Collateral as “all assets” of such Grantor or such other
description as the Collateral Agent may determine and (ii) contain the information required by Article 9 of the Uniform Commercial Code of each applicable jurisdiction for the filing of any financing statement or amendment, including
(A) whether such Grantor is an organization, the type of organization and any organizational identification number, if any, issued to such Grantor and (B) in the case of a financing statement filed as a fixture filing or covering
Collateral constituting minerals or the like to be extracted or timber to be cut, a sufficient description of the real property to which such Collateral relates. Each Grantor agrees to provide such information to the Collateral Agent promptly upon
request. 
 Each Grantor also ratifies its authorization for the Collateral Agent to file in any relevant jurisdiction any financing
statements (including fixture filings, as applicable) or other appropriate filings, recordings or registrations or amendments thereto. 
 The
Collateral Agent is further authorized to file with the United States Patent and Trademark Office or United States Copyright Office (or any successor office or any similar office in any other country) such documents as may be necessary or advisable
for the purpose of perfecting, confirming, continuing, enforcing or protecting the Security Interest granted by each Grantor, without the signature of any Grantor, and naming any Grantor or the Grantors as debtors and the Collateral Agent as secured
party. 
 (c) The Security Interest is granted as security only and shall not subject the Collateral Agent or any other Secured Creditor to,
or in any way alter or modify, any obligation or liability of any Grantor with respect to or arising out of the Collateral. 
 Section 4.02. Representations and Warranties. The Grantors jointly and severally represent and warrant to the Collateral Agent and the other Secured Creditors that: 
 (a) Each Grantor has good and valid rights in and title to the Article 9 Collateral and has full power and authority to grant to the Collateral
Agent, for the ratable benefit of the Secured Creditors, the Security Interest in such Article 9 Collateral pursuant hereto and to execute, deliver and perform its obligations in accordance with the terms in this Agreement, without the consent
or approval of any other Person other than any consent or approval that has been obtained. 
 (b) Attached on Part A of Schedule VII of the
GCA Disclosure Letter is, as of the Initial Borrowing Date, (i) the exact legal name of each Grantor as such name appears in its respective certificate or document of formation, (ii) each other legal name such Grantor has had in the past
five years, including the date of the relevant name change (if any), and (iii) each other name, including trade names and similar appellations, such Grantor or any of its divisions or other business units has used in connection with the conduct
of its business or the ownership of its properties at any time during the past five years. 
 (c) Except as set forth on Part B of Schedule
VII of the GCA Disclosure Letter, as of the Initial Borrowing Date, no Grantor has changed its identity or business structure in any way within the past five years. Changes in identity and business structure include mergers, acquisitions and
consolidations, as well as any change in form, nature or jurisdiction of formation. If any such merger, acquisition or consolidation has occurred, Schedule VII Part B to the GCA Disclosure Letter sets forth the information required by
Section 4.02(b) and (c) as to each acquiree and each other constituent party to such merger, acquisition or consolidation. 
  

 -12- 

 (d) Attached as Part C of Schedule VII of the GCA Disclosure Letter is, as of the Initial Borrowing
Date, the (i) type of organization of each Grantor, the location of each Grantor that is a registered organization, (ii) organizational identification number, if any, of such Grantor, (iii) address (including the county) of the chief
executive office of such Grantor and (iv) the federal taxpayer identification number of each Grantor. 
 (e) Attached as Schedule VIII
of the GCA Disclosure Letter, as of the Initial Borrowing Date, is (i) the name and address of any Person other than a Grantor that has possession of any Collateral (other than Collateral which is in transit or out for repair or maintenance and
Collateral consisting of computer equipment and software in possession of radiologists affiliated with the Grantors or movable computer equipment that has been temporarily removed by employees in the ordinary course of business) and (ii) any
other addresses where a Grantor maintains or has maintained during the previous four months a place of business or any Collateral (other than Accounts and General Intangibles and Collateral consisting of computer and radiology equipment in
possession of radiologists affiliated with the Grantors or movable computer equipment that has been temporarily removed by employees in the ordinary course of business) not otherwise identified on Part C of Schedule VII to the CGA Disclosure Letter.

 (f) Attached as Schedule IV of the GCA Disclosure Letter is, as of the Initial Borrowing Date, a true and correct list of commercial tort
claims held by any Grantor, including a brief description thereof. 
 (g) The Uniform Commercial Code financing statements or other
appropriate filings, recordings or registrations prepared by the Collateral Agent based upon the information provided to the Collateral Agent by the Grantors pursuant to this Agreement for filing in each governmental, municipal or other office
specified in Schedule IX of the GCA Disclosure Letter (or specified by notice from the Borrower to the Collateral Agent after the Effective Date in the case of filings, recordings or registrations required by Section 8.12 of the Credit
Agreement), are all the filings, recordings and registrations (other than (i) filings required to be made in the United States Patent and Trademark Office and the United States Copyright Office, or any other similar state or foreign office in
order to perfect the Security Interest in Article 9 Collateral consisting of Patents, Trademarks (and Trademarks for which registration applications are pending) and registered Copyrights, (ii) registrations required to be made with regard
to any Collateral which is the subject of any certificate of title or similar statute, (iii) filings or notices required to be made under any applicable Assignment of Claims Act (or similar statute) in respect of any Governmental Authority
which is an Account Debtor and (iv) filings pertaining to the perfection of fixtures) that are necessary to publish notice of and protect the validity of and to establish a legal, valid and perfected security interest in favor of the Collateral
Agent, for the ratable benefit of the Secured Creditors, in respect of all Collateral in which a security interest may be perfected by filing, recording or registration in the United States (or any political subdivision thereof) and its territories
and possessions, and no further or subsequent filing, refiling, recording, rerecording, registration or reregistration is necessary in any such jurisdiction, except as provided under applicable law with respect to the filing of continuation
statements or with respect to any changed circumstances requiring an amendment to such filing under applicable law. Each Grantor represents and warrants that a fully executed agreement in the form attached hereto as Exhibit IV, V or VI, as the case
may be, and containing a description of all Article 9 Collateral consisting of Intellectual Property with respect to United States Patents and United States registered Trademarks (and Trademarks for which United States registration applications
are pending) and United States registered Copyrights have been delivered to the Collateral Agent for recording by the United States Patent and Trademark Office and the United States Copyright Office pursuant to 35 U.S.C. § 261,
15 U.S.C. § 1060 or 17 U.S.C. § 205 and the regulations thereunder, as applicable to protect the validity of and to establish a legal, valid and perfected security interest in favor of the Collateral Agent,
for the ratable benefit of the Secured Creditors, in respect of all Article 9 Collateral consisting of United States Patents, United States registered Trademarks (and Trademarks for which United States registration applications are pending) and
United States registered Copyrights in which a security interest may be perfected by filing, recording or registration in the United States Patent and Trademark Office or the United States Copyright Office, as applicable, and no further or
subsequent filing, refiling, recording, rerecording, registration or reregistration is necessary (other than such actions as are necessary to perfect the Security Interest with respect to any Article 9 Collateral consisting of United States Patents,
United States registered Trademarks (and Trademarks for which United States registration applications are pending) and United States registered Copyrights acquired or developed after the date hereof or with respect to any changed circumstances
requiring an amendment to such filing under applicable law). 
  

 -13- 

 (h) The Security Interest constitutes (i) a legal and valid security interest in all the
Article 9 Collateral securing the payment and performance of the Obligations, (ii) subject to the filings described in Section 4.02(g), a perfected security interest in all Article 9 Collateral in which a security interest may be
perfected by filing, recording or registering a financing statement or analogous document in the United States (or any political subdivision thereof) and its territories and possessions pursuant to the Uniform Commercial Code or other applicable law
in such jurisdictions and (iii) a security interest that shall be perfected in all Article 9 Collateral in which a security interest may be perfected by and upon the receipt and recording of a Grant of Security Interest in United States
Trademarks, Patents and Copyrights, as the case may be, in the form (appropriately completed) attached hereto as Exhibits, IV, V and VI, respectively with the United States Patent and Trademark Office and the United States Copyright Office, as
applicable, within the three-month period (commencing as of the date hereof) pursuant to 35 U.S.C. § 261 or 15 U.S.C. § 1060 or the one-month period (commencing as of the date hereof) pursuant to 17 U.S.C.
§ 205 and otherwise as may be required pursuant to the laws of any other necessary jurisdiction. The Security Interest is and shall be prior to any other Lien on any of the Article 9 Collateral, other than Permitted Liens. 

(i) The Article 9 Collateral is owned by the Grantors free and clear of any Lien, except for Permitted Liens. None of the Grantors has filed or
consented to the filing of (i) any financing statement or analogous document under the Uniform Commercial Code or any other applicable laws covering any Collateral, (ii) any assignment intended as security in which any Grantor assigns any
Collateral or any security agreement or similar instrument covering any Article 9 Collateral with the United States Patent and Trademark Office or the United States Copyright Office or (iii) any assignment intended as security in which any
Grantor assigns any Article 9 Collateral or any security agreement or similar instrument covering any Article 9 Collateral with any foreign governmental, municipal or other office, which financing statement or analogous document,
assignment, security agreement or similar instrument is still in effect, except, in each case, for Permitted Liens. 
 Section 4.03.
Covenants. (a) Each Grantor agrees promptly (but in no case more than 15 days) to notify the Collateral Agent in writing of any change (i) in its corporate name, (ii) in the location of its chief executive office or its
principal place of business, (iii) in its identity or type of organization or corporate structure, (iv) in its Federal Taxpayer Identification Number or organizational identification number or (v) in its jurisdiction of organization.
Each Grantor agrees to promptly provide the Collateral Agent with certified organizational documents reflecting any of the changes described in the first sentence of this Section 4.03(a). Each Grantor agrees not to effect or permit any change
referred to in the second preceding sentence unless all filings have been made under the Uniform Commercial Code or otherwise that are required in order for the Collateral Agent to continue at all times following such change to have a valid, legal
and perfected first priority security interest (subject to Permitted Liens) in the Collateral. Each Grantor agrees promptly to notify the Collateral Agent if any portion of the Article 9 Collateral material to a Grantor’s business owned or
held by such Grantor is damaged or destroyed. 
 (b) Each Grantor shall, at its own expense, take any and all actions necessary to defend
title to the Collateral (other than Collateral that is deemed by such Grantor to be immaterial to the conduct of its business) against all Persons claiming any interest adverse to the Collateral Agent or any other Secured Creditor (other than the
holders of Permitted Liens) and to defend the security interests of the Collateral Agent in the Collateral and the priority thereof against any Lien (other than Permitted Liens). Nothing in this Agreement shall prevent any Grantor from discontinuing
the operation or maintenance of any of its assets or properties if such discontinuance is (x) in the judgment of its board of directors, desirable in the conduct of its business and (y) permitted by the Credit Agreement. 
 (c) Each Grantor agrees, at its own expense, to execute, acknowledge, deliver and cause to be duly filed all such further instruments and documents and
take all such actions as the Collateral Agent may from time to time reasonably request to better assure, preserve, protect and perfect the security interests and the rights and remedies created hereby, including the payment of any fees and taxes
required in connection with the execution and delivery of this Agreement, the granting of the security interests hereunder and the filing of any financing statements (including fixture filings) or other documents (including execution of agreements
in the form of Exhibits IV, V and VI attached hereto and filing such agreements with the United States Patent and Trademark Office or United States Copyright Office, as applicable, and any filings or notices required to be made under any applicable
Assignment of Claims Act (or similar statute) in respect of any Governmental Authority which is an Account Debtor) in connection herewith or therewith. If any amount payable to any Grantor under or in connection with any of the Article 9

  

 -14- 

 Collateral shall be or become evidenced by any promissory note or other instrument issued to such Grantor (i) by the
Borrower or any of its Subsidiaries or (ii) by any third Person and the face amount of such promissory note or other instrument is in excess of $250,000, in each such case such note or instrument shall be promptly pledged and delivered to the
Collateral Agent, duly endorsed in a manner reasonably satisfactory to the Collateral Agent. 
 (d) The Collateral Agent and such Persons as
the Collateral Agent may reasonably designate shall have the right to verify under reasonable procedures the validity, amount, quality, quantity, value, condition and status of, or any other matter relating to, the Article 9 Collateral, including
(upon the occurrence and during the continuation of an Event of Default or with the consent of the applicable Grantor), in the case of Accounts or other Article 9 Collateral in the possession of any third person, by contacting Account Debtors
or the third person possessing such Article 9 Collateral for the purpose of making such a verification. Subject to Section 12.16 of the Credit Agreement, the Collateral Agent shall have the absolute right to share any information it gains
from such inspection or verification with any Secured Creditor. 
 (e) At its option, the Collateral Agent may discharge past due Taxes,
assessments, charges, fees or Liens at any time levied or placed on the Collateral and not permitted pursuant to Section 9.01 of the Credit Agreement, and may pay for the maintenance and preservation of the Article 9 Collateral to the
extent any Grantor fails to do so as required by the Credit Agreement or this Agreement, and each Grantor jointly and severally agrees to reimburse the Collateral Agent on demand for any payment made or any expense incurred by the Collateral Agent
pursuant to the foregoing authorization, provided that nothing in this paragraph shall be interpreted as excusing any Grantor from the performance of, or imposing any obligation on the Collateral Agent or any Secured Creditor to cure or
perform, any covenants or other promises of any Grantor with respect to Taxes, assessments, charges, fees, Liens and maintenance as set forth in this Agreement or in the other Credit Documents. 
 (f) If at any time any Grantor shall take a security interest in any property of an Account Debtor or any other Person with a value in excess of $500,000
to secure payment and performance of an Account, such Grantor shall promptly assign such security interest to the Collateral Agent. Such assignment need not be filed of public record unless necessary to continue the perfected status of the security
interest against creditors of and transferees from the Account Debtor or other Person granting the security interest. 
 (g) Each Grantor
shall remain liable to observe and perform all the conditions and material obligations to be observed and performed by it under each contract, agreement or instrument relating to the Collateral, all in accordance with the terms and conditions
thereof. 
 (h) None of the Grantors shall make or permit to be made an assignment, pledge or hypothecation of the Collateral or shall grant
any other Lien in respect of the Collateral, except as permitted by the Credit Agreement. Subject to the immediately following sentence, none of the Grantors shall make or permit to be made any transfer of the Collateral and each Grantor shall
remain at all times in possession of the Collateral owned by it, except (i) as permitted by Sections 9.01 and 9.02 of the Credit Agreement, (ii) for any such Collateral as may be in transit from time to time or out for repair or
maintenance and (iii) for Collateral consisting of computer and radiology equipment in possession of radiologists affiliated with the Grantors or movable computer equipment that is temporarily removed by employees, in each case in the ordinary
course of business. Without limiting the generality of the foregoing, each Grantor agrees that it shall not permit any Inventory to be in the possession or control of any warehouseman, agent, bailee, or processor at any time unless (x) such
Inventory is in transit at such time, (y) the aggregate fair value of the Inventory in the possession of or subject to the control of such Person is less than $350,000 or (z) such Person shall have been notified of the Security Interest
and shall have acknowledged in writing, in form and substance reasonably satisfactory to the Collateral Agent, that such warehouseman, agent, bailee or processor holds the Inventory for the benefit of the Collateral Agent subject to the Security
Interest and shall act upon the instructions of the Collateral Agent without further consent from the Grantor, and that such warehouseman, agent, bailee or processor further agrees to waive and release any Lien held by it with respect to such
Inventory, whether arising by operation of law or otherwise. 
 (i) None of the Grantors will, without the Collateral Agent’s prior
written consent, grant any extension of the time of payment of any Accounts included in the Article 9 Collateral, compromise, compound or settle the same for less than the full amount thereof, release, wholly or partly, any Person liable for
the payment thereof or allow any credit or discount whatsoever thereon, other than compromises, compoundings, settlements and collections made in the ordinary course of business or in accordance with the reasonable business judgment of such Grantor.

  

 -15- 

 (j) The Grantors, at their own expense, shall maintain or cause to be maintained insurance covering
physical loss or damage to the Inventory and Equipment in accordance with the requirements set forth in Section 8.03 of the Credit Agreement. Each Grantor irrevocably makes, constitutes and appoints the Collateral Agent (and all officers,
employees or agents designated by the Collateral Agent) as such Grantor’s true and lawful agent (and attorney-in-fact) for the purpose, upon the occurrence and during the continuation of an Event of Default, of making, settling and adjusting
claims in respect of Article 9 Collateral under policies of insurance, endorsing the name of such Grantor on any check, draft, instrument or other item of payment for the proceeds of such policies of insurance and for making all determinations
and decisions with respect thereto. In the event that any Grantor at any time or times shall fail to obtain or maintain any of the policies of insurance required under the Credit Agreement or to pay any premium in whole or part relating thereto, the
Collateral Agent may, without waiving or releasing any obligation or liability of the Grantors hereunder or any Event of Default, in its sole reasonable discretion, obtain and maintain such policies of insurance and pay such premium and take any
other actions with respect thereto as the Collateral Agent deems advisable. All sums disbursed by the Collateral Agent in connection with this paragraph, including reasonable attorneys’ fees, court costs, out-of-pocket expenses and other
charges relating thereto, shall be payable, upon demand, by the Grantors to the Collateral Agent and shall be additional Obligations secured hereby. 
 Section 4.04. Other Actions. In order to insure the attachment, perfection and priority of, and the ability of the Collateral Agent to enforce, the Security Interest in accordance with the terms hereof,
each Grantor agrees, in each case at such Grantor’s own expense, to take the following actions with respect to the following Article 9 Collateral: 
 (a) Instruments and Tangible Chattel Paper. Each Grantor represents and warrants that each Instrument and each item of Tangible Chattel Paper with a value in excess of $250,000 in existence on the date hereof
has been properly endorsed, assigned and delivered to the Collateral Agent, accompanied by instruments of transfer or assignment duly executed in blank. If any Grantor shall at any time hold or acquire any Instruments or Chattel Paper with a value
in excess of $250,000, such Grantor shall forthwith endorse, assign and deliver the same to the Collateral Agent, accompanied by such undated instruments of transfer or assignment duly executed in blank as the Collateral Agent may from time to time
reasonably request. 
 (b) Electronic Chattel Paper and Transferable Records. If any Grantor at any time holds or acquires an interest
in any electronic chattel paper or any “transferable record,” as that term is defined in Section 201 of the Federal Electronic Signatures in Global and National Commerce Act, or in Section 16 of the Uniform Electronic
Transactions Act as in effect in any relevant jurisdiction, such Grantor shall promptly notify the Collateral Agent thereof and, at the request of the Collateral Agent, shall take such action as the Collateral Agent may reasonably request to vest in
the Collateral Agent control under New York UCC Section 9-105 of such electronic chattel paper or control under Section 201 of the Federal Electronic Signatures in Global and National Commerce Act or, as applicable, Section 16 of
the Uniform Electronic Transactions Act, as in effect in such jurisdiction, of such transferable record; provided that no Grantor shall be required to take any action described above in this clause (b) unless the aggregate amount payable to the
Grantors evidenced by Electronic Chattel Paper or any transferable record in which the Collateral Agent has not been vested control within the meaning of the statutes described above in this clause (b) exceeds $250,000. The Collateral Agent
agrees with such Grantor that the Collateral Agent will arrange, pursuant to procedures reasonably satisfactory to the Collateral Agent and so long as such procedures will not result in the Collateral Agent’s loss of control, for the Grantor to
make alterations to the electronic chattel paper or transferable record permitted under UCC Section 9-105 or, as applicable, Section 201 of the Federal Electronic Signatures in Global and National Commerce Act or Section 16 of the
Uniform Electronic Transactions Act for a party in control to allow without loss of control, unless an Event of Default has occurred and is continuing or would occur after taking into account any action by such Grantor with respect to such
electronic chattel paper or transferable record. 
 (c) Letter-of-Credit Rights. If any Grantor is at any time a beneficiary under a
letter of credit now or hereafter issued in favor of such Grantor in an amount in excess of $250,000, such Grantor shall promptly notify the Collateral Agent thereof and, at the request and option of the Collateral Agent, such Grantor shall,
pursuant to an agreement in form and substance reasonably satisfactory to the Collateral Agent, use commercially 
  

 -16- 

 reasonable efforts to either (i) arrange for the issuer and any confirmer of such letter of credit to consent to an
assignment to the Collateral Agent of the proceeds of any drawing under such letter of credit or (ii) arrange for the Collateral Agent to become the transferee beneficiary of such letter of credit, with the Collateral Agent agreeing, in each
case, that the proceeds of any drawing under such letter of credit are to be paid to the applicable Grantor unless an Event of Default has occurred or is continuing. 
 (d) Commercial Tort Claims. If any Grantor shall at any time hold or acquire a commercial tort claim in an amount reasonably estimated to exceed $250,000, the Grantor shall promptly notify the Collateral Agent
thereof in a writing signed by such Grantor including a summary description of such claim and grant to the Collateral Agent, for the ratable benefit of the Secured Creditors, in such writing a security interest therein and in the proceeds thereof,
all upon the terms of this Agreement, with such writing to be in form and substance reasonably satisfactory to the Collateral Agent. 
 Section 4.05. Covenants Regarding Patent, Trademark and Copyright Collateral. (a) Each Grantor agrees that it will not do any act or omit to do any act (and will exercise commercially reasonable efforts to prevent its
licensees from doing any act or omitting to do any act) whereby any Patent that is material to the conduct of the Grantors’ business (taken as a whole) would become invalidated or dedicated to the public, and agrees that it shall continue to
mark any products covered by a Patent with the relevant patent number as necessary and sufficient in its reasonable judgment to establish and preserve its material rights under applicable patent laws. 
 (b) Each Grantor (either itself or through its licensees or its sublicensees) will, for each Trademark material to the conduct of the Grantors’
business (taken as a whole), (i) maintain such Trademark in full force free from any claim of abandonment or invalidity for non-use, (ii) use commercially reasonable efforts to maintain the quality of products and services offered under
such Trademark, (iii) display such Trademark with notice of Federal or foreign registration (or, if such Trademark is unregistered, display such Trademark with notice as required for unregistered Trademarks) to the extent necessary and
sufficient in its reasonable judgment to establish and preserve its material rights under applicable law and (iv) not knowingly use or knowingly permit the use of such Trademark in any violation of any third party rights. 
 (c) Each Grantor (either itself or through its licensees or sublicensees) will, for each work covered by a Copyright material to the conduct of the
Grantors’ business (taken as a whole), continue to publish, reproduce, display, adopt and distribute the work with appropriate copyright notice as necessary and sufficient in its reasonable judgment to establish and preserve its material rights
under applicable copyright laws. 
 (d) Each Grantor shall notify the Collateral Agent promptly if it knows that any Patent, Trademark or
Copyright material to the conduct of the Grantors’ business (taken as a whole) could reasonably be expected to become abandoned, lost or dedicated to the public, or of any materially adverse determination or development (including the
institution of, or any such determination or development in, any proceeding in the United States Patent and Trademark Office, United States Copyright Office or any court or similar office of any country) regarding such Grantor’s ownership of
any such Patent, Trademark or Copyright, its right to register the same, or its right to keep and maintain the same. 
 (e) In no event shall
any Grantor, either itself or through any agent, employee, licensee or designee, file an application with respect to any Patent, Trademark or Copyright with the United States Patent and Trademark Office or the United States Copyright Office or in
any other country or any political subdivision thereof, unless it promptly thereafter informs the Collateral Agent and, upon request of the Collateral Agent, executes and delivers any and all agreements, instruments, documents and papers as the
Collateral Agent may reasonably request to evidence the Collateral Agent’s security interest in such Patent, Trademark or Copyright, and each Grantor hereby appoints the Collateral Agent as its attorney-in-fact to execute and file such writings
as are reasonably necessary for the foregoing purposes, all acts of such attorney being hereby ratified and confirmed; such power, being coupled with an interest, is irrevocable until such time as when the Total Commitment has terminated and the
Loans and Notes (in each case together with interest thereon), Fees and all other Obligations (other than indemnities described in Section 7.03 and in the other provisions of the Credit Documents which are not then due and payable) incurred
hereunder and under the other Credit Documents are paid in full. 
  

 -17- 

 (f) Each Grantor will take all reasonably necessary steps that are consistent with the practice in any
proceeding before the United States Patent and Trademark Office, United States Copyright Office or any office or agency in any political subdivision of the United States or in any other country or any political subdivision thereof, to maintain and
pursue each registration or application that is material to the conduct of the Grantors’ business (taken as a whole) relating to the Patents, Trademarks and/or Copyrights (and to obtain the relevant grant or registration) and to maintain each
issued Patent and each registration of the Trademarks and Copyrights that is material to the conduct of the Grantors’ business (taken as a whole) in such Grantor’s reasonable judgment, including timely filings of applications for renewal,
affidavits of use, affidavits of incontestability and payment of maintenance fees, and, if consistent with good business judgment, to initiate opposition, interference and cancellation proceedings against third parties. 
 (g) In the event that any Grantor knows that any Article 9 Collateral consisting of a Patent, Trademark or Copyright material to the conduct of the
Grantors’ business (taken as a whole) has been infringed, misappropriated or diluted by a third party, such Grantor promptly shall notify the Collateral Agent and shall, if consistent with good business judgment, promptly sue for infringement,
misappropriation or dilution and to recover any and all damages for such infringement, misappropriation or dilution (and take any actions required by applicable law prior to instituting such suit), and take such other actions as are appropriate
under the circumstances to protect such Article 9 Collateral. Nothing in this Agreement shall prevent any Grantor from discontinuing the use or maintenance of any Article 9 Collateral consisting of a Patent, Trademark or Copyright, or
require any Grantor to pursue any claim of infringement, misappropriation or dilution, if (x) such Grantor so determines in its good business judgment or (y) it is not prohibited by the Credit Agreement. 
 (h) Upon and during the continuation of an Event of Default, each Grantor shall, at the reasonable request of the Collateral Agent, use its commercially
reasonable efforts to obtain all requisite consents or approvals by the licensor of each Copyright License, Patent License or Trademark License to effect the assignment of all such Grantor’s right, title and interest thereunder to the
Collateral Agent or its designee. 
 Section 4.06. Cash Management System and Securities Accounts. 
 (a) Deposit Accounts. As of the date hereof each Grantor has neither opened nor maintains any Deposit Accounts other than the accounts listed on
Schedule V of the GCA Disclosure Letter. From and after the date occurring 60 days from the date hereof, or in the case of any Deposit Account which was an Excluded Account but ceases to constitute same, 30 days after such cessation, or in each
case, such longer period as is acceptable to the Collateral Agent, each of the Deposit Accounts of each Grantor shall be subject to the terms of a fully executed Deposit Account Control Agreement. No Grantor shall hereafter establish or maintain any
Deposit Account unless (1) the applicable Grantor shall have given the Collateral Agent 15 days’ prior written notice (or such shorter period as is agreed by the Collateral Agent) of its intention to establish such new Deposit Account with
a Bank and (2) such Bank and such Grantor shall have duly executed and delivered to the Collateral Agent a Deposit Account Control Agreement with respect to such Deposit Account. The Collateral Agent agrees with each Grantor that the Collateral
Agent shall not give any instructions directing the disposition of funds from time to time credited to any Deposit Account or withhold any withdrawal rights from such Grantor with respect to funds from time to time credited to any Deposit Account or
give any notice of sale or exclusive control over any Deposit Accounts except upon the occurrence and during the continuation of an Event of Default. No Grantor shall grant Control of any Deposit Account to any person other than the Collateral
Agent. The provisions of this Section 4.06 shall not apply to (1) any Deposit Accounts for which the Collateral Agent is the Bank, (2) any Deposit Account of the type described in clause (iv) or (v) of the last
paragraph of Section 4.01(a), (3) any Deposit Accounts which individually, or in the aggregate, do not have more than $10,000 on deposit therein for any period of more than five Business Days, (4) any Medicare Deposit Account until
such time, if any, as a change in applicable anti-assignment laws or regulations relating to Medicare and Medicaid receivables permits the relevant Grantor to enter into a Deposit Account Control Agreement with respect to such Medicare Deposit
Account without violating such laws or regulations and (5) Deposit Accounts held at ANZ Bank in Sydney, Australia in the name of the NightHawk Radiology Services, LLC, account numbers 1981-94604 and 9858-94802, together with any other Deposit
Account in the name of a Grantor maintained with a Bank located in Australia, so long as the aggregate amount of cash held in all such Deposit Accounts does not exceed the Australian Account Cap (each an “Excluded Account”). Each
Grantor agrees to cause all funds in all Medicare Deposit Accounts to be swept on a daily basis to a Deposit Account which is (or will be within 60 days of the date hereof or such longer period as the Administrative Agent may agree) subject to a
Deposit Account Control Agreement. 
  

 -18- 

 (b) Securities Accounts. As of the date
hereof each Grantor has no Securities Accounts other than those listed in Schedule VI of the GCA Disclosure Letter. From and after the date occurring 60 days from the date hereof (or such longer period as is acceptable to the Collateral Agent), the
Collateral Agent shall have a perfected first priority security interest in such Securities Accounts by Control. No Grantor shall hereafter establish and maintain any Securities Account with any Securities Intermediary unless (1) the applicable
Grantor shall have given the Collateral Agent 15 days’ prior written notice (or such shorter period as is agreed by the Collateral Agent) of its intention to establish such new Securities Account with such Securities Intermediary and
(2) except with respect to accounts of the type described in clause (v) of the last paragraph of Section 4.01(a), such Securities Intermediary and such Grantor shall have duly executed and delivered a Control Agreement with respect to
such Securities Account. Each Grantor shall (i) accept any cash and Investment Property (other than Excess Exempted Foreign Entity Voting Equity Interests) in trust for the benefit of the Collateral Agent and (ii) from and after the
60th day following the Initial Borrowing Date (or, if the requirements set forth in the second sentence of
Section 4.01(a) above have been satisfied prior to such date, such earlier date), deposit within five (5) Business Days of actual receipt thereof any and all cash and Investment Property (other than (x) cash deposited into a Deposit
Account of the type described in clause (2) or (3) of the penultimate sentence of Section 4.06(a) or a Securities Account described in clause (v) of the last paragraph of Section 4.01(a), (y) any Investment Property
pledged and delivered to the Collateral Agent pursuant to Section 3.02 and (z) any Excess Exempted Foreign Entity Voting Equity Interest) received by it into a Deposit Account or Securities Account subject to Collateral Agent’s
Control. The Collateral Agent agrees with each Grantor that the Collateral Agent shall not give any Entitlement Orders or instructions or directions to any issuer of uncertificated securities or Securities Intermediary, and shall not withhold its
consent to the exercise of any withdrawal or dealing rights by such Grantor, unless an Event of Default has occurred and is continuing or, after giving effect to any such investment and withdrawal rights, would occur. No Grantor shall grant control
over any Investment Property to any Person other than the Collateral Agent. 
 Section 4.07. Certain Uncertificated Securities.
In the event that any of the Pledged Collateral consists of limited liability company interests or partnership interests that are uncertificated securities for the purposes of the UCC, then the respective Grantor that owns such Pledged Collateral
shall cause (or, in the case of any issuer which is not a Subsidiary of such Grantor, use commercially reasonable efforts to cause) the issuer thereof to duly authorize, execute and deliver to the Collateral Agent an agreement for the benefit of the
Collateral Agent and the other Secured Creditors substantially in the form of Exhibit VII hereto. 
 ARTICLE V 
 Remedies 
 Section 5.01.
Remedies upon Default. Upon the occurrence and during the continuation of an Event of Default, each Grantor agrees to deliver each item of Collateral to the Collateral Agent on demand, and it is agreed that the Collateral Agent shall have the
right to take any of or all the following actions at the same or different times: (a) with respect to any Article 9 Collateral consisting of Intellectual Property, on demand, to cause the Security Interest to become an assignment, transfer
and conveyance of any of or all such Article 9 Collateral by the applicable Grantors to the Collateral Agent, for the ratable benefit of the Secured Creditors, or to license or sublicense, whether general, special or otherwise, and whether on
an exclusive or nonexclusive basis, any such Article 9 Collateral throughout the world on such terms and conditions and in such manner as the Collateral Agent shall determine (other than in violation of any then-existing licensing arrangements
to the extent that waivers cannot be obtained), and (b) with or without legal process and with or without prior notice or demand for performance, to take possession of the Article 9 Collateral and without liability for trespass to enter
any premises where the Article 9 Collateral may be located for the purpose of taking possession of or removing the Article 9 Collateral and, generally, to exercise any and all rights afforded to a secured party under the Uniform Commercial
Code or other applicable law. Without limiting the generality of the foregoing, each Grantor agrees that the Collateral Agent shall have the right, subject to the mandatory requirements of applicable law, to sell or otherwise dispose of all or any
part of the Collateral at a public or private sale or at any broker’s board or on any securities exchange, for cash, upon credit or for future delivery as the Collateral Agent shall deem appropriate. Each such purchaser at any sale of
Collateral shall hold the property sold absolutely, free from any claim or right on the part of any Grantor, and each Grantor hereby waives (to the extent permitted by law) all rights of redemption, stay and appraisal that such Grantor now has or
may at any time in the future have under any rule of law or statute now existing or hereafter enacted. 
  

 -19- 

 The Collateral Agent shall give the applicable Grantors 10 days’ written notice (which each
Grantor agrees is reasonable notice within the meaning of Section 9-611 of the New York UCC or its equivalent in other jurisdictions) of the Collateral Agent’s intention to make any sale of Collateral. Such notice, in the case of a
public sale, shall state the time and place for such sale and, in the case of a sale at a broker’s board or on a securities exchange, shall state the board or exchange at which such sale is to be made and the day on which the Collateral, or
portion thereof, will first be offered for sale at such board or exchange. Any such public sale shall be held at such time or times within ordinary business hours and at such place or places as the Collateral Agent may fix and state in the notice
(if any) of such sale. At any such sale, the Collateral, or portion thereof, to be sold may be sold in one lot as an entirety or in separate parcels, as the Collateral Agent may determine in its sole and absolute discretion. The Collateral Agent
shall not be obligated to make any sale of any Collateral if it shall determine not to do so, regardless of the fact that notice of sale of such Collateral shall have been given. The Collateral Agent may, without notice or publication, adjourn any
public or private sale or cause the same to be adjourned from time to time by announcement at the time and place fixed for sale, and such sale may, without further notice, be made at the time and place to which the same was so adjourned. In case any
sale of all or any part of the Collateral is made on credit or for future delivery, the Collateral so sold may be retained by the Collateral Agent until the sale price is paid by the purchaser or purchasers thereof, but the Collateral Agent and the
other Secured Creditors shall not incur any liability in case any such purchaser or purchasers shall fail to take up and pay for the Collateral so sold and, in case of any such failure, such Collateral may be sold again upon like notice. At any
public (or, to the extent permitted by law, private) sale made pursuant to this Agreement, any Secured Creditor may bid for or purchase, free (to the extent permitted by law) from any right of redemption, stay, valuation or appraisal on the part of
any Grantor (all said rights being also hereby waived and released to the extent permitted by law), the Collateral or any part thereof offered for sale and may make payment on account thereof by using any claim then due and payable to such Secured
Creditor from any Grantor as a credit against the purchase price, and such Secured Creditor may, upon compliance with the terms of sale, hold, retain and dispose of such property without further accountability to any Grantor therefor. For purposes
hereof, a written agreement to purchase the Collateral or any portion thereof shall be treated as a sale thereof; the Collateral Agent shall be free to carry out such sale pursuant to such agreement and no Grantor shall be entitled to the return of
the Collateral or any portion thereof subject thereto, notwithstanding the fact that after the Collateral Agent shall have entered into such an agreement, all Events of Default shall have been remedied and the Obligations paid in full. As an
alternative to exercising the power of sale herein conferred upon it, the Collateral Agent may proceed by a suit or suits at law or in equity to foreclose this Agreement and to sell the Collateral or any portion thereof pursuant to a judgment or
decree of a court or courts having competent jurisdiction or pursuant to a proceeding by a court-appointed receiver. Any sale pursuant to the provisions of this Section 5.01 shall be deemed to conform to the commercially reasonable standards as
provided in Section 9-610(b) of the New York UCC or its equivalent in other jurisdictions. 
 Section 5.02. Application of
Proceeds. (a) The Collateral Agent shall apply the proceeds of any collection or sale of Collateral pursuant to this Article V, including any Collateral consisting of cash, as follows: 
 FIRST, to the payment of all costs and expenses incurred by, and all indemnity and fee obligations owed to, the Collateral Agent and the
Administrative Agent in connection with such collection or sale or otherwise in connection with, or pursuant to, this Agreement, any other Credit Document or any of the Obligations, including all court costs and the fees and expenses of its agents
and legal counsel, the repayment of all advances made by the Collateral Agent hereunder or under any other Credit Document on behalf of any Grantor and any other costs or expenses incurred in connection with the exercise of any right or remedy
hereunder or under any other Credit Document; 
 SECOND, to the extent proceeds remain after the application pursuant to the
preceding clause FIRST, an amount equal to the outstanding Primary Obligations shall be paid to the Secured Creditors as provided in Section 5.02(d) hereof, with each Secured Creditor receiving an amount equal to its outstanding Primary
Obligations or, if the proceeds are insufficient to pay in full all such Primary Obligations, its Pro Rata Share of the amount remaining to be distributed; 
  

 -20- 

 THIRD, to the extent proceeds remain after the application pursuant to the preceding
clauses FIRST and SECOND, inclusive, an amount equal to the outstanding Secondary Obligations shall be paid to the Secured Creditors as provided in Section 5.02(d) hereof, with each Secured Creditor receiving an amount equal to its outstanding
Secondary Obligations or, if the proceeds are insufficient to pay in full all such Secondary Obligations, its Pro Rata Share of the amount remaining to be distributed; and 
 FOURTH, to the extent proceeds remain after the application pursuant to the preceding clauses FIRST through THIRD, inclusive, and
following the termination of the security interests created pursuant to this Agreement in accordance with the express provisions of Section 7.13(a) hereof, to the relevant GRANTOR or to whomever may be lawfully entitled to receive such surplus.

 (b) For purposes of this Agreement, (x) “Pro Rata Share” shall mean, when calculating a Secured Creditor’s
portion of any distribution or amount, that amount (expressed as a percentage) equal to a fraction the numerator of which is the then unpaid amount of such Secured Creditor’s Primary Obligations or Secondary Obligations, as the case may be, and
the denominator of which is the then outstanding amount of all Primary Obligations or Secondary Obligations, as the case may be, (y) “Primary Obligations” shall mean (i) in the case of the Credit Document Obligations, all
principal of, premium, fees and interest on, all Loans and all regularly accruing fees payable under the Credit Agreement and (ii) in the case of the Obligations under or with respect to Interest Rate Protection Agreements and the Other Hedging
Agreements, all amounts due under each Interest Rate Protection Agreement or Other Hedging Agreement to a Secured Creditor (other than indemnities, fees (including, without limitation, attorneys’ fees) and similar obligations and liabilities)
and (z) “Secondary Obligations” shall mean all Obligations other than Primary Obligations. 
 (c) When payments to
Secured Creditors are based upon their respective Pro Rata Shares, the amounts received by such Secured Creditors hereunder shall be applied (for purposes of making determinations under this Section 5.02 only) (i) first, to their Primary
Obligations and (ii) second, to their Secondary Obligations. 
 (d) All payments required to be made hereunder shall be made (x) if
to the Lenders, to the Administrative Agent for the account of the Lenders and (y) if to any Secured Creditor in respect of an Interest Rate Protection Agreement or Other Hedging Agreement, to the trustee, paying agent or other similar
representative (each, a “Representative”) for such Secured Creditor or, in the absence of such a Representative, directly to the relevant Secured Creditor. 
 (e) For purposes of applying payments received in accordance with this Section 5.02, the Collateral Agent shall be entitled to rely upon
(i) the Administrative Agent and (ii) the Representative or, in the absence of such a Representative, upon the respective Secured Creditors for a determination (which the Administrative Agent, each Representative and the respective Secured
Creditors agree (or shall agree) to provide upon request of the Collateral Agent) of the outstanding Primary Obligations and Secondary Obligations owed to the Lenders or the other Secured Creditors, as the case may be. Unless it has received written
notice from a Lender or another Secured Creditor to the contrary, the Administrative Agent and each Representative, in furnishing information pursuant to the preceding sentence, and the Collateral Agent, in acting hereunder, shall be entitled to
assume that no Secondary Obligations are outstanding. Unless it has written notice from a Secured Creditor to the contrary, the Collateral Agent, in acting hereunder, shall be entitled to assume that no Interest Rate Protection Agreements or Other
Hedging Agreements secured hereunder are in existence. 
 (f) It is understood that the Grantors shall remain jointly and severally liable to
the extent of any deficiency between the amount of the proceeds of the Collateral and the aggregate amount of the Obligations. 
 The Collateral Agent shall
have sole and absolute discretion as to the time of application of any such proceeds, moneys or balances in accordance with this Agreement. Upon any sale of Collateral by the Collateral Agent (including pursuant to a power of sale granted by statute
or under a judicial proceeding), the receipt of the Collateral Agent or of the officer making the sale shall be a sufficient discharge to the purchaser or purchasers of the Collateral so sold and such purchaser or purchasers shall not be obligated
to see to the application of any part of the purchase money paid over to the Collateral Agent or such officer or be answerable in any way for the misapplication thereof. 
  

 -21- 

 Section 5.03. Grant of License To Use Intellectual Property. For the purpose of enabling the
Collateral Agent to exercise rights and remedies under this Agreement at such time as the Collateral Agent shall be lawfully entitled to exercise such rights and remedies, each Grantor hereby grants to (in the Collateral Agent’s sole
discretion) a designee of the Collateral Agent or the Collateral Agent an irrevocable, nonexclusive license (exercisable without payment of royalty or other compensation to the Grantors) to use, license or sublicense any of the Article 9
Collateral consisting of Intellectual Property now owned or hereafter acquired by such Grantor, and wherever the same may be located, and including in such license reasonable access to all media in which any of the licensed items may be recorded or
stored and to all computer software and programs used for the compilation or printout thereof; provided that such license shall be revocable after such time as when the Total Commitment has terminated and the Loans and Notes (in each case together
with interest thereon), Fees and all other Obligations (other than indemnities described in Section 7.03 and the other provisions of the Credit Documents which are not then due and payable) incurred hereunder and thereunder, are paid in full.
The use of such license by the Collateral Agent shall be exercised, at the option of the Collateral Agent, only upon the occurrence and during the continuation of an Event of Default, provided that any license, sublicense or other transaction
entered into by the Collateral Agent in accordance herewith shall be binding upon the Grantors notwithstanding any subsequent cure of an Event of Default. 
 Section 5.04. Securities Act. In view of the position of the Grantors in relation to the Pledged Stock, or because of other current or future circumstances, a question may arise under the Securities Act of
1933, as now or hereafter in effect, or any similar statute hereafter enacted analogous in purpose or effect (such Act and any such similar statute as from time to time in effect being called the “Federal Securities Laws”) with
respect to any disposition of the Pledged Stock permitted hereunder. Each Grantor understands that compliance with the Federal Securities Laws might very strictly limit the course of conduct of the Collateral Agent if the Collateral Agent were to
attempt to dispose of all or any part of the Pledged Stock, and might also limit the extent to which or the manner in which any subsequent transferee of any Pledged Stock could dispose of the same. Similarly, there may be other legal restrictions or
limitations affecting the Collateral Agent in any attempt to dispose of all or part of the Pledged Stock under applicable Blue Sky or other state securities laws or similar laws analogous in purpose or effect. Each Grantor recognizes that in light
of such restrictions and limitations the Collateral Agent may, with respect to any sale of the Pledged Stock, limit the purchasers to those who will agree, among other things, to acquire such Pledged Stock for their own account, for investment, and
not with a view to the distribution or resale thereof. Each Grantor acknowledges and agrees that in light of such restrictions and limitations, the Collateral Agent, in its sole and absolute discretion (a) may proceed to make such a sale
whether or not a registration statement for the purpose of registering such Pledged Stock or part thereof shall have been filed under the Federal Securities Laws and (b) may approach and negotiate with a single potential purchaser to effect
such sale. Each Grantor acknowledges and agrees that any such sale might result in prices and other terms less favorable to the seller than if such sale were a public sale without such restrictions. In the event of any such sale, the Collateral
Agent shall incur no responsibility or liability for selling all or any part of the Pledged Stock at a price that the Collateral Agent, in its sole and absolute discretion, may in good faith deem reasonable under the circumstances, notwithstanding
the possibility that a substantially higher price might have been realized if the sale were deferred until after registration as aforesaid or if more than a single purchaser were approached. The provisions of this Section 5.04 will apply
notwithstanding the existence of a public or private market upon which the quotations or sales prices may exceed substantially the price at which the Collateral Agent sells the Pledged Stock. 
 Section 5.05. Medicare/Medicaid. The parties hereto understand and agree that the exercise of remedies hereunder with respect to Medicare and
Medicaid receivables may be subject to applicable federal laws. 
 ARTICLE VI 
 Indemnity, Subrogation and Subordination 
 Section 6.01. Indemnity and
Subrogation. In addition to all rights of indemnity and subrogation as the Guarantors may have under applicable law (but in each case subject to Section 6.03), the Borrower agrees that (a) in the event a payment of any Obligation shall
be made by any Guarantor under this Agreement, the Borrower shall indemnify such Guarantor for the full amount of such payment and such Guarantor shall be subrogated to the rights of the Person to whom such payment shall have been made to the extent
of such payment and (b) in the event any assets of any Grantor shall be sold pursuant to this Agreement or any other Security Document to satisfy in whole or in part any Obligation owed to any Secured Creditor, the Borrower shall indemnify such
Grantor in an amount equal to the fair value of the assets so sold. 
  

 -22- 

 Section 6.02. Contribution and Subrogation. Each Guarantor and Grantor other than the
Borrower (each a “Contributing Party”) agrees (subject to Section 6.03) that to the extent that a Subsidiary Credit Party shall have paid more than its proportionate share (based, to the maximum extent permitted by law, on the
respective Adjusted Net Worths of the Subsidiary Credit Parties on the date the respective payment is made) of any payment made hereunder (whether as Guarantor and/or Grantor hereunder, with proceeds of the Collateral of any Grantor applied
hereunder deemed for this purpose to be payments made by it), such Subsidiary Credit Party shall be entitled to seek and receive contribution from and against any other Subsidiary Credit Party hereunder that has not paid its proportionate share of
such payment. Each Subsidiary Credit Party’s right of contribution shall be subject to the terms and conditions of Section 6.03. Notwithstanding anything to the contrary contained above, any Guarantor that is released from this Agreement
(and its guarantees contained herein) in accordance with the express provisions of Section 7.13(b) shall thereafter have no contribution obligations, or rights, pursuant to this Section 6.02, and at the time of any such release, the
contribution rights and obligations of the remaining Guarantors shall be recalculated on the respective date of release (as otherwise provided herein) based on the payments made hereunder by the remaining Guarantors. The provisions of this
Section 6.02 shall in no respect limit the obligations and liabilities of any Guarantor or Grantor to the Collateral Agent and the other Secured Creditors, and each Guarantor shall remain liable to the Collateral Agent and the other Secured
Creditors for the full amount guaranteed by such Guarantor hereunder. 
 Section 6.03. Subordination. Notwithstanding any
provision in this Agreement to the contrary, all rights of the Guarantors and Grantors under Sections 6.01 and 6.02 and all other rights of indemnity, contribution or subrogation under applicable law or otherwise shall be fully subordinated to
the indefeasible payment in full in cash of the Obligations, and no Credit Party shall be entitled to be subrogated to any of the rights of the Collateral Agent or any other Secured Creditor against the Borrower or any other Credit Party or any
collateral security or guaranty or right of offset held by the Collateral Agent or any other Secured Creditor for the payment of any of the Obligations, nor shall any Credit Party seek or be entitled to seek any contribution or reimbursement from
the Borrower or any other Credit Party in respect of payments made by such Credit Party hereunder (or paid with proceeds of collateral of such Credit Party hereunder), until all amounts owing to the Collateral Agent and the other Secured Creditors
on account of the Obligations are paid in full in cash and the Total Commitment has been terminated. If any amount shall be paid to any Credit Party on account of such contribution or subrogation rights at any time when all of the Obligations shall
not have been paid in full in cash or any of the Commitments shall remain in effect, such amount shall be held by such Credit Party in trust for the Collateral Agent and the other Secured Creditors, segregated from other funds of such Credit Party,
and shall, forthwith upon receipt by such Credit Party, be turned over to the Collateral Agent in the exact form received by such Credit Party (duly indorsed by such Credit Party to the Collateral Agent, if required), to be held as collateral
security for all of the Obligations (whether matured or unmatured) of, or guaranteed by, such Credit Party and/or then or at any time thereafter may be applied against any Obligations, whether matured or unmatured, in such order as the Collateral
Agent may determine. 
 ARTICLE VII 
 Miscellaneous 
 Section 7.01. Notices. All communications and notices hereunder shall (except as otherwise
expressly permitted in this Agreement) be in writing and given as provided in Section 12.03 of the Credit Agreement, provided that any communication or notice hereunder from the Collateral Agent to any Credit Party upon the occurrence
and during the continuation of an Event of Default may be given by telephone if promptly confirmed in writing. All communications and notices hereunder to any Subsidiary Credit Party shall be given to it in care of the Borrower as provided in
Section 12.03 of the Credit Agreement. 
 Section 7.02. Waivers; Amendment. (a) No failure or delay by any Secured
Creditor in exercising any right or power hereunder or under any other Credit Document shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce
such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Secured Creditors hereunder and under the other Credit Documents are 
  

 -23- 

 cumulative and are not exclusive of any rights or remedies that they would otherwise have. No waiver of any provision in
this Agreement or consent to any departure by any Credit Party therefrom shall in any event be effective unless the same shall have been effected in accordance with paragraph (b) of this Section 7.02, and then such waiver or consent shall
be effective only in the specific instance and for the purpose for which given. Without limiting the generality of the foregoing, the making of a Loan shall not be construed as a waiver of any Default or Event of Default, regardless of whether any
Secured Creditor may have had notice or knowledge of such Default or Event of Default at the time. No notice or demand on any Credit Party in any case shall entitle any Credit Party to any other or further notice or demand in similar or other
circumstances. 
 (b) Neither this Agreement nor any provision hereof may be waived, amended or modified except pursuant to an agreement or
agreements in writing entered into by the Collateral Agent and the Credit Party or Credit Parties with respect to which such waiver, amendment or modification is to apply, subject to any consent required in accordance with Section 12.12 of the
Credit Agreement. 
 Section 7.03. Collateral Agent’s Fees and Expenses; Indemnification. (a) The parties hereto agree
that the Collateral Agent shall be entitled to reimbursement of its reasonable out-of-pocket expenses incurred hereunder as provided in Section 12.01 of the Credit Agreement. 
 (b) Without limitation of its indemnification obligations under the other Credit Documents, each Grantor and each Guarantor jointly and severally agrees
to indemnify the Collateral Agent, each other Secured Creditor and their respective successors, assigns, employees, affiliates and agents (hereinafter in this Section 7.03 referred to individually as “Indemnitee”) against, and
hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related out-of-pocket expenses, including the fees, charges and disbursements of any external counsel for any Indemnitee, incurred by or asserted against any
Indemnitee arising out of, in connection with, or as a result of, the execution, delivery or performance of this Agreement or any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing agreements or
instruments contemplated hereby, or to the Collateral, whether or not any Indemnitee is a party thereto; provided that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities
and related out-of-pocket expenses have resulted from the Indemnitee’s (or such affiliate’s) gross negligence, willful misconduct or breach of its obligations under this Agreement (in each case, as determined by a court of competent
jurisdiction in a final and non-appealable decision). 
 (c) Any such amounts payable as provided hereunder shall be additional Obligations
secured hereby and by the other Security Documents. The provisions of this Section 7.03 shall remain operative and in full force and effect regardless of the termination of this Agreement or any other Credit Document, the consummation of the
transactions contemplated hereby, the repayment of any of the Obligations, the invalidity or unenforceability of any term or provision of this Agreement or any other Credit Document, or any investigation made by or on behalf of the Collateral Agent
or any other Secured Creditor. All amounts due under this Section 7.03 shall be payable within 15 days after written demand therefor. 
 Section 7.04. Successors and Assigns. Whenever in this Agreement any of the parties hereto is referred to, such reference shall be deemed to include the permitted successors and assigns of such party; and all covenants, promises
and agreements by or on behalf of any Guarantor, Grantor or the Collateral Agent that are contained in this Agreement shall bind and inure to the benefit of their respective successors and assigns and shall inure to the benefit of the other Secured
Creditors and their respective successors and assigns. 
 Section 7.05. Survival of Agreement. All covenants, agreements,
representations and warranties made by the Credit Parties in the Credit Documents and in the certificates or other instruments prepared or delivered in connection with or pursuant to this Agreement or any other Credit Document shall be considered to
have been relied upon by the Lenders and shall survive the execution and delivery of the Credit Documents and the making of any Loans, regardless of any investigation made by any Lender or on its behalf and notwithstanding that the Administrative
Agent, the Collateral Agent or any Lender may have had notice or knowledge of any Default or incorrect representation or warranty at the time any credit is extended under the Credit Agreement, and shall continue in full force and effect as long as
the principal of or any accrued interest on any Loan or any fee or any other amount payable under any Credit Document is outstanding and unpaid and so long as the Commitments have not expired or terminated. 
  

 -24- 

 Section 7.06. Counterparts; Effectiveness; Several Agreement. This Agreement may be executed
in counterparts, each of which shall constitute an original but all of which, when taken together, shall constitute single contract. Delivery of an executed signature page to this Agreement by facsimile transmission shall be as effective as delivery
of a manually signed counterpart of this Agreement. This Agreement shall become effective as to any Credit Party when a counterpart hereof executed on behalf of such Credit Party shall have been delivered to the Collateral Agent and a counterpart
hereof shall have been executed on behalf of the Collateral Agent, and thereafter shall be binding upon such Credit Party and the Collateral Agent and their respective permitted successors and assigns, and shall inure to the benefit of such Credit
Party, the Administrative Agent, the Collateral Agent and the other Secured Creditors and their respective successors and assigns, except that no Credit Party shall have the right to assign or transfer its rights or obligations hereunder or any
interest in this Agreement or in the Collateral (and any such assignment or transfer shall be void) except as contemplated by this Agreement or the Credit Agreement. This Agreement shall be construed as a separate agreement with respect to each
Credit Party and may be amended, modified, supplemented, waived or released with respect to any Credit Party without the approval of any other Credit Party and without affecting the obligations of any other Credit Party hereunder. 
 Section 7.07. Severability. Any provision in this Agreement held to be invalid, illegal or unenforceable in any jurisdiction shall, as to
such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions hereof; the invalidity of a particular provision in a
particular jurisdiction shall not invalidate such provision in any other jurisdiction. The parties shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of
which comes as close as possible to that of the invalid, illegal or unenforceable provisions. 
 Section 7.08. Right of Set-Off.
If an Event of Default shall have occurred and be continuing, each Lender and each of its Affiliates is hereby authorized at any time and from time to time, to the fullest extent permitted by law, to set off and apply any and all deposits (general
or special, time or demand, provisional or final) at any time held (other than Deposit Accounts excluded from the Collateral pursuant to the last paragraph of Section 4.01(a)) and other obligations at any time owing by such Lender or Affiliate
to or for the credit or the account of any Credit Party against any of and all the obligations of such Credit Party now or hereafter existing under this Agreement owed to such Lender, irrespective of whether or not such Lender shall have made any
demand under this Agreement and although such obligations may be unmatured. The applicable Lender shall notify the Borrower, the Collateral Agent and the Administrative Agent of such set-off or application, provided that any failure to give
or any delay in giving such notice shall not affect the validity of any such set-off or application under this Section 7.08. The rights of each Lender under this Section 7.08 are in addition to other rights and remedies (including other
rights of set-off) which such Lender may have. 
 Section 7.09. Governing Law; Jurisdiction; Consent to Service of Process.
(a) This Agreement shall be construed in accordance with and governed by the law of the State of New York. 
 (b) Each of the parties
hereto hereby irrevocably and unconditionally submits, for itself and its property, to the nonexclusive jurisdiction of the Supreme Court of the State of New York sitting in New York County and of the United States District Court of the Southern
District of New York, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement or any other Credit Document, or for recognition or enforcement of any judgment, and each of the parties hereto
hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in such New York State or, to the extent permitted by law, in such Federal court. Each of the parties hereto
agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in this Agreement or any other Credit Document shall
affect any right that the Collateral Agent, any Lender or any Credit Party may otherwise have to bring any action or proceeding relating to this Agreement or any other Credit Document in the courts of any jurisdiction. 
 (c) Each of the parties hereto hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection
that it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement or any other Credit Document in any court referred to in paragraph (b) of this Section 7.09. Each of
the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court. 
  

 -25- 

 (d) Each party to this Agreement irrevocably consents to service of process in the manner provided for
notices in Section 7.01. Nothing in this Agreement or any other Credit Document will affect the right of any party to this Agreement to serve process in any other manner permitted by law. 
 Section 7.10. WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE
TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, ANY OTHER CREDIT DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY
HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND
(B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 7.10. 
 Section 7.11. Headings. Article and Section headings and the Table of Contents used in this Agreement are for convenience of reference only,
are not part of this Agreement and are not to affect the construction of, or to be taken into consideration in interpreting, this Agreement. 
 Section 7.12. Security Interest Absolute. All rights of the Collateral Agent hereunder, the Security Interest, the grant of a security interest in the Pledged Collateral and all obligations of each Grantor and Guarantor
hereunder shall be absolute and unconditional irrespective of (a) any lack of validity or enforceability of the Credit Agreement, any other Credit Document, any agreement with respect to any of the Obligations or any other agreement or
instrument relating to any of the foregoing, (b) any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to any departure from the Credit
Agreement, any other Credit Document or any other agreement or instrument, in each case, in accordance with their respective terms, (c) any exchange, release or non-perfection of any Lien on other collateral, or any release or amendment or
waiver of or consent under or departure from any guaranty, securing or guaranteeing all or any of the Obligations, or (d) any other circumstance that might otherwise constitute a defense available to, or a discharge of, any Grantor or Guarantor
in respect of the Obligations or this Agreement (other than a release of any Grantor or Guarantor in accordance with Section 7.13). 
 Section 7.13. Termination or Release. (a) The Security Interest and all other security interests granted hereby shall be automatically released when all the Credit Document Obligations (other than inchoate indemnity
obligations) have been indefeasibly paid in full and the Lenders have no further commitment to lend under the Credit Agreement. 
 (b) A
Subsidiary of the Borrower which was a Credit Party immediately prior to the consummation of any transaction permitted by the Credit Agreement shall automatically be released from its obligations hereunder and the Security Interest in the Collateral
of such Person shall be automatically released upon the consummation of any transaction permitted by the Credit Agreement as a result of which such Person ceases to be a Credit Party. 
 (c) Upon any sale or other transfer by any Grantor of any Collateral that is permitted under the Credit Agreement to a Person other than the Borrower or
a Subsidiary thereof, or upon the effectiveness of any written consent to the release of the security interest granted hereby in any Collateral pursuant to Section 12.12 of the Credit Agreement, the security interest in such Collateral shall be
automatically released. 
 (d) In connection with any termination or release pursuant to paragraph (a), (b) or (c) of this
Section 7.13, the Collateral Agent shall execute and deliver to any Person, at such Person’s expense, all documents that such Person shall reasonably request to evidence such termination or release of its obligations or the security
interests in its Collateral. Any execution and delivery of documents pursuant to this Section 7.13 shall be without recourse to or warranty by the Collateral Agent. 
  

 -26- 

 Section 7.14. Additional Subsidiaries. Pursuant to Section 9.14 of the Credit Agreement, each
Domestic Subsidiary of a Credit Party that was not in existence or not a Subsidiary on the date of the Credit Agreement, is required to enter in this Agreement as a Subsidiary Credit Party upon becoming such a Domestic Subsidiary. Upon execution and
delivery by the Collateral Agent and such Subsidiary of an instrument in the form of Exhibit I hereto, such Subsidiary shall become a Subsidiary Credit Party hereunder with the same force and effect as if originally named as a Subsidiary Credit
Party in this Agreement. The execution and delivery of any such instrument shall not require the consent of any other Credit Party hereunder. The rights and obligations of each Credit Party hereunder shall remain in full force and effect
notwithstanding the addition of any new Credit Party as a party to this Agreement. 
 Section 7.15. Collateral Agent Appointed
Attorney-in-Fact. Each Grantor hereby appoints the Collateral Agent the attorney-in-fact of such Grantor for the purpose of carrying out the provisions of this Agreement and taking any action and executing any instrument that the Collateral
Agent may deem necessary or advisable to accomplish the purposes hereof upon the occurrence of and during the continuation of an Event of Default, which appointment is irrevocable (until the Total Commitment has terminated and the Loans and Notes
(in each case together with interest thereon), Fees and all other Obligations (other than indemnities described in Section 7.03 and the other provisions of the Credit Documents which are not then due and payable) incurred hereunder and
thereunder, are paid in full) and coupled with an interest. Without limiting the generality of the foregoing, the Collateral Agent shall have the right, upon the occurrence and during the continuation of an Event of Default, with full power of
substitution either in the Collateral Agent’s name or in the name of such Grantor (except to the extent such action would be prohibited by applicable law with respect to Medicare and Medicaid receivables) (a) to receive, endorse, assign
and/or deliver any and all notes, acceptances, checks, drafts, money orders or other evidences of payment relating to the Collateral or any part thereof; (b) to demand, collect, receive payment of, give receipt for and give discharges and
releases of all or any of the Collateral; (c) to sign the name of any Grantor on any invoice or bill of lading relating to any of the Collateral; (d) to send verifications of Accounts to any Account Debtor; (e) to commence and
prosecute any and all suits, actions or proceedings at law or in equity in any court of competent jurisdiction to collect or otherwise realize on all or any of the Collateral or to enforce any rights in respect of any Collateral; (f) to settle,
compromise, compound, adjust or defend any actions, suits or proceedings relating to all or any of the Collateral; (g) to notify, or to require any Grantor to notify, Account Debtors to make payment directly to the Collateral Agent; and
(h) to use, sell, assign, transfer, pledge, make any agreement with respect to or otherwise deal with all or any of the Collateral, and to do all other acts and things necessary to carry out the purposes of this Agreement, as fully and
completely as though the Collateral Agent were the absolute owner of the Collateral for all purposes, provided that nothing in this Agreement contained shall be construed as requiring or obligating the Collateral Agent to make any commitment
or to make any inquiry as to the nature or sufficiency of any payment received by the Collateral Agent, or to present or file any claim or notice, or to take any action with respect to the Collateral or any part thereof or the moneys due or to
become due in respect thereof or any property covered thereby. The Collateral Agent and the other Secured Creditors shall be accountable only for amounts actually received as a result of the exercise of the powers granted to them in this Agreement,
and neither they nor their officers, directors, employees or agents shall be responsible to any Grantor for any act or failure to act hereunder, except for their own gross negligence or willful misconduct (as determined by a court of competent
jurisdiction in a final and non-appealable decision). 
 Section 7.16. Further Assurances. Notwithstanding anything to the
contrary herein, the parties hereto agree to comply with the requirements set forth in Section 8.12 of the Credit Agreement. 
 Section 7.17. Collateral Agent. The Collateral Agent shall act in accordance with the provisions of Section 11 of the Credit Agreement, the provisions of which shall be deemed incorporated by reference herein as fully as if
set forth in their entirety herein. Each Secured Creditor, by accepting the benefits of this Agreement, agrees to the provisions of Section 11 of the Credit Agreement, including as same apply to the actions of the Collateral Agent hereunder.

  

 -27- 

 [Signature Pages to Follow] 
  

 -28- 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and year first
above written. 
  

			
	NIGHTHAWK RADIOLOGY HOLDINGS, INC.
		
	By:	 	 /s/ Andrea M. Clegg

	Name:	 	
	Title:	 	Vice President of Finance
	
	NIGHTHAWK RADIOLOGY SERVICES, LLC
		
	By:	 	 /s/ Paul E. Cartee

	Name:	 	
	Title:	 	Vice President & General Counsel

  

 -29- 

			
	MORGAN STANLEY & CO. INCORPORATED, as Collateral Agent
		
	By:	 	 /s/ Gene Martin

	Name:	 	
	Title:	 	

  

 -30- 

 Exhibit I to the 
 Guaranty and 
 Collateral Agreement 
 SUPPLEMENT NO.      (this “Supplement”) dated as of [    ], to the Guaranty and
Collateral Agreement dated as of April 5, 2007, among NIGHTHAWK RADIOLOGY HOLDINGS, INC., a Delaware corporation (“Borrower”), each subsidiary of the Borrower listed on Schedule I thereto (each such subsidiary individually a
“Subsidiary Guarantor” and collectively, the “Subsidiary Guarantors”; the Subsidiary Guarantors and the Borrower are referred to collectively herein as the “Grantors”) and MORGAN STANLEY
& CO. INCORPORATED, as Collateral Agent (in such capacity, the “Collateral Agent”). 
 A. Reference is made to the
Credit Agreement dated as of April 5, 2007 (as amended, amended and restated, waived, supplemented or otherwise modified from time to time, the “Credit Agreement”), among the Borrower, the lenders from time to time party
thereto, and Morgan Stanley Senior Funding, Inc., as Administrative Agent. 
 B. Capitalized terms used in this Agreement and not otherwise
defined in this Agreement shall have the meanings assigned to such terms in the Credit Agreement and the Guaranty and Collateral Agreement referred to therein. 
 C. The Grantors have entered into the Guaranty and Collateral Agreement in order to induce the Lenders to make Loans. Section 7.14 of the Guaranty and Collateral Agreement provides that additional Subsidiaries of
the Borrower may become Subsidiary Credit Parties under the Guaranty and Collateral Agreement by execution and delivery of an instrument in the form of this Supplement. The undersigned Subsidiary (the “New Subsidiary”) is executing
this Supplement in accordance with the requirements of the Credit Agreement to become a Subsidiary Credit Party under the Guaranty and Collateral Agreement in order to induce the Lenders to make additional Loans and as consideration for Loans
previously made. 
 Accordingly, the Collateral Agent and the New Subsidiary agree as follows: 
 SECTION 1. In accordance with Section 7.14 of the Guaranty and Collateral Agreement, the New Subsidiary by its signature below becomes a Subsidiary
Credit Party, a Grantor and a Guarantor under the Guaranty and Collateral Agreement with the same force and effect as if originally named therein as a Subsidiary Credit Party, a Grantor and a Guarantor and the New Subsidiary hereby (a) agrees
to all the terms and provisions of the Guaranty and Collateral Agreement applicable to it as a Subsidiary Credit Party, Grantor and Guarantor thereunder and (b) represents and warrants that the representations and warranties made by it as a
Grantor and Guarantor thereunder are true and correct in all material respects on and as of the date hereof (it being understood and agreed that any representation or warranty which by its terms is made as of a specified date shall be required to be
true and correct in all material respects only as of such specified date). In furtherance of the foregoing, the New Subsidiary, as security for the payment and performance in full of the Obligations (as defined in the Guaranty and Collateral
Agreement), does hereby create and grant to the Collateral Agent, its successors and assigns, for the ratable benefit of the Secured Creditors, their successors and assigns, a security interest in and lien on all the New Subsidiary’s right,
title and interest in and to the Collateral (as defined in the Guaranty and Collateral Agreement) of the New Subsidiary. Each reference to a “Guarantor” or “Grantor” in the Guaranty and Collateral Agreement shall be deemed to
include the New Subsidiary. The Guaranty and Collateral Agreement is hereby incorporated in this Agreement by reference. 
 SECTION 2. The
New Subsidiary represents and warrants to the Collateral Agent and the other Secured Creditors that this Supplement has been duly authorized, executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against
it in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally any by principles of equity. 

 SECTION 3. This Supplement may be executed in counterparts, each of which shall constitute an original,
but all of which when taken together shall constitute a single contract. This Supplement shall become effective when the Collateral Agent shall have received a counterpart of this Supplement that bears the signature of the New Subsidiary and the
Collateral Agent has executed a counterpart hereof. Delivery of an executed signature page to this Supplement by facsimile transmission shall be as effective as delivery of a manually signed counterpart of this Supplement. 
 SECTION 4. The New Subsidiary hereby represents and warrants that set forth under its signature hereto is, as of the date hereof, (i) the true and
correct legal name of the New Subsidiary, (ii) its jurisdiction of formation, (iii) its Federal Taxpayer Identification Number or its organizational identification number (if any) and (iv) the location of its chief executive office.
The New Subsidiary hereby further represents and warrants that, as of the date hereof, Schedule I hereto accurately sets forth all information which would have been required pursuant to the GCA Disclosure Letter had the New Subsidiary been a Grantor
on the date of the execution and delivery of the Guaranty and Collateral Agreement (it being understood and agreed, however, that the information so furnished by the New Subsidiary is accurate as of the date of this Supplement rather than the date
of the Guaranty and Collateral Agreement). 
 SECTION 5. Except as expressly supplemented hereby, the Guaranty and Collateral Agreement shall
remain in full force and effect. 
 SECTION 6. THIS SUPPLEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE
STATE OF NEW YORK. 
 SECTION 7. Any provision of this Supplement held to be invalid, illegal or unenforceable in any jurisdiction
shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions hereof and in the Guaranty and Collateral
Agreement; the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction. The parties shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable
provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions. 
 SECTION 8. All communications and notices hereunder shall be in writing and given as provided in Section 7.01 of the Guaranty and Collateral Agreement. 
 SECTION 9. The New Subsidiary agrees to reimburse the Collateral Agent for its reasonable out-of-pocket expenses in connection with this Supplement,
including the reasonable fees, other charges and disbursements of counsel for the Collateral Agent. 
 IN WITNESS WHEREOF, the New Subsidiary
and the Collateral Agent have duly executed this Supplement to the Guaranty and Collateral Agreement as of the day and year first above written. 
  

			
	[NAME OF NEW SUBSIDIARY]
		
	By:	 	  

	Name:	 	
	Title:	 	
		
		 	 Legal Name:
 Jurisdiction of Formation:
 Location of Chief Executive Office:

  

 -2- 

			
	MORGAN STANLEY & CO. INCORPORATED, as Collateral Agent
		
	By:	 	  

	Name:	 	
	Title:	 	

  

 -3- 

 Schedule I 
 to the Supplement No.      
 to the Guaranty and 
 Collateral Agreement 
 LOCATION OF COLLATERAL

  

			
	Description	 	Location

 EQUITY INTERESTS 
  

									
	Issuer	 	Registered
Owner	 	Certificate
Number	 	Number and
Class of
Equity Interests	 	Percentage of
Equity Interests

 DEBT SECURITIES 
  

							
	Issuer	 	Principal
Amount	 	Date of
Note	 	Maturity Date

 INTELLECTUAL PROPERTY 
  

	I.	Copyrights 

  

							
	Registered
Owner	 	Title	 	Registration
Number	 	Expiration
Date

  

	II.	Copyright Applications 

  

							
	Registered
Owner	 	Title	 	 Registration
 Number
	 	 Date
 Filed

  

	III.	Copyright Licenses 

  

									
	Licensee	 	Licensor	 	Title	 	Registration
Number	 	Expiration
Date

  

	IV.	Patents 

  

							
	Registered
Owner	 	Mark	 	Registration
Number	 	Expiration
Date

  

	V.	Patent Applications 

  

							
	Registered
Owner	 	Mark	 	Registration
Number	 	Date
Filed

  

	VI.	Patent Licenses 

  

									
	Licensee	 	Licensor	 	Mark	 	Registration
Number	 	Expiration
Date

  

	VII.	Trademarks 

  

							
	Registered
Owner	 	Type	 	Registration
Number	 	Expiration
Date

  

 -2- 

	VIII.	Trademark Applications 

  

							
	Registered
Owner	 	Type	 	Registration
Number	 	Date
Filed

  

	IX.	Trademark Licenses 

  

									
	Licensee	 	Licensor	 	Type	 	Registration
Number	 	Expiration
Date

  

 -3- 

 Exhibit II to 
 the Guaranty and 
 Collateral Agreement 
 DEPOSIT ACCOUNT CONTROL AGREEMENT 
 (“Shifting Control”)

 AGREEMENT dated as of             , 200_, by and among [name of Grantor]
(“Company”), MORGAN STANLEY & CO. INCORPORATED (“Lender”) and
                                     (“Depositary”).

 The parties hereto refer to Account No.
                         in the name of Company maintained at Depositary (the “Account”) and hereby agree
as follows: 
 (a) Company and Lender notify Depositary that by separate agreement Company has granted Lender a security
interest in the Account and all funds on deposit from time to time therein. Depositary acknowledges being so notified. 
 (b)
The Depositary has not entered, and will not enter, into any agreement with any third party regarding the Account and has not agreed, and will not agree, that it will comply with any orders concerning the Account originated by any such third party.

 (c) Until Depositary shall have received from Lender a Shifting Control Notice (as defined below), Company shall be
entitled to present items drawn on and otherwise to withdraw or direct the disposition of funds from the Account and give instructions in respect of the Account. If Lender shall give to Depositary a notice of Lender’s exclusive control of the
Account, in substantially the same form as Exhibit A attached hereto, with a copy of this agreement attached thereto (a “Shifting Control Notice”), only Lender without further consent of the Company shall be entitled to withdraw
funds from the Account, to give any instructions in respect of the Account and any funds held therein or credited thereto or otherwise to deal with the Account. At the time Lender delivers a Shifting Control Notice to the Depositary it shall deliver
a copy of same to Company, provided that the failure of Lender to send a copy of any Shifting Control Notice to Company will not impact the effectiveness of any Shifting Control Notice delivered to the Depositary. 
 Notwithstanding the foregoing: (i) all transactions involving or resulting in a transaction involving the Account duly commenced by Depositary prior to its receipt
of a Shifting Control Notice and so consummated or processed thereafter shall be deemed not to constitute a violation of this Agreement; and (ii) Depositary may (at its discretion and without any obligation to do so) commence honoring solely
Lender’s instructions concerning the Account at any time or from time to time after it becomes aware that Lender has sent to it a Shifting Control Notice but prior to Depositary’s receipt thereof (including without limitation halting,
reversing or redirecting any transaction referred to in clause (i) above) with no liability whatsoever to Company or any other party for doing so. 
 (d) This Agreement supplements, rather than replaces, Depositary’s deposit account agreement, terms and conditions and other standard documentation in effect from time to time with respect to the Account or
services provided in connection with the Account (the “Account Documentation”), which Account Documentation will continue to apply to the Account and such services, and the respective rights, powers, duties, obligations, liabilities
and responsibilities of the parties thereto and hereto, to the extent not expressly conflicting with the provisions of this Agreement (however, in the event of any such conflict, the provisions of this Agreement shall control). 
 (e) Depositary agrees not to exercise or claim any right of offset, banker’s lien or other like right against the Account for so long
as this Agreement is in effect except with respect to (i) returned or charged-back items, (ii) reversals or cancellations of payment orders and other electronic fund transfers, (iii) Depositary’s charges, fees and expenses with
respect to the Account or the services provided hereunder or (iv) overdrafts in the Account. 

 (f) Notwithstanding anything to the contrary in this Agreement: (i) Depositary shall
have only the duties and responsibilities with respect to the matters set forth herein as is expressly set forth in writing herein and shall not be deemed to be an agent, bailee or fiduciary for any party hereto; (ii) Depositary shall be fully
protected in acting or refraining from acting in good faith without investigation on any notice (including without limitation a Shifting Control Notice), instruction or request purportedly furnished to it by Company or Lender in accordance with the
terms hereof, in which case the parties hereto agree that Depositary has no duty to make any further inquiry whatsoever; (iii) it is hereby acknowledged and agreed that Depositary has no knowledge of (and is not required to know) the terms and
provisions of the separate agreement referred to in paragraph 1 above or any other related documentation or whether any actions by Lender (including without limitation the sending of a Shifting Control Notice), Company or any other person or entity
are permitted or a breach thereunder or consistent or inconsistent therewith, (iv) Depositary shall not be liable to any party hereto or any other person for any action or failure to act under or in connection with this Agreement except to the
extent such conduct constitutes a breach of this Agreement, its own willful misconduct or negligence (and to the maximum extent permitted by law, shall under no circumstances be liable for any incidental, indirect, special, consequential or punitive
damages); and (v) Depositary shall not be liable for losses or delays caused by force majeure, interruption or malfunction of computer, transmission or communications facilities, labor difficulties, court order or decree, the
commencement of bankruptcy or other similar proceedings or other matters beyond Depositary’s reasonable control. 
 (g)
Company hereby agrees to indemnify, defend and save harmless Depositary against any loss, liability or expense (including reasonable fees and disbursements of outside counsel) (collectively, “Covered Items”) incurred in connection
with this Agreement or the Account (except to the extent due to Depositary’s breach of this Agreement, willful misconduct or negligence) or any interpleader proceeding relating thereto or incurred at Company’s direction or instruction. To
the extent the Depositary is not indemnified as provided above, Lender hereby agrees to indemnify, defend and save harmless Depositary against any Covered Items incurred (i) in connection with this Agreement or the Account (except to the extent
due to Depositary’s breach of this Agreement, willful misconduct or negligence) or any interpleader proceeding related thereto at any time a Shifting Control Notice is in effect, (ii) at Lender’s direction or instruction (including
without limitation Depositary’s honoring of a Shifting Control Notice) or (iii) due to any claim by Lender of an interest in the Account or the funds on deposit therein. 
 (h) Depositary may terminate this Agreement in its discretion upon the sending of at least thirty (30) days’ advance written
notice to the other parties hereto. Any other termination or any amendment or waiver of this Agreement shall be effected solely by an instrument in writing executed by all the parties hereto; provided that any termination of this agreement by Lender
shall not require the consent of Depositary. The provisions of paragraphs (f) and (g) above shall survive any such termination. 
 (i) Company shall compensate Depositary for the opening and administration of the Account and services provided hereunder in accordance with Depositary’s fee schedules from time to time in effect. Payment will be
effected by a direct debit to the Account. 
 (j) This Agreement: (i) may be signed in any number of counterparts
(including by means of facsimile transmission), each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument; (ii) shall become effective when counterparts hereof have been
signed and delivered by the parties hereto; and (iii) shall be governed by and construed in accordance with the laws of the State of New York. For purposes of the Uniform Commercial Code, the State of New York shall be deemed to be the
Depositary’s jurisdiction and the Account shall be governed by the laws of the State of New York. All parties hereby waive all rights to a trial by jury in any action or proceeding relating to the Account or this Agreement. All notices under
this Agreement shall be in writing and sent (including via facsimile transmission) to the parties hereto at their respective addresses or fax numbers set forth below (or to such other address or fax number as any such party shall designate in
writing to the other parties from time to time). 
  

 -2- 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the date first above
written. 
  

											
	[NAME OF COMPANY]	 	MORGAN STANLEY & CO. INCORPORATED, as Lender
				
	By:	 	  
	 	By:	 	  

	Name:	 		 		 	Name:	 		 	
	Title:	 		 		 	Title:	 		 	
	Address for	 	  
	 		 	  

	 Notices:
	 	  
	 		 	  

		 	  
	 		 	  

		 	Fax No.:	 	  
	 		 	Fax No.:	 	  

				
	[NAME OF DEPOSITARY]	 		 		 	
					
	By:	 	  
	 		 		 	
	Name:	 		 		 		 		 	
	Title:	 		 		 		 		 	
	Address for	 	  
	 		 		 	
	 Notices:
	 	  
	 		 		 	
		 	 Attention: [Customer Service
                     Officer] and
                    
	 		 		 	
		 	Fax No.:	 	  
	 		 		 	

  

 -3- 

 Exhibit A to 
 Deposit Account 
 Control Agreement 
 MORGAN STANLEY & CO. INCORPORATED 
 1585 Broadway, New York, 
 New York 10036 
 DEPOSIT ACCOUNT AGREEMENT

 SHIFTING CONTROL NOTICE 
  

	
	                            ,
        

 [Depositary] 
 [Address] 
 Attention: [Customer Service Officer] or
                             
  

	 	Re:	Deposit Account Control Agreement dated as of                     ,
200     (the “Agreement”) by and among                      (“Company”), Morgan
Stanley & Co. Incorporated, and [Depositary] 

 Ladies and Gentlemen: 
 This constitutes a Shifting Control Notice referred to in paragraph (c) of the Agreement, a copy of which is attached hereto. You are hereby
directed and instructed not to accept any direction or instruction with respect to the Account (as such term is defined in the Agreement) or any funds credited thereto from any Person other than the undersigned. 
  

			
	MORGAN STANLEY & CO. INCORPORATED
		
	By:	 	  

	Name:	 	
	Title:	 	
		
	By:	 	  

	Name:	 	
	Title:	 	

  

 Exhibit III to 
 the Guaranty and 
 Collateral Agreement 
 SECURITIES ACCOUNT CONTROL AGREEMENT 
 This Securities Account Control Agreement (this
“Control Agreement”), dated as of [                    ], by and among
[                    ] (the “Pledgor”), Morgan Stanley & Co. Incorporated, as Collateral Agent (as defined herein)
and [            ] (the “Securities Intermediary”), is delivered pursuant to Section 4.06(b) of that certain Guaranty and Collateral Agreement (as amended,
amended and restated, supplemented or otherwise modified from time to time, the “Collateral Agreement”), dated as of April 5, 2007, among NIGHTHAWK RADIOLOGY HOLDINGS, INC. (the “Borrower”), and each of the
other Guarantors listed on the signature pages thereto in favor of Morgan Stanley & Co. Incorporated, as collateral agent, as pledgee, assignee and Secured Creditor (the “Collateral Agent”). This Control Agreement is for
the purpose of perfecting the security interests of the Secured Creditors granted by the Pledgor in the Designated Accounts (as defined below). All references herein to the “UCC” shall mean the Uniform Commercial Code as in effect from
time to time in the State of New York. Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Guaranty and Collateral Agreement. 
 Section 1. Confirmation of Establishment and Maintenance of Designated. Accounts. The Securities Intermediary hereby confirms and agrees that
(i) the Securities Intermediary has established for the Pledgor and maintains the account(s) listed in Schedule I annexed hereto (such account(s), together with each such other securities account maintained by the Pledgor with the Securities
Intermediary collectively, the “Designated Accounts” and each a “Designated Account”), (ii) each Designated Account will be maintained in the manner set forth herein until termination of this Control Agreement,
(iii) this Control Agreement is the valid and legally binding obligation of the Securities Intermediary, (iv) the Securities Intermediary is a “securities intermediary” as defined in Article 8-102(a)(14) of the UCC and
(v) each of the Designated Accounts is a “securities account” as such term is defined in Section 8-501(a) of the UCC. 
 Section 2. “Financial Assets” Election. All parties hereto agree that each item of Investment Property and all other property held in or credited to any Designated Account (the “Account Property”)
shall be treated as a “financial asset” within the meaning of Section 8102(a)(9) of the UCC. 
 Section 3. Entitlement
Order. The Securities Intermediary shall comply with instructions directing the Securities Intermediary with respect to the sale, exchange or transfer of any Account Property held in each Designated Account originated by the Pledgor (or any
representative of, or investment manager appointed by, the Pledgor) until such time as the Collateral Agent delivers a Notice of Sole Control (as defined herein) pursuant to Section 9(i) of this Control Agreement to the Securities Intermediary.
If after the delivery of a Notice of Sole Control, the Securities Intermediary shall receive an “entitlement order” (within the meaning of Section 8-102(a)(8) of the UCC) issued by the Collateral Agent and relating to any financial
asset maintained in one or more of the Designated Accounts, the Securities Intermediary shall comply with such entitlement order without further consent by the Pledgor or any other Person. After the delivery of a Notice of Sole Control, the
Securities Intermediary shall comply with, and is fully entitled to rely upon, any entitlement order from the Collateral Agent, even if such entitlement order is contrary to any entitlement order that the Pledgor may give or may have given to the
Securities Intermediary. 
 Section 4. Subordination of Lien; Waiver of Set-Off. The Securities Intermediary hereby agrees that
any security interest in, lien on, encumbrance, claim or (except as provided in the next sentence) right of setoff against, any Designated Account or any Account Property it now has or subsequently obtains shall be subordinate to the security
interest of the Collateral Agent in the Designated Accounts and the Account Property therein or credited thereto. The Securities Intermediary agrees not to exercise any present or future right of recoupment or set-off against any of the Designated
Accounts or to assert against any of the Designated Accounts any present or future security interest, banker’s lien or any other lien or claim (including claim for penalties) that the Securities Intermediary may at any time have against or in
any of the Designated Accounts or any Account Property 
  

 therein or credited thereto; provided, however, that the Securities Intermediary may set off all amounts due to the
Securities Intermediary in respect of its customary fees and expenses for the routine maintenance and operation of the Designated Accounts, including overdraft fees and amounts advanced to settle authorized transactions. 
 Section 5. Choice of Law. Both this Control Agreement and the Designated Accounts shall be governed by the laws of the State of New York.
Regardless of any provision in any other agreement, for purposes of the UCC, New York shall be deemed to be the Securities Intermediary’s jurisdiction and the Designated Accounts (as well as the security entitlements related thereto) shall be
governed by the laws of the State of New York. 
 Section 6. Conflict with Other Agreements; Amendments. As of the date hereof,
there are no other agreements entered into between the Securities Intermediary and the Pledgor with respect to any Designated Account or any security entitlements or other financial assets credited thereto (other than standard and customary
documentation with respect to the establishment and maintenance of such Designated Accounts). The Securities Intermediary and the Pledgor will not enter into any other agreement with respect to any Designated Account unless the Collateral Agent
shall have received prior written notice thereof; provided that, for the avoidance of doubt, until the Securities Intermediary receives a Notice of Sole Control, the Pledgor may designate an investment manager or other representative to provide
entitlement orders on behalf of the Pledgor. The Securities Intermediary and the Pledgor have not and will not enter into any other agreement with respect to (i) creation or perfection of any security interest in or (ii) control of
security entitlements maintained in any of the Designated Accounts or purporting to limit or condition the obligation of the Securities Intermediary to comply with entitlement orders with respect to any Account Property held in or credited to any
Designated Account as set forth in Section 3 hereof without the prior written consent of the Collateral Agent. In the event of any conflict with respect to control over any Designated Account between this Control Agreement (or any portion
hereof) and any other agreement now existing or hereafter entered into, the terms of this Control Agreement shall prevail. No amendment or modification of this Control Agreement or waiver of any rights hereunder shall be binding on any party hereto
unless it is in writing and is signed by all the parties hereto. 
 Section 7. Certain Agreements. 
 (i) As of the date hereof, the Securities Intermediary has furnished to the Collateral Agent the most recent account statement issued by
the Securities Intermediary with respect to each of the Designated Accounts and the financial assets and cash balances held therein, identifying the financial assets held therein in reasonable detail. Each such statement accurately reflects the
assets held in such Designated Account as of the date thereof. 
 (ii) The Securities Intermediary will, upon its receipt of
each supplement to the Guaranty and Collateral Agreement signed by the Pledgor and identifying one or more financial assets as “Pledged Collateral,” enter into its records, including computer records, with respect to each Designated
Account a notation with respect to any such financial asset so that such records and reports generated with respect thereto identify such financial asset as “Pledged.” 
 Section 8. Notice of Adverse Claims. Except for the claims and interest of the Collateral Agent and of the Pledgor in the Account Property
held in or credited to the Designated Accounts, the Securities Intermediary on the date hereof does not know of any claim to, security interest in, lien on, or encumbrance against, any Designated Account or Account Property held in or credited
thereto and does not know of any claim that any Person or entity other than the Collateral Agent has been given “control” (within the meaning of Section 8-106 of the UCC) of any Designated Account or any such Account Property. If the
Securities Intermediary becomes aware that any person or entity is asserting any lien, encumbrance, security interest or adverse claim (including any writ, garnishment, judgment, warrant of attachment, execution or similar process or any claim of
control) against any of the Account Property held in or credited to any Designated Account, the Securities Intermediary shall promptly notify the Collateral Agent and the Pledgor thereof. 
 Section 9. Maintenance of Designated Accounts. In addition to the obligations of the Securities Intermediary in Section 3 hereof, the
Securities Intermediary agrees to maintain the Designated Accounts as follows: 
 (i) Notice of Sole Control. If at any
time the Collateral Agent delivers to the Securities Intermediary a notice instructing the Securities Intermediary to terminate Pledgor’s access to any Designated Account (the “Notice of Sole Control”), the Securities
Intermediary agrees that, after receipt of such notice, it will take all instructions with respect to such Designated Account solely from the Collateral Agent, and cease taking instructions from Pledgor, including, without limitation, instructions
for investment, distribution or transfer of any financial asset maintained in any Designated Account. Permitting settlement of trades pending at the time of receipt of such notice shall not constitute a violation of the immediately preceding
sentence. 
  

 2 

 (ii) Voting Rights. Prior to such time as the Securities Intermediary receives a
Notice of Sole Control, the Pledgor, an investment manager or other representative on behalf of the Pledgor, shall direct the Securities Intermediary with respect to the voting of any financial assets credited to any Designated Account. 

(iii) Statements and Confirmations. The Securities Intermediary will send copies of all statements and other correspondence
(excluding routine confirmations) concerning any Designated Account or any financial assets credited thereto to the Pledgor and, after the delivery of a Notice of Sole Control, simultaneously to each of the Pledgor and the Collateral Agent at the
address set forth in Section 11 hereof. The Securities Intermediary will provide to the Collateral Agent, upon the Collateral Agent’s request therefor from time to time, a statement of the market value of each financial asset
maintained in each Designed Account. The Securities Intermediary shall not change the name or account number of any Designated Account without the prior written consent of the Collateral Agent. 
 (iv) Perfection in Certificated Securities. The Securities Intermediary acknowledges that, in the event that it should come into
possession of any certificate representing any security or other Account Property held in or credited to any of the Designated Accounts, the Securities Intermediary shall retain possession of the same on behalf and for the benefit of the Collateral
Agent and such act shall cause the Securities Intermediary to be deemed holding such certificate for the Collateral Agent, if necessary to perfect the Collateral Agent’s security interest in such securities or assets. The Securities
Intermediary hereby acknowledges its receipt of a copy of the Guaranty and Collateral Agreement, which shall also serve as notice to the Securities Intermediary of a security interest in collateral held on behalf and for the benefit of the
Collateral Agent. 
 Section 10. Successors; Assignment. The terms of this Control Agreement shall be binding upon, and shall
inure to the benefit of, the parties hereto and their respective corporate successors and permitted assignees. 
 Section 11.
Notices. Any notice, request or other communication required or permitted to be given under this Control Agreement shall be in writing and deemed to have been properly given when delivered in person, or when sent by telecopy or other
electronic means and electronic confirmation of error free receipt is received or two (2) days after being sent by certified or registered United States mail, return receipt requested, postage prepaid, addressed to the party at the address set
forth below. 
  

			
	Pledgor:	  	[                                ]
		  	[Address]
		  	Attention:
		  	Telecopy:
		  	Telephone:
		
		  	with copy to:
		
		  	[                                ]
		  	[Address]
		  	Attention:
		  	Telecopy:
		  	Telephone:

  

 3 

					
	Securities	  		  	
	Intermediary:	  	[                                ]
		  	[Address]	  	
		  	 Attention:
 Telecopy:
 Telephone:
	  	
	Collateral Agent:	  	

Morgan Stanley & Co. Incorporated
		  	Attention:	  	[                    ]
		  	Telecopy:	  	[                    ]
		  	Telephone:	  	[                    ]
		
		  	with a copy to:
		  	 White & Case LLP
 1155 Avenue of the
Americas
 New York, New York 10036

		  	Attention:	  	Joseph Brazil
		  	Telecopy:	  	(212) 354-8113
		  	Telephone:	  	(212) 819-8401

 Any party may change its address for notices in the manner set forth above. 
 Section 12. Termination. 
 (i) Except as otherwise provided in this Section 12, the obligations of the Securities Intermediary hereunder and this Control Agreement shall continue in effect until the security interests of the Collateral Agent in the Designated
Accounts and any and all Account Property held therein or credited thereto have been terminated pursuant to the terms of the Guaranty and Collateral Agreement and the Collateral Agent has notified the Securities Intermediary of such termination in
writing. 
 (ii) The Securities Intermediary, acting alone, may terminate this Control Agreement at any time and for any
reason by written notice delivered to the Collateral Agent and the Pledgor not less than thirty (30) days prior to the effective termination date. 
 (iii) Prior to any termination of this Control Agreement pursuant to this Section 12, the Securities Intermediary hereby agrees that it shall promptly take, at Pledgor’s sole cost and expense, all reasonable
actions necessary to facilitate the transfer of any Account Property in or credited to the Designated Accounts as follows: (i) in the case of a termination of this Control Agreement under Section 12(i), to the institution designated in
writing by Pledgor; and (ii) in all other cases, to the institution designated in writing by the Collateral Agent. 
 Section 13.
Fees and Expenses. The Securities Intermediary agrees to look solely to the Pledgor for payment of any and all reasonable fees, costs, charges and expenses incurred or otherwise relating to the Designated Accounts and services provided by the
Securities Intermediary hereunder (collectively, the “Account Expenses”), and the Pledgor agrees to pay such Account Expenses to the Securities Intermediary on demand therefor. The Pledgor acknowledges and agrees that it shall be,
and at all times remains, solely liable to the Securities Intermediary for all Account Expenses. 
 Section 14. Severability. If
any term or provision set forth in this Control Agreement shall be invalid or unenforceable, the remainder of this Control Agreement, other than those provisions held invalid or unenforceable, shall be construed in all respects as if such invalid or
unenforceable term or provision were omitted. 
  

 4 

 Section 15. Counterparts. This Control Agreement may be executed in any number of
counterparts (including by means of facsimile transmission), all of which shall constitute one and the same instrument, and any party hereto may execute this Control Agreement by signing and delivering one or more counterparts. 
 [signature page follows] 
  

 5 

			
		 	[                    ], as Pledgor
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	MORGAN STANLEY & CO. INCORPORATED, as Collateral Agent
		
	By:	 	  

	Name:	 	
	Title:	 	[                    ], as Securities Intermediary
		
	By:	 	  

	Name:	 	
	Title:	 	

  

 6 

 SCHEDULE I 
 Designated Account(s) 

 Exhibit IV to 
 The Guaranty and 
 Collateral Agreement 
 FORM OF GRANT OF SECURITY INTEREST 
 IN UNITED STATES TRADEMARKS  
 FOR GOOD AND VALUABLE CONSIDERATION, receipt and sufficiency of which are hereby acknowledged, [Name of Grantor], a
[                    ] (the “Grantor”) with principal offices at
[                                ], hereby grants to Morgan Stanley & Co.
Incorporated, as Collateral Agent, with principal offices at 1585 Broadway, New York, New York 10036 (the “Grantee”), a continuing security interest in (i) all of the Grantor’s right, title and interest in, to and under to
the United States trademarks, trademark registrations and trademark applications (the “Marks”) set forth on Schedule A attached hereto, (ii) all Proceeds (as such term is defined in the Guaranty and Collateral Agreement
referred to below) and products of the Marks, (iii) the goodwill of the businesses with which the Marks are associated and (iv) all causes of action arising prior to or after the date hereof for infringement of any of the Marks or unfair
competition regarding the same. 
 THIS GRANT is made to secure the satisfactory performance and payment of all the Obligations of the Grantor, as such term
is defined in the Guaranty and Collateral Agreement among the Grantor, the other grantors from time to time party thereto and the Grantee, dated as of April 5, 2007 (as amended, modified, restated and/or supplemented from time to time, the
“Guaranty and Collateral Agreement”). 
 This Grant has been granted in conjunction with the security interest granted to the Grantee under
the Guaranty and Collateral Agreement. The rights and remedies of the Grantee with respect to the security interest granted herein are as set forth in the Guaranty and Collateral Agreement, all terms and provisions of which are incorporated herein
by reference. In the event that any provisions of this Grant are deemed to conflict with the Guaranty and Collateral Agreement, the provisions of the Guaranty and Collateral Agreement shall govern. 
 [Remainder of this page intentionally left blank; signature page follows] 

 IN WITNESS WHEREOF, the undersigned have executed this Grant as of the [    ] day of
[                    ], [    ]. 
  

			
	[NAME OF GRANTOR], Grantor
		
	By	 	  

	Name:	 	
	Title:	 	
	
	MORGAN STANLEY & CO. INCORPORATED, as Collateral Agent and Grantee
		
	By	 	  

	Name:	 	
	Title:	 	

  

 -2- 

 SCHEDULE A 
  

					
	 MARK
	 	 REG. NO.
	 	 REG. DATE

 Exhibit V to 
 The Guaranty and 
 Collateral Agreement 
 FORM OF GRANT OF SECURITY INTEREST 
 IN UNITED STATES PATENTS 
 FOR GOOD AND VALUABLE CONSIDERATION, receipt and sufficiency of which are hereby acknowledged, [Name of Grantor], a
[                    ] (the “Grantor”) with principal offices at
[                                ], hereby grants to Morgan Stanley & Co.
Incorporated, as Collateral Agent, with principal offices at 1585 Broadway, New York, New York 10036 (the “Grantee”), a continuing security interest in (i) all of the Grantor’s rights, title and interest in, to and under
the United States patents (the “Patents”) set forth on Schedule A attached hereto, in each case together with (ii) all Proceeds (as such term is defined in the Guaranty and Collateral Agreement referred to below) and products
of the Patents, and (iii) all causes of action arising prior to or after the date hereof for infringement of any of the Patents or unfair competition regarding the same. 
 THIS GRANT is made to secure the satisfactory performance and payment of all the Obligations of the Grantor, as such term is defined in the Guaranty and Collateral Agreement among the Grantor, the other grantors from
time to time party thereto and the Grantee, dated as of April 5, 2007 (as amended, modified, restated and/or supplemented from time to time, the “Guaranty and Collateral Agreement”). 
 This Grant has been granted in conjunction with the security interest granted to the Grantee under the Guaranty and Collateral Agreement. The rights and remedies of the
Grantee with respect to the security interest granted herein are as set forth in the Guaranty and Collateral Agreement, all terms and provisions of which are incorporated herein by reference. In the event that any provisions of this Grant are deemed
to conflict with the Guaranty and Collateral Agreement, the provisions of the Guaranty and Collateral Agreement shall govern. 
 [Remainder
of this page intentionally left blank; signature page follows] 

 IN WITNESS WHEREOF, the undersigned have executed this Grant as of the [    ] day of
[                    ], [    ]. 
  

			
	[NAME OF GRANTOR], Grantor
		
	By	 	  

	Name:	 	
	Title:	 	
	
	MORGAN STANLEY & CO. INCORPORATED, as Collateral Agent and Grantee
		
	By	 	  

	Name:	 	
	Title:	 	

  

 -2- 

 SCHEDULE A 
  

					
	 PATENT
	 	 PATENT NO.
	 	 ISSUE DATE

 Exhibit VI to 
 The Guaranty and 
 Collateral Agreement 
 FORM OF GRANT OF SECURITY INTEREST 
 IN UNITED STATES COPYRIGHTS 
 WHEREAS, [Name of Grantor], a
[                            ]
[                    ] (the “Grantor”), having its chief executive office at
[                    ],
[                    ], is the owner of all right, title and interest in and to the United States copyrights and associated United States
copyright registrations and applications for registration set forth in Schedule A attached hereto; 
 WHEREAS, Morgan Stanley & Co. Incorporated, as
Collateral Agent, having its principal offices at 1585 Broadway, New York, New York 10036 (the “Grantee”), desires to acquire a security interest in said copyrights and copyright registrations and applications therefor; and

 WHEREAS, the Grantor is willing to grant to the Grantee a security interest in and lien upon the copyrights and copyright registrations and applications
therefor described above. 
 NOW, THEREFORE, for good and valuable consideration, the receipt of which is hereby acknowledged, and subject to the terms and
conditions of the Guaranty and Collateral Agreement, dated as of April 5, 2007, made by the Grantor, the other grantors from time to time party thereto and the Grantee (as amended, modified, restated and/or supplemented from time to time, the
“Guaranty and Collateral Agreement”), the Grantor hereby assigns to the Grantee as collateral security, and grants to the Grantee a continuing security interest in, to and under the copyrights and copyright registrations and
applications therefor set forth in Schedule A attached hereto. 
 This Grant has been granted in conjunction with the security interest
granted to the Grantee under the Guaranty and Collateral Agreement. The rights and remedies of the Grantee with respect to the security interest granted herein are as set forth in the Guaranty and Collateral Agreement, all terms and provisions of
which are incorporated herein by reference. In the event that any provisions of this Grant are deemed to conflict with the Guaranty and Collateral Agreement, the provisions of the Guaranty and Collateral Agreement shall govern. 
 [Remainder of this page intentionally left blank; signature page follows] 

 IN WITNESS WHEREOF, the undersigned have executed this Grant as of the [    ]
day of [                    ], [            ]. 
  

			
	[NAME OF GRANTOR], Grantor
		
	By	 	  

	Name:	 	
	Title:	 	
	
	 MORGAN STANLEY & CO. INCORPORATED,
 as
Collateral Agent and Grantee

		
	By	 	  

	Name:	 	
	Title:	 	

  

 -2- 

 Schedule A 
  

					
	COPYRIGHT	 	COPYRIGHT NO.	 	ISSUE DATE

 Exhibit VII to 
 The Guaranty and 
 Collateral Agreement 
 UNCERTIFICATED SECURITIES CONTROL AGREEMENT 
 AGREEMENT (as amended, modified,
restated and/or supplemented from time to time, this “Agreement”), dated as of [                 , 200    ],
among the undersigned pledgor (the “Pledgor”), Morgan Stanley & Co., Incorporated, not in its individual capacity but solely as Collateral Agent (the “Pledgee”), and
[                    ], as the issuer of the Uncertificated Securities (each as defined below) (the “Issuer”). 
 W I T N E S S E T H : 
 WHEREAS, the Pledgor, certain of its affiliates and the Pledgee have entered into a Guaranty and Collateral Agreement, dated as of April 5, 2007 (as
amended, modified, restated and/or supplemented from time to time, the “Guaranty and Collateral Agreement”), under which, among other things, in order to secure the payment of the Obligations (as defined in the Guaranty and
Collateral Agreement), the Pledgor has or will pledge to the Pledgee for the benefit of the Secured Creditors (as defined in the Guaranty and Collateral Agreement), and grant a security interest in favor of the Pledgee for the benefit of the Secured
Creditors in, all of the right, title and interest of the Pledgor in and to any and all “uncertificated securities” (as defined in Section 8-102(a)(18) of the Uniform Commercial Code, as adopted in the State of New York)
(“Uncertificated Securities”), from time to time issued by the Issuer, whether now existing or hereafter from time to time acquired by the Pledgor; and 
 WHEREAS, the Pledgor desires the Issuer to enter into this Agreement in order to perfect the security interest of the Pledgee under the Guaranty and Collateral Agreement in the Uncertificated Securities, to vest in
the Pledgee control of the Uncertificated Securities and to provide for the rights of the parties under this Agreement; 
 NOW THEREFORE, in
consideration of the premises and the mutual promises and agreements contained herein, and for other valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 
 1. The Pledgor hereby irrevocably authorizes and directs the Issuer, and the Issuer hereby agrees, to comply with any and all instructions and orders
originated by the Pledgee (and its successors and assigns) regarding any and all of the Uncertificated Securities without the further consent by the registered owner (including the Pledgor), and, following its receipt of a notice from the Pledgee
stating that the Pledgee is exercising exclusive control of the Uncertificated Securities, not to comply with any instructions or orders regarding any or all of the Issuer Pledged Securities originated by any person or entity other than the Pledgee
(and its successors and assigns) or a court of competent jurisdiction. 
 2. The Issuer hereby certifies that (i) no notice of any
security interest, lien or other encumbrance or claim affecting the Uncertificated Securities (other than the security interest of the Pledgee) has been received by it, and (ii) the security interest of the Pledgee in the Uncertificated
Securities has been registered in the books and records of the Issuer. 
 3. The Issuer hereby represents and warrants that (i) the
pledge by the Pledgor of, and the granting by the Pledgor of a security interest in, the Uncertificated Securities to the Pledgee, for the benefit of the Secured Creditors, does not violate the charter, by-laws, partnership agreement, membership
agreement or any other agreement governing the Issuer or the Uncertificated Securities, and (ii) the Uncertificated Securities consisting of capital stock of a corporation are fully paid and nonassessable. 
 4. Following delivery by the Pledgee of a notice of exclusive control, all notices, statements of accounts, reports, prospectuses, financial statements
and other communications to be sent to the Pledgor by the Issuer in respect of the Issuer will also be sent to the Pledgee at the following address: 
 [                    ] 
 [                    ] 

			
	Attention:	  	[                    ]
	Telephone No.:	  	[                    ]
	Telecopier No.:	  	[                    ]

 5. Following its receipt of a notice from the Pledgee stating that the Pledgee is exercising
exclusive control of the Uncertificated Securities and until the Pledgee shall have delivered written notice to the Issuer that this Agreement is terminated, the Issuer will send any and all redemptions, distributions, interest or other payments in
respect of the Uncertificated Securities from the Issuer for the account of the Pledgee only by wire transfers to such account as the Pledgee shall instruct. 
 6. Except as expressly provided otherwise in Sections 4 and 5, all notices, instructions, orders and communications hereunder shall be sent or delivered by mail, telegraph, telex, telecopy, cable or overnight courier
service and all such notices and communications shall, when mailed, telexed, telecopied, cabled or sent by overnight courier, be effective when deposited in the mails or delivered to overnight courier, prepaid and properly addressed for delivery on
such or the next Business Day, or sent by telex or telecopier, except that notices and communications to the Pledgee or the Issuer shall not be effective until received. All notices and other communications shall be in writing and addressed as
follows: 
  

	(a)	if to the Pledgor, at: 

  

	
	__________________
	__________________
	__________________
	__________________
	Attention:                     
	Telephone No.:
	Fax No.:

  

	(b)	if to the Pledgee, at the address given in Section 4 hereof; 

  

	(c)	if to the Issuer, at: 

  

	
	__________________
	__________________
	__________________

 or at such other address as shall have been furnished in writing by any Person described above to the party
required to give notice hereunder. As used in this Section 6, “Business Day” means any day other than a Saturday, Sunday, or other day in which banks in New York are authorized to remain closed. 
 7. This Agreement shall be binding upon the successors and assigns of the Pledgor and the Issuer and shall inure to the benefit of and be enforceable by
the Pledgee and its successors and assigns. This Agreement may be executed in any number of counterparts (including by means of facsimile transmission), each of which shall be an original, including by means of facsimile transmission, but all of
which shall constitute one instrument. In the event that any provision of this Agreement shall prove to be invalid or unenforceable, such provision shall be deemed to be severable from the other provisions of this Agreement which shall remain
binding on all parties hereto. None of the terms and conditions of this Agreement may be changed, waived, modified or varied in any manner whatsoever except in writing signed by the Pledgee, the Issuer and the Pledgor. 
 8. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to its principles of conflict
of laws. 
  

 -2- 

 IN WITNESS WHEREOF, the Pledgor, the Pledgee and the Issuer have caused this Agreement to be executed by
their duly elected officers duly authorized as of the date first above written. 
  

			
	[                                      
  ],
		 	as Pledgor
		
	By	 	  

	Name:	 	
	Title:	 	
	
	MORGAN STANLEY & CO. INCORPORATED, not in its individual capacity but solely as Collateral Agent
		
	By	 	  

	Name:	 	
	Title:	 	
	
	[                                      
  ],
		 	as the Issuer
		
	By	 	  

	Name:	 	
	Title:	 	

  

 -3-Stock and Partnership Interest Purchase Agreement

 Exhibit 10.36 
 STOCK AND PARTNERSHIP INTEREST PURCHASE AGREEMENT 
 BY AND AMONG 
 NIGHTHAWK RADIOLOGY HOLDINGS, INC. 
 THE RADLINX GROUP, LTD. 
 RADLINX GROUP MANAGEMENT COMPANY, LLC 
 HEALTHLINX, INC. 
 DW HEALTHCARE
PARTNERS, L.P. 
 GREGORY A. LOWENSTEIN 
 MARK J. BAKKEN 
 M. WAYNE SOMERS 
 MARK PANTENBURG 
 CALVIN B. HALL 
 AND 
 GREGORY A. LOWENSTEIN, AS
PARTNER REPRESENTATIVE 
 DATED AS OF APRIL 5, 2007 

 TABLE OF CONTENTS 
 INDEX OF EXHIBITS, SCHEDULES AND APPENDICES 
  

			
	 Exhibits
	  	
		
	 Exhibit A:
	  	Defined Terms
	 Exhibit B:
	  	Form of Opinion of Outside Counsel
	 Exhibit C:
	  	List of Entities
		
	Schedules	  	
		
	 Schedule 1.1(c)
	  	Partners, Equity Ownership and Payment Amounts
	 Schedule 1.3
	  	Wire Transfer Instructions
	 Schedule 1.6
	  	Form of Assignment of interests or shares
	 Schedule 5.1
	  	Encumbrances on Interests or Shares of Partners

  

 -i- 

 STOCK AND PARTNERSHIP INTEREST PURCHASE AGREEMENT 
 THIS STOCK AND PARTNERSHIP INTEREST PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of April 5, 2007 (the
“Execution Date”) by and among Nighthawk Radiology Holdings, Inc., a Delaware corporation (“Buyer”), The Radlinx Group, Ltd., a Texas limited partnership (the “Company”), Radlinx Management Company,
LLC, a Texas limited liability company (the “General Partner”), Healthlinx, Inc, a Delaware corporation (“Blocker Corp.”), DW Healthcare Partners, LP, a Delaware limited partnership (“DWHP”),
Gregory A. Lowenstein (“GL”), Mark J. Bakken (“MB”), M. Wayne Somers (“MS”), Mark Pantenburg (“MP”) , Calvin B. Hall (“CH,” and together with MS and MP, the
“Series B Holders” and the Series B Holders together with MB, GL, the General Partner and DWHP, each a “Partner” and collectively, the “Partners”) and Gregory A. Lowenstein as Partner Representative
(as such term is hereinafter defined). Capitalized terms used and not otherwise defined in this Agreement shall have the meanings ascribed to them in Exhibit A. 
 RECITALS 
 A. The General Partner is the sole general partner of the Company.

 B. DWHP owns all of the issued and outstanding capital stock of Blocker Corp. (“Blocker Corp. Stock”). 
 C. Blocker Corp., GL and MB collectively own all of the issued and outstanding membership interests of the General Partner. 
 D. Blocker Corp., GL, MB and the Series B Holders collectively own a 99% partnership interest in the Company. 
 E. The General Partner owns a 1% partnership interest in the Company. 
 F. Buyer and the Partners desire to enter into this Agreement and for Buyer to purchase (i) all issued and outstanding shares of Blocker Corp. Stock, (ii) all of the limited partnership interests in the
Company not owned by Blocker Corp. and (iii) all of the membership interests in the General Partner not owned by Blocker Corp. (collectively, the “Acquisition”). 
 NOW, THEREFORE, in consideration of the mutual agreements, covenants and other promises set forth herein, the receipt and sufficiency of which are hereby
acknowledged and accepted, the parties hereby agree as follows: 
 ARTICLE I 
 THE ACQUISITION 
 1.1 Purchase and Sale of Stock and Partnership Interests.

 (a) Sale and Transfer of Blocker Corp. Stock. At the Closing (as defined in Section 1.6) and subject to and upon the
terms and conditions of this Agreement, Buyer shall purchase from DWHP and DWHP shall sell, convey, transfer, assign and deliver to Buyer, 1,000 shares of Blocker Corp. Stock (the “Shares”), which Shares represent 100% of the issued
and outstanding capital stock of Blocker Corp., free and clear of all Encumbrances or other defects of title, for its Consideration Percentage of the Purchase Price. 
 (b) Sale and Transfer of Interests. At the Closing and subject to and upon the terms and conditions of this Agreement, Buyer shall purchase from GL, MB and the Series B Holders, and GL, MB and the Series B
Holders shall severally, sell, convey, transfer, assign and deliver to Buyer, all of the (i) partnership interests of the Company owned or held by each of them (the “LP Interests”), and (ii) membership interests of the
General Partner owned or held by each of them (the “GP Interests” and together with the LP Interests, the “Interests”), free 

 
and clear of all Encumbrances or other defects of title, for their respective Consideration Percentage of the Purchase Price, which Interests together with
the Shares (the Interests and the Shares together, the “Equity”) directly or indirectly represent 100% ownership of the issued and outstanding partnership interests of the Company and the General Partner. 
 (c) Schedule 1.1(c). Opposite each Partner’s name on Schedule 1.1(c) is the type and amount of Equity held by such Partner,
the payment to be made to each such Partner at the Closing after giving effect to the adjustments and provisions of Sections 1.3, 1.4 and 1.5 below and the amount of each payment to be held in escrow on such Partner’s
behalf. 
 1.2 Purchase Price. Subject to the terms and conditions of this Agreement, including any adjustments required by
Sections 1.3, 1.4 and 1.5 below, Buyer will pay to the Partners at the times and in the manner specified in Sections 1.3, 1.4 and 1.5 below, an aggregate purchase price of $53,000,000 plus any
Earnout Amount plus the Final Working Capital Amount (the “Purchase Price”). 
 1.3 Closing Payments.
 (a) Closing Payment to Partners. Subject to the terms and conditions of this Agreement (including Section 1.5), at the Closing, Buyer
shall pay to each Partner its Consideration Percentage of: 
 (i) $53,000,000 of the Purchase Price; 
 MINUS 
 (ii) the outstanding principal
balance of, and all accrued and unpaid interest on, Indebtedness outstanding on the Closing Date (including any prepayment and similar charges associated with repayment of the Indebtedness prior to maturity (calculated as of the Closing Date));

 MINUS 
 (iii) the amount
(the “Closing Date Working Capital Offset”), if any, by which the Closing Date Net Working Capital is less than the Working Capital Threshold; 
 by wire transfer, in cash, in accordance with the wire transfer instructions set forth on Schedule 1.3 or as otherwise directed by the Partner Representative (the “Closing Payment”). Company shall deliver to Buyer a
calculation of Closing Date Net Working Capital and the Working Capital Threshold certified as to accuracy by the Company’s Chief Financial Officer. 
 (b) Final Working Capital Amount. As soon as reasonably practicable after the date that is 120 days after the Closing (the “Cut-Off Date”), the Final Working Capital Amount shall be
determined in the manner set forth in the succeeding sections: 
 (i) Buyer shall prepare and deliver to the Partner
Representative as soon as reasonably practicable after the Cut-Off Date any proposed revisions to the Closing Balance Sheet and any proposed revisions to the Closing Date Net Working Capital, including adjustments to Accounts Receivable reflected on
the Closing Balance Sheet and Collected AR as of the Cut-Off Date (the “Final Working Capital Amount”). Buyer’s revised Closing Balance Sheet shall be prepared in accordance with GAAP (it being understood and agreed that the
amount of any proposed revision shall be disregarded for purposes of calculating the Final Working Capital Amount to the extent such proposed revision shall result from the application of any accounting policy (A) required by Regulation S-X or
(B) that, as between Buyer and the Company, is unique to Buyer, unless the Company’s practices failed to conform to GAAP with respect to the accounting treatment of the item(s) under review, in which case Buyer shall be entitled to make
such proposed revision). Buyer shall make available to the Partner Representative and its accountants during regular business hours all pertinent information reasonably requested by the Partner Representative in order to confirm the amounts set
forth in the revised Closing Balance Sheet and Final Working Capital Amount. 
  

 -2- 

 (ii) Within thirty (30) days after the Buyer’s proposed revisions are delivered
to the Partner Representative pursuant to subsection (i) above, the Partner Representative shall complete its examination thereof and shall deliver to Buyer either (A) a written acknowledgement accepting the Buyer’s revisions or
(B) a written report setting forth in reasonable detail any proposed adjustments to the Buyer’s revisions (the “Adjustment Report”). A failure by the Partner Representative to deliver the Adjustment Report to Buyer within
such thirty (30) day period shall be deemed to constitute the Partner Representative’s acceptance of Buyer’s calculation of the Closing Balance Sheet and the Final Working Capital Amount. 
 (iii) During a period of thirty (30) days following the receipt by Buyer of the Adjustment Report, the Partner Representative and
Buyer shall attempt to resolve any differences they may have with respect to the matters set forth in the Adjustment Report. In the event the Buyer and the Partner Representative fail to agree on the Closing Balance Sheet and the Final Working
Capital Amount within such thirty (30) day period, then the Partner Representative and Buyer mutually agree that the Seattle, Washington office of a firm of nationally recognized independent auditors (or if any such firm is unwilling or unable
to serve, another national accounting firm mutually agreed upon by the Partner Representative and Buyer (the “Independent Auditors”), acting as an expert and not as an arbitrator, shall make the final determination with respect to
the correctness of the proposed adjustments in the Adjustment Report in light of the terms and provisions of this Agreement. The parties shall use reasonable efforts to cause the Independent Auditors to render their decision as soon as practicable
within sixty (60) days after the submission to the Independent Auditors of the proposed adjustments, including by promptly complying with all reasonable requests by the Independent Auditors for information, books, records and similar items. The
Independent Auditors shall make a determination as to each of the items in dispute (and each item affected thereby), which determination shall be in writing and furnished to the Partner Representative and Buyer as promptly as practicable after the
items in dispute have been referred to the Independent Auditors (but in any event within sixty (60) days thereafter). The decision of the Independent Auditors shall be final and binding on the Buyer and the Partner Representative, and may be
used in a court of law by either the Buyer or the Partner Representative for the purpose of enforcing such decision. The costs and expenses of the Independent Auditors pursuant to this section shall be borne by the Buyer and the Partner
Representative pro rata in an amount inversely proportional to the dollar value of the disputed items determined in each party’s favor. By way of example, if the Buyer had taken the position that the Final Working Capital Amount was $100, the
Partner Representative had taken the position that the Final Working Capital Amount was $200, and the Independent Auditors determine the Final Working Capital Amount to be $130, then the Buyer would pay 30% of the Independent Auditors’ fees and
expenses and the Partner Representative, on behalf of the Partners, would pay 70% of the Independent Auditors’ fees and expenses. 
 (iv) If, after determination of the Final Working Capital Amount pursuant to the foregoing, the Final Working Capital Amount exceeds the Working Capital Threshold, the Buyer shall pay to each Partner its Consideration
Percentage of such excess plus the amount of the Closing Date Working Capital Offset, if any, made by Buyer pursuant to Section 1.3(a)(iii). If, after determination of the Final Working Capital Amount pursuant to the foregoing, the Final
Working Capital Amount is less than the Working Capital Threshold (the “Working Capital Shortfall”), Buyer shall be entitled to recover from the Escrow Fund an amount equal to such Working Capital Shortfall but only to the extent
Buyer shall not have recovered such Working Capital Shortfall pursuant to any Closing Date Working Capital Offset made pursuant to Section 1.3(a)(iii). 
 (c) Accounts Receivable. During the period between Closing and the Cut-Off Date, Buyer will
use, and will cause the Company to use, commercially reasonable efforts to collect Accounts Receivable in the Ordinary Course of Business and will consult with the Partner Representative regarding such efforts and, to the extent Buyer or Company
collect such Accounts Receivable, credit such Accounts Receivable to the oldest outstanding amount due from the party obligated thereon. On the 60th and 90th day after the Closing Date, the Buyer agrees to provide
the Partner Representative a schedule of Accounts Receivable activity since the Closing Date. If 

  

 -3- 

 
any Accounts Receivable reflected on the Closing Balance Sheet have not become Collected AR by the Cut-Off Date and accordingly are not included in the
computation of the Final Working Capital Amount, neither the Company nor the Buyer will have any further obligation to any of the Partners or the Partner Representative with respect thereto. 
 1.4 Earnout.
 (a) Earnout
Payment. Following the Closing, subject to the terms and conditions of this Agreement (including Section 1.4(e)), Buyer shall pay to each Partner its Consideration Percentage of the Earnout Amount (the “Earnout
Payment”), by wire transfer, in cash, in accordance with the wire transfer instructions set forth on Schedule 1.3, within forty-five (45) days after the one-year anniversary of the Closing Date (the “Earnout Payment
Date”). 
 (b) No Conditions to Payment. The parties acknowledge and agree that (i) the Earnout Amount is a material
factor in determining the valuation of the Company, (ii) the right to the Earnout Payment is material to the Partners’ decision to enter into this Agreement and (iii) payment of the Earnout Amount is not contingent on the employment
of either of GL, MB or any Series B Holder with Buyer or any of Buyer’s Affiliates on the Earnout Payment Date. 
 (c) Buyer’s
Obligations With Respect to Earnout. The Partners agree that (i) following the Closing Date, the Buyer shall have the right and power to control all aspects of the business and operations of the Company (including decisions regarding
the features, functions and characteristics of its products and services, the technology on which its products and services are delivered, whether and when to launch its products and services, and how to price, market and distribute its products and
services), and nothing in this Agreement shall require Buyer to take any action that would be, or shall otherwise be interpreted in a manner that is, inconsistent with such right and power and (ii) nothing herein shall constitute a guarantee of
employment of any Key Personnel or any other employee, and Buyer may terminate any Key Personnel or other employee, with or without cause, at any time and such termination shall not constitute a breach of this Agreement. Notwithstanding the
foregoing, the Buyer covenants that if, prior to the Earnout Payment Date, it should sell or otherwise dispose of the business historically conducted by the Company, it will cause the purchaser of such business to assume Buyer’s obligation to
make the Earnout Payment due hereunder. 
 (d) Tax Treatment. The Earnout Payment is intended to be treated for all Tax purposes as
additional consideration for the purchase of the Equity by Buyer pursuant to this Agreement (subject to the requirement to treat a portion as imputed interest). Each of the Partners acknowledges that it is relying solely on its own tax advisors in
connection with the tax treatment and tax consequences of the transactions contemplated hereby. 
 (e) No Transfer or Assignment. No
Partner may sell, exchange, transfer or otherwise dispose of its right to receive the Earnout Payment, if any, or any portion thereof, except for transfers for estate planning purposes provided that Buyer is provided with written notice prior to any
such transfer. Any transfer in violation of this Section 1.4(e) shall be null and void and need not be recognized by Buyer. 
 (f) No Other Representations, Warranties or Commitments. Each Partner expressly acknowledges and agrees that this Section 1.4 contains the entire agreement with respect to Buyer’s obligations in connection with the
Earnout, and that notwithstanding anything else (including any prior or contemporaneous discussions) to the contrary, for purposes of this Agreement, no party makes or is relying on any, representations, warranties or covenants with respect to
support provided to achieve, or the feasibility of achieving, the Earnout. 
 1.5 Escrow. Notwithstanding anything in this
Agreement to the contrary, $5,300,000 of the Purchase Price will not be paid at the Closing to the Partners, but instead will be paid over to the Escrow Agent to be held and disbursed upon the terms and subject to the conditions set forth in the
Escrow Agreement. This amount shall be referred to as the “Escrow Amount,” and the Escrow Amount, together with any accrued interest thereon, will constitute the “Escrow Fund.” Payments from the Escrow Fund will be
made in accordance with Section 8.2 hereof. 
  

 -4- 

 1.6 Closing.
 (a) The closing of the Acquisition (the “Closing”) will take place
contemporaneously with the execution and delivery of this Agreement at the offices of Wilson Sonsini Goodrich & Rosati, located at 701 5th Avenue, Suite 5100, Seattle, Washington 98104 by electronic deliveries from multiple locations, unless another place is mutually agreed by Buyer and the Company. The date upon which the Closing
actually occurs shall be referred to herein as the “Closing Date.” 
 (b) Subject to the conditions set forth in this
Agreement, at or prior to the Closing: 
 (i) Buyer shall pay each Partner the portion of the Closing Payment to which such Partner is
entitled pursuant to this ARTICLE I, by wire transfer of immediately available funds; and 
 (ii) each Partner shall deliver to Buyer
duly executed assignments of their Interests or Shares, as the case may be, substantially in the form attached as Schedule 1.6. 
 1.7
Effect of Transaction; Partner Approval. As a result of the transactions contemplated by this Agreement, upon the Closing, the Partners will have sold to Buyer, directly or indirectly, all of the partnership interests in the Company and
there shall be no outstanding options, warrants or rights to subscribe for any purchase any interest in the Company, the General Partner or the Blocker Corp. By executing this Agreement, each Partner hereby approves (a) the transfer by each
Partner of the Interests and the Shares, as the case may be, to Buyer pursuant to this Agreement and (b) the execution and performance of this Agreement and the consummation of the Acquisition and transactions contemplated by this Agreement by
the Company. By executing this Agreement, each Partner hereby agrees to waive any rights such Partner may have under the Limited Partnership Agreement and General Partnership Agreement, including rights of first refusal and rights to distributions
following the Closing, upon transfer of the Equity to Buyer. 
 1.8 Expenses. The Partners will be liable for the costs and
expenses incurred by the Company, the General Partner, the Blocker Corp. and the Partners (including those of their respective employees and attorneys’ fees) in negotiating and consummating the transactions contemplated hereby, and Buyer will
be solely responsible for the costs and expenses (including those of its employees and attorneys’ fees) incurred by Buyer in negotiating and consummating the transactions contemplated hereby. Any expenses incurred by the Company (including
those of its employees and attorneys’ fees) in negotiating and consummating the transactions contemplated hereby, to the extent not included in the computation of the Final Working Capital Amount, shall be borne by the Partners. 
 1.9 Required Withholding. Buyer shall be entitled to deduct and withhold from any consideration payable or otherwise deliverable pursuant to
this Agreement such amounts as may be required to be deducted or withheld therefrom under the Code, or under any provision of state, local or foreign Tax law, and to request and be provided any necessary Tax forms, including Internal Revenue Service
Form W-9 or the appropriate series of Form W-8, as applicable, or any similar information, from the Partners and, to the extent required by applicable Tax laws, any beneficial owner of an interest in any of the Partners. To the extent such
amounts are so deducted or withheld, such amounts shall be treated for all purposes under this Agreement as having been paid to the Person to whom such amounts would otherwise have been paid. 
 1.10 Taking of Necessary Action; Further Action. If at any time after the Closing, any further action is necessary or desirable to carry out
the purposes of this Agreement, to vest in Buyer the full right and title to all the Equity or to ensure that the Company retains full right, title and possession to any and all assets, property, rights, privileges, powers and franchises of the
Company, Buyer and the officers and directors of the Company are fully authorized in the name of the Company and/or the Partners, as the case may be, to take all such lawful and necessary action, it being understood and agreed that if such further
action is necessary or desirable due to a breach of this Agreement or an agreement contemplated by this Agreement by the Company, the Partners or the Partner Representative, the cost and expense of taking such action may be paid by or reimbursed to
Buyer from the Escrow Fund. 
  

 -5- 

 ARTICLE II 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY 
 The Company represents and warrants to and for the benefit
of Buyer (except, with respect to any particular section or subsection of this ARTICLE II, to the extent specifically described in the corresponding section or subsection a letter delivered to the Buyer at the time of execution hereof (the
“Company Disclosure Letter”)): 
 2.1 Organization, Good Standing, Qualification.
 (a) The Company is a limited partnership duly formed and validly existing, and is in good standing, under the laws of the State of Texas, and is duly
qualified to conduct business and is in good standing in each jurisdiction in which the failure to be so qualified and in good standing would or could reasonably be expected to have a Material Adverse Effect. Section 2.1(a) of the
Company Disclosure Letter identifies all jurisdictions in which the Company owns Real Property, conducts business or is qualified as a foreign entity to conduct business. The Company has all requisite power and authority to own and operate its
properties and assets, to execute and deliver this Agreement and the other Transaction Agreements contemplated to be executed and delivered by it, to carry out the provisions hereof and thereof, and to carry on its business as currently conducted
and as presently proposed to be conducted. 
 (b) Section 2.1(b) of the Company Disclosure Letter accurately sets forth
(i) the names of the members of the General Partner’s managers and (ii) the names and titles of the Company’s officers. 
 (c) None of the Company, the General Partner or the Partners have ever approved, or commenced any proceeding, or made any election contemplating, the dissolution or liquidation of the Company or the winding up or cessation of the
Company’s business or affairs. 
 (d) The Company has no Subsidiaries and has never owned, beneficially or otherwise, any Equity
Interests (other than de minimis holdings in publicly traded companies in connection with investment accounts, if any). 
 2.2 Certificate
of Limited Partnership and Limited Partnership Agreement; Records.
 (a) The Company has delivered or otherwise made available to Buyer
accurate and complete copies of: 
 (i) the Company’s Certificate of Limited Partnership and Limited Partnership Agreement, including
all amendments thereto, as presently in effect; 
 (ii) the partnership interest records of the Company; and 
 (iii) the minutes and other records of the meetings and other actions (including any actions taken by written consent or otherwise without a meeting)
relating to the Company, the General Partner and the Blocker Corp. 
 (b) The Company has never conducted any business under or otherwise
used, for any purpose or in any jurisdiction, any fictitious name, assumed name, trade name or other name, other than the name “The Radlinx Group, Ltd.” 
 (c) There has not been any uncured violation of any of the provisions of the Company’s Certificate of Limited Partnership or Limited Partnership Agreement within the last five (5) years, and no event has
occurred, and no condition or circumstance exists, that (with or without notice or lapse of time) constitutes or is reasonably likely to result directly or indirectly in such a violation. 
  

 -6- 

 (d) The books of account, partnership interest records, minute books and other records of the Company are
accurate, up to date and complete in all material respects. All of the records of the Company are in the actual possession or control of the Company. The Company has been administered and the Company’s limited partnership and other records
maintained as required by Legal Requirements to maintain the separate legal existence of the Company. 
 2.3
Capitalization.
 (a) As of the date of the Agreement, the authorized partnership interests of the Company consist of 180,000
Class A Units, of which 95,000 are issued and outstanding and 5,000 Class B Units, 4,476 of which are issued and outstanding. No other Interests are authorized or issued and outstanding. Section 2.3 of the Company Disclosure
Letter sets forth a true and complete list of the record holders of such Interests listing the type, amount and percentage total of such Interests held by each such holder. All issued and outstanding Interests, and have been issued in compliance
with all applicable securities laws and other applicable Legal Requirements. 
 (b) The Company has not granted any purchaser or other
recipient of its partnership interests or other securities the right to require the Company to register any securities under the Securities Act or to qualify for any exemption thereunder. 
 (c) Section 2.3(c) of the Company Disclosure Letter sets forth a true and complete list of all other Equity Interests in or related to
Company describing in reasonable detail such other Equity Interests. 
 (d) Except as set forth on Section 2.3(d) of the Company
Disclosure Letter, there is no: 
 (i) outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to
acquire any partnership interests or other securities of the Company; 
 (ii) outstanding security, instrument or obligation that is or may
become convertible into or exchangeable for any partnership interests or other securities of the Company; 
 (iii) Contract under which the
Company is or may become obligated to sell or otherwise issue any of its partnership interests or any other securities; 
 (iv) condition or
circumstance that will directly or indirectly give rise to or provide a reasonable basis for the assertion of a claim by any Person to the effect that such Person is entitled to acquire or receive from the Company any partnership interests or other
securities of the Company; or 
 (v) other Equity Interest existing with respect to the Company. 
 (e) The Company has never repurchased, redeemed or otherwise reacquired (or, except as provided in the Partnership Agreement, agreed, committed or
offered (in writing or otherwise) to repurchase, redeem or otherwise reacquire) any partnership interests or other securities. 
 2.4
Authority; Binding Nature of Agreements. The execution, delivery and performance by the Company of this Agreement and such Transaction Agreements to which it is contemplated to be a party have been duly authorized by all necessary
partnership action on the part of the Company, the General Partner (including its board of managers), the Blocker Corp. and the Partners. This Agreement and the other Transaction Agreements constitute (assuming such agreements constitute legal,
valid and binding obligations of Buyer to the extent it is executing such agreements), or upon execution and delivery will constitute (assuming such agreements constitute legal, valid and binding obligations of Buyer to the extent it is executing
such agreements), the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms, subject only to bankruptcy, insolvency, reorganization and similar Legal Requirements. 

 

 -7- 

 2.5 Non-Contravention; Consents.
 (a) The execution, delivery and performance of this Agreement and the other Transaction Agreements by the applicable parties other than Buyer and the
consummation of the Acquisition will not, directly or indirectly (with or without notice or lapse of time): 
 (i) contravene or result in a
violation of (A) any provisions of the Company’s Certificate of Limited Partnership or Limited Partnership Agreement or (B) any resolution adopted by the Company’s board of managers or any committee thereof; 
 (ii) contravene, conflict with or result in a violation of, or give any Governmental Authority or other Person the right to challenge the Acquisition or
to exercise any remedy or obtain any relief under, any Legal Requirement or any Order to which the Company or any assets owned by the Company are subject; 
 (iii) cause the Company to become subject to, or to become liable for the payment of, any Tax; 
 (iv) cause
any assets owned or used by the Company to be reassessed or revalued by any taxing authority or other Governmental Authority; 
 (v)
contravene, conflict with or result in a violation of any of the terms or requirements of, or give any Governmental Authority the right to revoke, withdraw, suspend, cancel, terminate, modify or charge any material fee with respect to, any
Governmental Approval that is held by the Company or that otherwise relates to the Company’s business or to any of the assets owned or used by the Company; 
 (vi) contravene, conflict with or result in a violation or breach of, or default under, any provision of any Company Contract; 
 (vii) give any Person the right to (A) declare a default or exercise any remedy under any Company Contract, (B) accelerate the maturity or performance of any Company Contract in any material respect or
(C) cancel, terminate or modify any Company Contract; 
 (viii) give any Person the right to any payment by the Company or give rise to
any acceleration or change in the award, grant, vesting or determination of options, warrants, rights, severance payments or other contingent obligations of any nature whatsoever of the Company in favor of any Person, in any such case as a result of
the change in control of the Company or otherwise resulting from the Acquisition; or 
 (ix) result in the imposition or creation of any
Encumbrance upon or with respect to any material asset owned or used by the Company. 
 (b) Except as set forth in Section 2.5(b)
of the Company Disclosure Letter, the Company is not required to make any filing with or give any notice to, or obtain any Consent from, any Governmental Authority, party to a Company Contract or any other Person in connection with the execution and
delivery of this Agreement and the other Transaction Agreements or the consummation or performance of the Acquisition. As of the Closing Date, all filings, notices and Consents to, with or with respect to Governmental Authorities set forth on such
schedule have been duly made, given or obtained and are in full force and effect. 
 2.6 Proceedings; Orders.
 (a) There is no pending Proceeding and, to the Company’s Knowledge, no Person has threatened to commence any Proceeding: 
 (i) to which Company is a party or which directly relates to any of the assets owned or used by the Company (whether or not the Company is named as a
party thereto) and, to the Company’s Knowledge, no event has occurred, and no claim, dispute or other condition or circumstance exists, that would be reasonably expected to give rise to, or serve as a reasonable basis for, the commencement of
any such Proceeding; or 
  

 -8- 

 (ii) that challenges, or that may have the effect of preventing, delaying, making illegal or otherwise
interfering with, the Acquisition or the Company’s ability to comply with or perform its obligations and covenants under this Agreement or any of the other Transaction Agreements and, to the Company’s Knowledge, no event has occurred, and
no claim, dispute or other condition or circumstance exists, that would be reasonably expected to give rise to, or serve as a reasonable basis for, the commencement of any such Proceeding. 
 (b) Within the last five years, no material Proceeding has been commenced by or against the Company and, to the Company’s Knowledge, no such
Proceeding has been threatened. 
 (c) There is no Order to which the Company, or any of the assets owned by the Company, is subject.

 (d) To the Company’s Knowledge, neither the General Partner nor any officer, employee, or contractor of the Company or of the General
Partner, is subject to any Order that prohibits the General Partner, officer, employee or contractor of the Company or the General Partner from engaging in or continuing any conduct, activity or practice relating to the Company’s business.

 (e) There is no proposed Order that, if issued or otherwise put into effect (i) would or could reasonably be expected to have a
Material Adverse Effect or (ii) would otherwise have the effect of preventing, delaying, making illegal or otherwise interfering with the Acquisition. 
 2.7 Disputes Among Partners. There is no actual, or to the Company’s Knowledge, threatened Proceeding by a Partner against another Partner in respect of the Company or such holder’s Interest or
Shares, as the case may be (a “Partner Proceeding”) and, to Company’s Knowledge, no event has occurred and no condition or circumstance exists that is reasonably likely to result in a Partner Proceeding. 
 2.8 Compliance with Legal Requirements.
 (a) The Company, the General Partner and the Blocker Corp. are each in full compliance in all material respects with all Legal Requirements that are respectively applicable to it or to the conduct of their respective businesses or the
ownership or use of any of their respective assets. 
 (b) No event has occurred, and no condition or circumstance exists, that (with or
without notice or lapse of time) constitutes or is reasonably likely to result directly or indirectly in a material violation by the Company, the General Partner or the Blocker Corp. of, or a failure on the part of the Company to materially comply
with, any Legal Requirement. 
 (c) The Company has not received, at any time, any written notice from any Governmental Authority or any
other Person, and has no Knowledge, regarding (i) any actual or alleged violation of, or failure to comply with, any Legal Requirement by the Company, the General Partner or the Blocker Corp. or (ii) any actual or alleged obligation on the
part of the Company, the General Partner or the Blocker Corp. to undertake, or to bear all or any portion of the cost of, any cleanup or any remedial, corrective or responsive action of any nature. 
 (d) To the Knowledge of the Company, no Governmental Authority has enacted or publicly proposed any Legal Requirement that, if adopted or otherwise put
into effect, would prevent, delay, make illegal or otherwise interfere with the Acquisition. 
 (e) The Company is not a “covered
entity” as that term is defined by 45 C.F.R. § 160.103 nor is the Company subject as a “covered entity” to the Standards for Privacy of Individually Identifiable Health Information promulgated by the U.S. Department of
Health and Human Services in accordance with the Administration Simplification provisions of the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”). The Company is not subject to or is in compliance in all
respects with any similar privacy laws in existence in any state or foreign jurisdiction. 
  

 -9- 

 (f) The Company holds all permits, licenses, certificates, accreditations (including, without limitation,
accreditation by the Joint Commission on Accreditation of Health Organizations (“JCAHO”) as an ambulatory care organization) and other authorizations of foreign, federal, state and local governmental agencies required for the
conduct of the business of the Company, and Section 2.8(f) of the Company Disclosure Letter sets forth a list of all such permits, licenses, certificates, accreditations, and other authorizations, and the Company (and each of the
physicians that provides teleradiology or other services on behalf of the Company) are in compliance with all terms and conditions of any such required permits, licenses, certificates, accreditations and authorizations. 
 (g) The Company’s services meet or exceed the standards for radiology established by the American College of Radiology, including but not limited to
the Technical Standard for Teleradiology, the Technical Standard for Digital Image Data Management and the Practice Guideline for Communication: Diagnostic Radiology. 
 (h) Each of the physicians who provide reading services on behalf of the Company (a) meets all qualifications for readers under any agreement for services pursuant to which such physician provides services on
behalf of the Company, (b) is licensed to practice medicine in each of the states in which the patients are located for which such physician provides medical services, (c) has obtained medical staff privileges at the hospitals for which
such physician provides medical services, (d) has never been excluded or sanctioned by any third-party payor, including, without limitation, Medicare, Medicaid or any private insurance plan, (e) is an independent contractor or an
independent licensed practitioner for all purposes including, without limitation, all Tax purposes and for the JCAHO standards set forth in the 2004 JCAHO Comprehensive Accreditation Manual for Hospitals and (f) does not review mammograms or
participate in interventional radiology on behalf of the Company. 
 (i) Neither the Company nor any physician who provides readings on
behalf of the Company submits any claims for reimbursement for such readings to any third-party payor, including, without limitation, Medicare, Medicaid or any private insurance plan. 
 2.9 Governmental Approvals.
 (a)
Section 2.9(a) of the Company Disclosure Letter identifies each Governmental Approval held by the Company the failure of which to hold would or could reasonably be expected to have a Material Adverse Effect. 
 (b) The Company has delivered or made available to Buyer accurate and complete copies of all such Governmental Approvals, including all renewals thereof
and all amendments thereto. Each Governmental Approval identified or required to be identified in Section 2.9(a) of the Company Disclosure Letter is valid and in full force and effect, Company is in compliance with such Governmental
Approvals, and no fines or penalties are owed by Company in respect of such Governmental Approvals or the failure to obtain or maintain any such Governmental Approvals. Company has received no written notice of any, and there is no pending, or to
Company’s Knowledge threatened, Proceeding which could result in the suspension, termination, revocation, cancellation, limitation or impairment of any such Governmental Approval. To the Knowledge of Company (i) no event or circumstance
exists that would cause Company to be deemed to be out of compliance with, or would cause the suspension, termination, revocation, cancellation, limitation or impairment of, any such Governmental Approval and (ii) Company has not received any
notice of any of the foregoing. 
 (c) The Governmental Approvals identified in Section 2.9(a) of the Company Disclosure Letter
constitute all the Governmental Approvals necessary (i) to enable the Company to conduct its business in the manner in which its business is currently being conducted and as has been conducted in the past year and (ii) to permit the
Company to own and use its assets in the manner in which they are currently owned and used. 
  

 -10- 

 2.10 Financial Statements.
 (a) The Company has delivered to Buyer the following financial statements (collectively, the “Financial Statements”) which are attached
hereto as Section 2.10(a) of the Company Disclosure Letter: 
 (i) the audited combined balance sheets of the Company and General
Partner as of December 31, 2005 and 2006 and the related audited statements of operations, cash flows and changes in Partners capital as of December 31, 2005 and 2006, in each case together with the notes thereto and the report and
certification of the auditor thereto; and 
 (ii) the unaudited combined balance sheet of the Company and General Partner as of
(i) February 28, 2007 and the related unaudited statements of operations, cash flows and changes in Partners capital as of February 28, 2007 (the “Interim Financial Statements”). 
 (b) All the Financial Statements (including the Interim Financial Statements) are accurate and complete in all material respects, in accordance with the
books and records of the Company and present fairly the combined financial position of the Company and General Partner as of the respective dates thereof and the combined results of operations of the Company and General Partner, changes in
Partner’s capital and cash flows for the periods covered thereby. The Financial Statements and the Interim Financial Statements have been prepared in accordance with GAAP, applied on a consistent basis with past periods and practice (except
that the Interim Financial Statements do not have notes thereto and are subject to normal year-end adjustments in accordance with GAAP and past practice). All reserves set forth or reflected in the unaudited balance sheet of the Company as of
February 28, 2007 (the “Interim Balance Sheet”) were established in accordance with GAAP. 
 2.11 Absence of
Undisclosed Liabilities. Neither the Company nor the General Partner has any Liabilities except (i) as set forth on the Interim Balance Sheet prepared in accordance with GAAP and (ii) Liabilities (matured or unmatured, fixed or
contingent) arising after the date of such balance sheet in the Ordinary Course of Business and including Transaction Expenses. 
 2.12
Accounts Receivable.
 (a) Section 2.12(a) of the Company Disclosure Letter sets forth aging, true and complete in all
material respects, of all accounts receivable, notes receivable and other receivables of the Company (including “Accrued Invoices” set forth on the Closing Balance Sheet) (collectively, “Accounts Receivable”) as of the
date immediately prior to the date of the Closing Balance Sheet. 
 (b) All Accounts Receivable of the Company: 
 (i) represent valid and enforceable obligations of customers of the Company arising from bona fide transactions entered into in the Ordinary Course of
Business; 
 (ii) are collectible in the Ordinary Course of Business at the aggregate recorded amounts thereof, net of any applicable
allowance for doubtful accounts reflected on the Closing Balance Sheet; and 
 (iii) are free and clear of all Encumbrances. 
 2.13 Cash Equivalents/Bank Accounts.
 (a) Section 2.13 of the Company Disclosure Letter accurately sets forth, with respect to each account maintained by or for the benefit of the Company at any bank or other financial institution: 
 (i) the name and location of the institution at which such account is maintained; 
 (ii) the name in which such account is maintained and the account number of such account; and 
  

 -11- 

 (iii) the names of all individuals authorized to draw on or make withdrawals from such account.

 The Company has full legal and beneficial interest in all cash, cash equivalents and other financial assets deposited in such accounts, free and clear of
any Encumbrances, other than Permitted Encumbrances. 
 (b) The bank accounts listed on Section 2.13 of the Company Disclosure
Letter have been reconciled as of February 28, 2007. 
 2.14 Title to, Condition of and Sufficiency of Assets; Tangible
Assets.
 (a) Except for leased property set forth on Section 2.14(e) of the Company Disclosure Letter, the leases for the
Leased Premises set forth on Section 2.16 of the Company Disclosure Letter and any Intellectual Property Rights licensed to the Company pursuant to the licenses set forth on Section 2.15(e) of the Company Disclosure Letter,
the Company owns, and has good, valid and marketable title to, all assets purported to be owned by it or used in its business, free and clear of any Encumbrances, except for Permitted Encumbrances, including: 
 (i) all assets reflected on the Interim Balance Sheet; 
 (ii) all assets acquired by the Company since the date of the Interim Balance Sheet; 
 (iii) all other
assets reflected in the Company’s books and records as being owned by the Company; and 
 (iv) all supplies used in the Ordinary Course
of Business (“Supplies”). 
 (b) Section 2.14(b) of the Company Disclosure Letter identifies all equipment,
furniture, fixtures, improvements and other tangible assets owned or leased (indicating those items which are leased) by the Company, in each case having a net book value in excess of $5,000. 
 (c) Except as otherwise indicated, each asset identified in Section 2.14(b) of the Company Disclosure Letter: 
 (i) is in good condition and repair, consistent with its intended use (ordinary wear and tear excepted); and 
 (ii) is adequate for the uses to which it is being put. 
 (d) The assets identified in Section 2.14(b) of the Company Disclosure Letter and the Supplies constitute all of the material tangible assets the Company used for the conduct of its business. 

(e) Section 2.14(e) of the Company Disclosure Letter identifies all equipment and other material tangible or other personal property that
is being leased or licensed to the Company. Except as otherwise indicated, all leases pursuant to which the Company leases such property are in good standing and are valid and effective in accordance with their respective terms, and there exists no
default thereunder or occurrence or condition that is reasonably likely to result in a default thereunder or termination thereof. There are no Encumbrances, other than Permitted Encumbrances, on such property other than as set forth in the
respective leases for such property. 
 (f) Section 2.14(f) of the Company Disclosure Letter sets forth a list of all premises
currently leased by the Company (“Current Leased Premises”) and all premises for which the Company terminated its lease during the past two (2) years (“Prior Leased Premises”). The Current Leased Premises are
in good operating condition, ordinary wear and tear excepted, and are useable in the Ordinary Course of Business. The Company has no liability to the lessor of the Prior Leased Premises for damages to such Prior Leased Premises or as a result of any
obligation of the Company arising on its vacation of the Prior Leased Premises, in each case in excess of any deposit 

  

 -12- 

 
or other reserve specifically established with respect to such liability reflected on the Interim Balance Sheet. The Company has not caused any damage to the
Current Leased Premises and would have no liability to the lessor thereof on its vacation of such Current Leased Premises in accordance with the terms of the lease therefor, in each case in excess of any deposit or other reserve specifically
established with respect to such liability and reflected on the Interim Balance Sheet. 
 (g) The Company owns, or has valid leasehold
interests in, all material (individually or in the aggregate) assets necessary for the conduct of its business as currently conducted. 
 (h)
Notwithstanding anything to the contrary herein, the representations and warranties of the Company set forth in this Section 2.14 do not extend to Intellectual Property Rights owned or used by Company, or any Encumbrances arising out of
or relating to any such Intellectual Property Rights, which Intellectual Property Rights and related Encumbrances shall instead be governed by the representations and warranties of Company set forth in Section 2.15 below. 
 2.15 Intellectual Property.
 (a)
Section 2.15(a) of the Company Disclosure Letter lists all Company Intellectual Property, specifying in each case whether such Company Intellectual Property is owned or controlled by or for, licensed to, or otherwise held by or for the
benefit of Company, including all Registered Intellectual Property Rights owned by, filed in the name of or applied for by Company and used in its business (the “Company Registered Intellectual Property Rights”). 
 (b) Each item of Company Intellectual Property owned by the Company (i) is valid, subsisting and in full force and effect, (ii) has not been
abandoned or passed into the public domain and (iii) is free and clear of any Encumbrances. 
 (c) The Company Intellectual Property
constitutes all the Intellectual Property Rights used in the conduct of its business as it is currently conducted. 
 (d) Each item of
Company Intellectual Property either (i) is exclusively owned by Company and was written and created solely by employees of Company acting within the scope of their employment or by third parties, all of which employees and third parties have
validly and irrevocably assigned all of their rights, including Intellectual Property Rights therein, to Company, and no third party owns or has any rights to any such Company Intellectual Property or (ii) is duly and validly licensed to
Company for use in the manner currently used by Company in the conduct of its business and as it is currently planned to be conducted by Company prior to the Closing. 
 (e) Except as set forth in Section 2.15(e) of the Company Disclosure Letter, in each case in which Company has acquired ownership to any Intellectual Property Rights from any Person, to the Company’s
Knowledge the Company has obtained a valid and enforceable assignment sufficient to irrevocably transfer all rights in such Intellectual Property Rights (including the right to seek past and future damages with respect thereto) to Company. No Person
who has licensed Intellectual Property Rights to Company has ownership rights or license rights to improvements made by Company in such Intellectual Property Rights. Company has not transferred ownership of, or granted any exclusive license of or
right to use, or authorized the retention of any exclusive rights to use or joint ownership of, any Intellectual Property Rights that is or was Company Intellectual Property to any Person. 
 (f) The Company has no Knowledge of any facts, circumstances or information that (i) would render any Company Intellectual Property invalid or
unenforceable, (ii) would adversely affect any pending application for any Company Registered Intellectual Property Right or (iii) would adversely affect or impede the ability of Company to use any Company Intellectual Property in the
conduct of its business as it is currently conducted or as it is currently planned to be conducted by the Company prior to Closing. The Company has not misrepresented, or failed to disclose, and has no Knowledge of any misrepresentation or failure
to disclose, 

  

 -13- 

 
any fact or circumstances in any application for any Company Registered Intellectual Property Right that would constitute fraud or a misrepresentation with
respect to such application or that would otherwise affect the validity or enforceability of any Company Registered Intellectual Property Right. 
 (g) All necessary registration, maintenance and renewal fees in connection with each item of Company Registered Intellectual Property Rights have been paid and all necessary documents and certificates in connection with such Company
Registered Intellectual Property Rights have been filed with the relevant patent, copyright, trademark or other authorities in the United States or foreign jurisdictions, as the case may be, for the purposes of maintaining such Company Registered
Intellectual Property Rights. There are no actions that must be taken by the Company within sixty (60) days following the Closing Date, including the payment of any registration, maintenance or renewal fees or the filing of any responses to
office actions, documents, applications or certificates for the purposes of obtaining, maintaining, perfecting, preserving or renewing any Company Registered Intellectual Property Rights. To the maximum extent provided for by, and in accordance
with, applicable laws and regulations, Company has recorded in a timely manner each such assignment of a Registered Intellectual Property Right assigned to Company with the relevant governmental authority, including the United States Patent and
Trademark Office (the “PTO”), the U.S. Copyright Office or their respective counterparts in any relevant foreign jurisdiction, as the case may be. 
 (h) Company has taken all necessary action to maintain and protect (i) Company’s Intellectual Property and (ii) the secrecy, confidentiality, value and Company’s rights in the Confidential
Information and Trade Secrets of Company and those provided by any Person to Company, including by having and enforcing a policy requiring all current and former employees, consultants and contractors of Company to execute appropriate
confidentiality and assignment agreements. All copies thereof shall be delivered to Buyer at or prior to Closing. Company has no Knowledge of any violation or unauthorized disclosure of any Trade Secret or Confidential Information related to its
business or obligations of confidentiality with respect to its business. 
 (i) To the Knowledge of the Company, the operation of the
Company’s business as it is currently conducted, or as it is currently planned to be conducted by Company prior to Closing, does not and will not, and will not when operated by Buyer substantially in the same manner following the Closing,
violate, infringe or misappropriate any Intellectual Property Rights of any Person. 
 (j) To the Knowledge of the Company, no Person is
violating, infringing or misappropriating any Company Intellectual Property Right. 
 (k) To the Knowledge of the Company, there are no
Proceedings before any Governmental Authority (including before the PTO) anywhere in the world related to any of the Company Intellectual Property, including any Company Registered Intellectual Property Rights. 
 (l) No Company Intellectual Property is subject to any Proceeding or any outstanding decree, order, judgment, office action or settlement agreement or
stipulation that restricts in any manner the use, transfer or licensing thereof by Company or, to the Knowledge of the Company, that may affect the validity, use or enforceability of such Company Intellectual Property. 
 (m) Section 2.15(m) of the Company Disclosure Letter lists all Contracts affecting any Intellectual Property Rights. Company is not in breach
of, nor has Company failed to perform under, any such Contracts and, to Company’s Knowledge, no other party to any such Contracts, is in breach thereof or has failed to perform thereunder. 
 (n) To the extent not listed in Section 2.15(m) of the Company Disclosure Letter, Section 2.15(n) of the Company Disclosure
Letter lists all Contracts under which Company has agreed to, or assumed, any obligation or duty to warrant, indemnify, reimburse, hold harmless, guaranty or otherwise assume or incur any obligation or liability, or provide a right of rescission,
with respect to the infringement or misappropriation by Company or such other person of the Intellectual Property Rights of any Person other than Company. 
  

 -14- 

 (o) To the Knowledge of Company, there is no Contract affecting any Company Intellectual Property under
which there is any dispute regarding the scope of such Contract, or performance under such Contract, including with respect to any payments to be made or received by Company thereunder. 
 (p) All Company Intellectual Property owned by the Company will be fully transferable, alienable or licensable by Buyer or the Company without
restriction (other than restrictions on sublicensing that exist as of the Closing) and without payment of any kind to any third party. The consummation of the transaction as contemplated hereby will not result in any loss of any Company Intellectual
Property or the right to use any Company Intellectual Property. 
 (q) Neither this Agreement nor the transactions contemplated herein,
including the assignment to Buyer, by operation of law or otherwise, of any Contracts will result in (i) Buyer granting to any third party any right to, or with respect to, any Intellectual Property Right owned by, or licensed to, Buyer,
(ii) Buyer being bound by, or subject to, any non-compete or other restriction on the operation or scope of its businesses or (iii) Buyer being obligated to pay any royalties or other amounts to any third party. 
 2.16 Real Property. The Company does not own any Real Property or any interest in Real Property except for the leaseholds created under the
Real Property leases identified in Section 2.16 of the Company Disclosure Letter (the “Leased Premises”) pursuant to which the Company is the lessee. The Company enjoys peaceful and undisturbed possession of such
premises. The Company has delivered or made available to Buyer complete copies of all such leases. All leases pursuant to which the Company leases such property are valid and effective in accordance with their respective terms, and there exists no
material default thereunder by Company or, to the Knowledge of Company, any occurrence or condition that is reasonably likely to result in a default thereunder or termination thereof. The Company will obtain a valid leasehold interest in such
leases, in each case free and clear of all Encumbrances, except Permitted Encumbrances. 
 2.17 Employees, Consultants and
Physicians.
 (a) Section 2.17(a) of the Company Disclosure Letter contains a list of all employees of the Company (including
any employee on a leave of absence or layoff status), showing for each employee, the employee’s hire date, title and current annualized compensation (including separately base salary and bonus or commission). 
 (b) Section 2.17(b) of the Company Disclosure Letter contains a list of individuals who are currently performing services for the Company and
are classified as “consultants” or “independent contractors,” and the respective compensation, including any compensation that may become due as a result of the Acquisition or other event agreed to by the parties, of each such
“consultant” or “independent contractor.” The Company has no direct or indirect liability with respect to any misclassification of any person as an independent contractor rather than as an employee, or with respect to any
employee leased from another employer. 
 (c) Section 2.17(c) of the Company Disclosure Letter contains a list of
(i) physicians who are currently providing radiological interpretations to or on behalf of the Company, (ii) agreed compensation paid to each such physician by the Company, including any compensation that may become due as a result of the
Acquisition or other event agreed to by the parties, (iii) the states in which each such physician is licensed to practice medicine, by physician and (iv) the hospitals at which each such physician has staff privileges, by physician.

 (d) The Company has no collective bargaining agreements, union Contracts or similar Contracts with any of its employees. There is no labor
union organizing activity pending or, to the Company’s Knowledge, threatened with respect to the Company. 
 (e) Except as set forth in
Section 2.17(e) of the Company Disclosure Letter, the employment of each of the Company’s employees is terminable by the Company at will, and no employee has any agreement or contract, written or verbal, regarding his or her
employment other than the employment offer letter delivered by the 

  

 -15- 

 
Company to such employee, in the Company’s standard form, a copy of which form has been made available to Buyer. The Company has delivered or made
available to Buyer accurate and complete copies of all employee manuals and handbooks, disclosure materials, policy statements, employment agreements and other materials relating to the employment of its current employees, and to the extent that the
Company has outstanding payment obligations or Liabilities thereunder, relating to the employment of former employees. 
 (f) To the
Company’s Knowledge (i) no employee of the Company, nor any consultant with whom the Company has contracted, is in violation of any term of any employment contract, proprietary information agreement or other agreement relating to the right
of any such individual to be employed by, or to contract with, the Company because of the nature of the business to be conducted by the Company and (ii) the continued employment by the Company of its present employees, and the performance of
the Company’s Contracts with its independent contractors, will not result in any such violation. The Company has not received any written notice alleging that any such violation has occurred. No employee of the Company has been granted the
right to any continued employment with Company or to any material compensation following termination of employment with the Company. To the Knowledge of the Company, no officer or key employee, or any group of employees, or any independent
contractor or consultant, intends to terminate his, her or their employment with the Company. The Company does not have a present intention to terminate the employment of any officer, key employee, key contractor or group of employees or
contractors. 
 (g) The Company is not engaged, and has never been engaged, in any unfair labor practice of any nature. There has never been
any slowdown, work stoppage, labor dispute or union organizing activity, or any similar activity or dispute, materially affecting the Company or any of its employees. There is not now pending, and to the Knowledge of the Company no Person has
threatened to commence, any such slowdown, work stoppage, labor dispute or union organizing activity or any similar activity or dispute, nor has any event occurred. 
 (h) There are no Proceedings pending with respect to the employees or consultants of the Company in connection with their service with the Company, and to the Knowledge of Company, no such Proceedings are threatened.

 (i) Except as set forth in Section 2.17(i) of the Company Disclosure Letter, the Company has no obligation to pay, and has not
paid or agreed to pay, any bonus or similar amount to any employee or consultant of Company in connection with the Acquisition or this Agreement. 
 2.18 Benefit Plans; ERISA.
 (a) Section 2.18 of the Company Disclosure Letter lists (i) all Employee Benefit
Plans, (ii) all employment agreements, including any individual benefit arrangement, policy or practice with respect to any current or former employee, officer or director of the Company or ERISA Affiliate and (iii) all other employee
benefit, bonus or other incentive compensation, partnership interest option, partnership interest purchase, partnership interest appreciation, severance pay, lay-off or reduction in force, change in control, sick pay, vacation pay, salary
continuation, retainer, leave of absence, educational assistance, service award, employee discount, and fringe benefit plans, arrangements, policies or practices, written or unwritten, whether legally binding or not, which the Company or any ERISA
Affiliate maintains, contributes to or has or could have any obligation to or Liability for (collectively, the “Plans”). 
 (b) None of the Plans is or was a Pension Plan, and neither the Company nor any ERISA Affiliate has ever sponsored, maintained or contributed to, or ever been obligated to contribute to, a Pension Plan. 
 (c) None of the Plans is or was a Multiemployer Plan, and neither the Company nor any ERISA Affiliate has ever contributed to, or ever been obligated to
contribute to, a Multiemployer Plan. 
 (d) The Company does not maintain or contribute to any welfare benefit plan which provides health
benefits to an employee after the employee’s termination of employment or retirement except as required under Section 4980B of the Code and Sections 601 through 608 of ERISA. The Company and its ERISA Affiliates have never maintained,
sponsored or participated in any self insurance medical plan (including any such plan to which a stop-loss policy or contract applies) and no Plan is self-insured. 
  

 -16- 

 (e) Each Plan materially complies by its terms and in operation with the requirements provided by any and
all statutes, orders or governmental rules or regulations currently in effect and applicable to the Plan, including but not limited to ERISA and the Code. 
 (f) All reports, forms and other documents required to be filed with any government entity or furnished to employees, former employees or beneficiaries with respect to any Plan or benefit arrangement (including
without limitation, summary plan descriptions, Forms 5500 and summary annual reports) have been timely filed and furnished and are accurate. 
 (g) Each of the Plans that is intended to qualify under Section 401(a) of the Code is the subject of a favorable determination letter issued by the Internal Revenue Service after January 1, 1997 approving such Plans as so amended
(or (i) the Company has time remaining in which to apply for a favorable determination letter, or (ii) if reliance is permitted under IRS Revenue Procedure 2005-16, the Company relies on the favorable opinion letter or advisory letter of
the master and prototype or volume submitter plan sponsor of such Plan). Each trust maintained pursuant to any such Plan has been determined by the Internal Revenue Service to be exempt from taxation under Section 501 of the Code. To the
Knowledge of Company, nothing has occurred since the date of the Internal Revenue Service’s favorable determination letter that could adversely affect the qualification of the Plan and its related trust. The Company and each ERISA Affiliate
have timely amended and operated each of the applicable Plans in material compliance with the Economic Growth and Tax Relief Reconciliation Act of 2001 and subsequent legislation enacted through the date hereof, and Section 501 of the Code.

 (h) All contributions for each Plan for all periods ending prior to the Closing Date (including periods from the first day of the current
plan year to the Closing Date) have been made prior to the Closing Date by the Company in accordance with applicable Legal Requirements and the recommended contribution in any applicable actuarial report. 
 (i) All required insurance premiums have been paid, subject only to normal retrospective adjustments in the Ordinary Course of Business, with regard to
the Plans for plan years ending on or before the Closing Date. 
 (j) With respect to each Plan: 
 (i) no prohibited transactions (as defined in Section 406 or 407 of ERISA or Section 4975 of the Code) have occurred for which a statutory
exemption is not available; 
 (ii) no actions or claims (other than routine claims for benefits made in the ordinary course of the Plan
administration for which Plan administrative review procedures have not been exhausted) are pending, or, to the Knowledge of the Company, threatened against or with respect to the Plan, any employer who is participating (or who has participated) in
any Plan or any fiduciary (as defined in Section 3(21) of ERISA) of the Plan; 
 (iii) the Company has no Knowledge of any facts which
could give rise to any such action or claim; and 
 (iv) the plan document provides that it may be amended or terminated at any time and,
except for benefits protected under Section 411(d) of the Code, all benefits payable to current or terminated employees or any beneficiary may be amended or terminated by the Company at any time without Liability. 
 (k) Neither the Company nor any ERISA Affiliate has any Liability or is threatened with any Liability (whether joint or several) (i) for any excise
tax imposed by Section 4971, 4975, 4976, 4977 or 4979 of the Code, or (ii) to a fine under Section 502 of ERISA. 
  

 -17- 

 (l) All of the Plans, to the extent applicable, are in material compliance with the continuation of group
health coverage provisions contained in Section 4980B of the Code and Sections 601 through 608 of ERISA, the requirements of the Family Medical Leave Act of 1993, as amended, the requirements of the Health Insurance Portability and
Accountability Act of 1996 (including the regulations set forth in Parts 160, 162, and 164 of Title 45 of the Code of Federal Regulations), the requirements of the Women’s Health and Cancer Rights Act of 1998, the requirements of the
Newborns’ and Mothers’ Health Protection Act of 1996, and any amendment to each such act, or any similar state law requirements. 
 (m) The Company has delivered to Buyer true, correct and complete copies of (i) all documents amending, creating or evidencing any Plan, (ii) all reports, forms and other documents required to be filed with any governmental entity
or furnished to employees, former employees or beneficiaries (including, without limitation, summary plan descriptions, Forms 5500 and summary annual reports for all plans subject to ERISA, but excluding individual account statements and tax forms)
for the preceding plan year, (iii) all IRS determination, opinion, notification and advisory letters and rulings relating to any Plan; (iv) all applications and correspondence to or from the IRS, Department of Labor or any other
governmental agency with respect to any Plan and (v) all material written agreements and contracts relating to each Plan or its related trust (if any), including, but not limited to, administrative service agreements, group annuity contracts
and group insurance contracts. There are no negotiations, demands, proposals, or commitments which are, to the Knowledge of the Company, pending or have been made to increase or enhance the compensation or benefits made available through the Plans
except as otherwise provided in Section 2.18 of the Company Disclosure Letter. 
 (n) No compensation is or will be includable in
income for any current or former employee, officer or director as a result of the operation of Code Section 409A with respect to arrangements or agreements in effect prior to the Closing Date. 
 2.19 Tax Matters.
 (a) The Company has
prepared and timely filed all required Tax Returns relating to any and all Taxes concerning or attributable to the Company or its operations and such Tax Returns are true and correct in all material respects and have been completed in accordance
with applicable law. 
 (b) The Company has timely paid all Taxes required to be paid and timely paid or withheld with respect to its
employees and other third parties (and timely paid over any withheld amounts to the appropriate Governmental Authority) all income taxes, Federal Insurance Contribution Act and Federal Unemployment Tax Act amounts and other Taxes required to be
withheld. 
 (c) The Company has not been delinquent in the payment of any Tax, nor is there any Tax deficiency outstanding, assessed or
proposed against the Company, nor has the Company executed any outstanding waiver of any statute of limitations on or extension of the period for the assessment or collection of any Tax. 
 (d) No audit or other examination of any Tax Return of the Company is presently in progress, nor has the Company been notified of any request for such an
audit or other examination. No adjustment relating to any Tax Return filed by the Company has been proposed by any Governmental Authority to the Company or any representative thereof. No claim has ever been made by a Governmental Authority in a
jurisdiction where the Company files Tax Returns that the Company is or may be subject to taxation by that jurisdiction. 
 (e) The Company
has no liabilities for unpaid Taxes as of the respective date of its Interim Financial Statements which have not been accrued or reserved on the balance sheet included in such Interim Financial Statements, whether asserted or unasserted, contingent
or otherwise, nor has the Company incurred any liability for Taxes since the date of such Interim Financial Statements other than in the Ordinary Course of Business. 
 (f) The Company has made available to Buyer or its legal counsel or accountants copies of all Tax Returns for the Company filed for all periods since inception. 
  

 -18- 

 (g) There are (and immediately following the Closing there will be) no Encumbrances on the assets of the
Company relating to or attributable to Taxes other than Permitted Encumbrances. There is no basis for the assertion of any claim relating or attributable to Taxes which, if adversely determined, would result in any Encumbrance for Taxes on the
assets of the Company. 
 (h) The Company has (a) never been a party to any Tax sharing, indemnification or allocation agreement or
arrangement, nor does the Company owe any amount under any such agreement or arrangement, (b) no liability for the Taxes of any other person as a transferee or successor, by contract, or otherwise or (c) never been a party to any joint
venture, partnership or other agreement that could be treated as a partnership for Tax purposes. 
 (i) The Company has not engaged in a
reportable transaction under Treas. Reg. § 1.6011-4(b), including any transaction that is the same as or substantially similar to one of the types of transactions that the Internal Revenue Service has determined to be a tax avoidance
transaction and identified by notice, regulation, or other form of published guidance as a listed transaction, as set forth in Treas. Reg. § 1.6011-4(b)(2). 
 (j) The Company has been an entity treated as a partnership for U.S. federal income tax purposes at all times since its inception. 
 2.20 Environmental Compliance.
 (a) The Company is and has been at all times in compliance in all
material respects with all Environmental Laws. The Company has now and at all times has had all the necessary permits and other Governmental Approvals required under Environmental Laws for the operation of its business, and is not and has not been
in violation in any material respect of any of the terms and conditions of any of such permits or such other Governmental Approvals. The Company has not received any written notice or other written communication that alleges that the Company is not
in compliance with any Environmental Law. 
 (b) The Company has not generated, manufactured, produced, transported, imported, used, treated,
refined, processed, handled, stored, discharged, released, or disposed of any Hazardous Materials (whether lawfully or unlawfully) at any premises occupied or controlled by the Company on or at any time prior to the Closing Date. There (i) are
not and have not been any releases or threatened releases of any Hazardous Materials by Company, or in connection with the business of Company, or to Company’s Knowledge in any other respect, in any quantity at, on or from any such premises
(ii) are no circumstances that may prevent or interfere with the Company’s material compliance with any Environmental Law (iii) is not, to the Knowledge of the Company, any former owner or user of any such premises who was engaged in
any type of manufacturing or commercial activity on such premises which would be reasonably expected to generate, manufacture, produce, transport, import, use, treat, refine, process, handle, store, discharge, release or dispose of any Hazardous
Materials (whether lawfully or unlawfully) on such premises. 
 2.21 Company Contracts.
 (a) Section 2.21(a) of the Company Disclosure Letter lists each Contract in effect on the date hereof to which Company is a party, to which
any other Person has entered into on behalf of or for the benefit of Company, or pursuant to which Company’s assets or liabilities are otherwise bound or affected, and in each case that falls within one of the following categories,
(collectively, the “Company Contracts”): 
 (i) Partner agreements, voting trusts, proxies or other binding arrangements or
understandings among all or any of the General Partner, Blocker Corp. or the Partners relating to the voting of their respective Interests or Shares, as the case may be; 
 (ii) Investor rights agreements, registration rights agreements and other Contracts granting rights of any nature to any holder of Company partnership interests, general Partner membership interests or Blocker Corp.
securities or other securities of, or other Equity Interest in, the Company, the General Partner or the Blocker Corp., or to persons having rights to acquire such partnership or membership interests, securities or Equity Interest; 
  

 -19- 

 (iii) Contracts related to the issuance or transfer of the partnership interests of, or any other Equity
Interest in, the Company, including partnership interest purchase agreements, warrants, convertible notes, and other notes; 
 (iv) Personal
property leases and conditional sales and title retention agreements for personal property; 
 (v) Real Property leases and subleases and
any other Contracts relating to any right, title or interest in or to Real Property; 
 (vi) any Customer Contract; 
 (vii) any in-bound licenses and related Contracts, other than licenses for commercial off the shelf software licensed by the Company in the Ordinary
Course of Business not required to be set forth on Section 2.15(c) of the Company Disclosure Letter; 
 (viii) any out-bound
licenses and related Contracts, other than Customer Contracts entered into in the Ordinary Course of Business; 
 (ix) any Contract relating
to any sales, agency, distribution, marketing, service/product tie-in, barter or in-kind agreement; 
 (x) any Contract for the manufacture,
service or maintenance of any equipment or other personal property of Company; 
 (xi) any other Contract for capital expenditures or for
the purchase of goods or services; 
 (xii) any mortgage or other Contract involving financing or borrowing of money for the Company, or
evidencing indebtedness or any Liability for borrowed money or any obligation for the deferred purchase price of property in each case for or of the Company (excluding normal trade payables); 
 (xiii) any Contract to indemnify any Person, to share in or contribute to the Liability of any Person or to guarantee any Liability of any Person, other
than Customer Contracts entered into in the Ordinary Course of Business; 
 (xiv) any joint venture, partnership, cooperative arrangement or
similar Contract and any other Contract involving a sharing of profits; 
 (xv) any Contract related to the acquisition of a business or the
equity of any other Person; 
 (xvi) any Contract for the purchase or sale of any assets or for the option or rights to purchase or sell any
assets, in either case in excess of $10,000; 
 (xvii) any Contract with or with respect to any consultant, independent contractor or
employee of the Company, including with respect to bonus, partnership interest option or other incentive equity, termination payments or other compensation, and further including any Contract with any labor union, other than employment offer letters
in the Company’s standard form; 
 (xviii) any Contract with any Governmental Authority; 
  

 -20- 

 (xix) any insurance policy or other Contract pertaining to insurance not disclosed pursuant to
Section 2.27; 
 (xx) any Contract containing covenants not to compete applicable to the Company, with any Person in any
geographical area; 
 (xxi) any power of attorney, proxy or similar instrument; 
 (xxii) any Contract for the purchase or sale of foreign currency or otherwise involving foreign exchange transactions; 
 (xxiii) any Contract containing a “most-favored nation” or other provision requiring adjustment of cost, pricing, priority or other terms or
conditions of the Contract, or performance obligations under such Contract; 
 (xxiv) any Contract requiring Company to “pass
through” or otherwise provide any party to such Contract the full or partial benefit of reduced royalty rates, production or other costs; 
 (xxv) any Contract which by its terms requires the consent of the other party to the transfer or assignment of such Contract, including in the event the Company shall sell all or substantially all of its assets or business or otherwise be
subject to a merger, reorganization, consolidation or change in control; 
 (xxvi) any Contract between Company and an Affiliate, other than
employment offer letters in the Company’s standard form; 
 (xxvii) any confidentiality, non-disclosure or similar Contract between
Company and any third party; and 
 (xxviii)(1) any other Contract which provides for payment or performance by any party thereto
having an aggregate value of $10,000 or more, including future payments, performance of services or delivery of goods or materials to or by Company of an aggregate amount or value in excess of $50,000 on an annual basis, (2) any other Contract
outside the Ordinary Course of Business of Company and (3) any Contract the terms of which are not arm’s-length. 
 (b)
Section 2.21(b) of the Company Disclosure Letter sets forth the material terms of any proposed Contract under negotiation or discussion by the Company that would fall under any of the categories in subsection (a) above if it were
executed or otherwise becomes legally binding at any time in the future. 
 (c) The Company Contracts constitute all of the contracts used in
and necessary for the conduct of the business of the Company as currently conducted, including in a manner consistent with the conduct of the business in the previous year. 
 (d) Company has provided to Buyer true, accurate and complete copies of all of the Company Contracts, and there are no oral or written amendments,
modifications, side letters, supplements or other arrangements or agreements in existence with respect to the Company Contracts which have not been provided to Buyer. 
 (e) Each Company Contract is in full force and effect and is valid and legally binding on Company and, to Company’s Knowledge, the other parties thereto, and each Company Contract is enforceable in accordance
with its terms with respect to Company and, to the Knowledge of Company, with respect to each other party to such Company Contract. Company has no Knowledge of any pending or threatened bankruptcy, insolvency or similar Proceeding with respect to
any party to any Company Contract. 
  

 -21- 

 (f) To the Knowledge of Company, no audit or similar review or investigation has been or is being
conducted by any party to a Company Contract. Company has no Knowledge of, and has not received any written notice or written request with respect to, any such audit, review or investigation, and Company has no Knowledge of any facts that are
reasonably likely to lead to the commencement of any such audit, review or investigation. 
 (g) Company is not in violation or breach of or
default under any Company Contract. To the Knowledge of Company, no third party to any Company Contract is in violation or breach of or default under any Company Contract. No action by Company has been taken, and to Company’s Knowledge, no
action has been taken by another Person, which would, with or without notice or lapse of time, (i) result in a violation or breach of any of the provisions of any Company Contract other than immaterial violations or breaches, (ii) give any
Person the right to declare a default under or exercise any remedy under any Company Contract, (iii) give any Person the right to accelerate the maturity or performance of any Company Contract or (iv) give any Person the right to cancel,
terminate or modify any Company Contract or assert a counterclaim, defense or offsetting claim under a Company Contract. Company has no Knowledge of, and has received no written notice of, any of the foregoing, and Company has no Knowledge of facts
that are reasonably likely to result in any of the foregoing. 
 (h) No Person (i) is renegotiating or (ii) has requested a
renegotiation of, any amount paid or payable to Company under any Company Contract or any other term or provision of any Company Contract. Company has not waived any of its material rights under any Company Contract. Performance of the Company
Contracts by Company as of and immediately following the Closing Date will not result in any violation of or failure to comply with any Legal Requirement. Company has not guaranteed or otherwise agreed to insure or become liable for in any way any
Contract or Liability of another Person, or pledged any of Company’s assets to secure the performance or payment of any Company Contract. Neither Company nor any of its Affiliates or officers nor, to the Knowledge of Company, any employee or
agent of Company or any other Person acting on Company’s behalf, has directly or indirectly within the last five (5) years provided, or agreed to provide, any tangible or intangible benefit to any customer, supplier, Governmental
Authority, employee or other Person that would result in any violation of any Legal Requirement. 
 2.22 Government
Contracts.
 (a) The Company has not been suspended or debarred from bidding on contracts or subcontracts for any Government Authority
nor, to the Company’s Knowledge, has any suspension or debarment action been commenced. There is no valid basis for the Company’s suspension or debarment from bidding on contracts or subcontracts for any Government Authority. 

(b) The Company has not within the preceding three (3) years been, nor is it now being, audited or, to Company’s Knowledge, investigated by
any Government Authority, including without limitation the Government Accountability Office, the Defense Contract Audit Agency, the Defense Contract Administrative Service, the Department of Labor, the Department of Health and Human Services, the
Environmental Protection Agency, the General Services Administration, or the inspector general or auditor general or similar functionary of any agency or instrumentality nor, to the best of Company’s Knowledge, is any such audit or
investigation threatened. 
 (c) No material cost incurred by the Company pertaining to any contracts or subcontracts for any Government
Authority has been questioned or challenged by representatives of a Government Authority, or is, to the Knowledge of Company, the subject of any investigation, or has been disallowed by the United States government, and no amount of money due to the
Company pertaining to any contracts or subcontracts for any Government Authority has been withheld or set off nor has any claim been made to withhold or set off money and the Company is entitled to all progress payments received with respect
thereto; and all amounts previously charged or at present carried as chargeable by the Company to any contracts or subcontracts for any Government Authority have been or will be reasonable, allowable and allocable to each such contracts or
subcontracts for any Government Authority. 
  

 -22- 

 (d) The operation of its business by the Company, as it relates to the contracts or subcontracts for any
Government Authority, has been conducted in all material respects in accordance with all applicable laws, regulations, and other requirements of all Government Authorities. 
 2.23 Medical Liability. Company is not subject to any Liability arising from any injury to Person or property or as a result of any claim of
medical malpractice or similar circumstance. There are no pending claims, and within the last five (5) years there have not been any material claims involving any of the Company’s physician contractors or physician employees. 

2.24 Customers and Contractors. The Company has not received any written notice of, and Company has no Knowledge of, facts or
circumstances indicating that any current customer or contractor including in connection with the consummation of the Acquisition or otherwise (i) intends to cease dealing with Company, (ii) intends to otherwise materially reduce the
volume of business transacted by such Person with Company, (iii) is otherwise materially dissatisfied with the services the Company provides such person or otherwise with its relationship with Company or (iv) is threatened with bankruptcy
or insolvency. 
 2.25 Restrictive Covenants. There is no Contract to which the Company is a party or any Order or Legal
Requirement binding upon or applicable to the Company which has or would reasonably be expected to have the effect of (a) prohibiting or materially impairing any business or medical practice material to the Company, (b) prohibiting or
materially impairing any acquisition of property by the Company or (c) restricting or prohibiting, through a non-competition or similar obligation or otherwise, the Company from conducting business or competing in any line of business with any
Person or in any geographic area. 
 2.26 Competing Business. Except as described in Section 2.26 of the Company
Disclosure Letter, neither Company nor, to the Knowledge of Company, any officer, director or Partner (or any Affiliate thereof) directly or indirectly holds any interest in (excepting not more than two percent (2%) stockholdings for investment
purposes in securities of publicly held and traded companies), or is an officer, director, employee or consultant of, or otherwise receives remuneration from, any Person that is, or is engaged in business as, a competitor, lessor, lessee, customer
or supplier of Company or is party to any Contract with the Company. 
 2.27 Insurance.
 (a) Section 2.27 of the Company Disclosure Letter sets forth, with respect to each insurance policy maintained by or at the expense of, or for
the direct or indirect benefit of, the Company as of the Execution Date: 
 (i) the name of the insurance carrier that issued such policy and
the policy number of such policy; 
 (ii) whether such policy is a “claims made” or an “occurrences” policy; 

(iii) a description of the coverage provided by such policy; 
 (iv) the annual premium payable with respect to such policy; and 
 (v) a description of any claims pending,
and any claims that have been asserted in the past, with respect to such policy. 
 (b) The Company has delivered or made available to Buyer
accurate and complete copies of each of the insurance policies identified in Section 2.27 of the Company Disclosure Letter (including all renewals thereof and endorsements thereto) and binders relating thereto indicating that such
policies are in full force and effect as of the date hereof, and all of the pending applications identified in Section 2.27 of the Company Disclosure Letter. The Company does not have any self-insurance or risk sharing arrangement
affecting the Company or any of its assets. 
  

 -23- 

 (c) Each of the policies identified in Section 2.27 of the Company Disclosure Letter is
valid, enforceable and in full force and effect, and has been issued by an insurance carrier that, to the Knowledge of the Company, is solvent and financially sound. All of the information contained in the applications submitted in connection with
said policies was (at the times said applications were submitted) accurate and complete in all material respects, and all premiums and other amounts owing with respect to said policies have been paid in full. The Company maintains policies of
insurance of the type and in amounts reasonably and customarily carried by persons conducting businesses or owning assets similar in type and size and in similar industries to those of the Company, including medical liability and all legally
required workers’ compensation insurance and errors and omissions, casualty, fire and general liability insurance. Each of the policies identified in Section 2.27 of the Company Disclosure Letter will continue in full force and
effect following the Closing, and the Company has paid all premiums due, and has otherwise performed in all material respects all of its obligations, under each policy to which it is a party or that provides coverage to it or any of its directors,
officers or contractors in connection with their performance of services to the Company. 
 (d) There is no pending claim under or based upon
any of the policies identified in Section 2.27 of the Company Disclosure Letter and, to the Knowledge of the Company, no event has occurred, and to the Company’s Knowledge, no condition or circumstance exists, that would (with or
without notice or lapse of time) directly or indirectly give rise to or serve as a reasonable basis for any such claim. 
 (e) The Company
has not received: 
 (i) any notice regarding the actual or possible cancellation or invalidation of any of the policies identified in
Section 2.27 of the Company Disclosure Letter or regarding any actual or possible adjustment in the amount of the premiums payable with respect to any of said policies; or 
 (ii) any notice regarding any actual or possible refusal of coverage under, or any actual or possible rejection of any claim under, any of the policies
identified in Section 2.27 of the Company Disclosure Letter. 
 2.28 Affiliate Transactions. Except as provided in
Section 2.28 of the Company Disclosure Letter: 
 (a) no Affiliate of the Company has, and no such Affiliate of the Company has at
any time had, any direct or indirect interest of any nature in any asset used in or otherwise relating to the business of the Company. 
 (b)
no Affiliate of the Company is indebted to the Company for an amount, individually or in the aggregate, in excess of $1,000. 
 (c) no
Affiliate of the Company has entered into, or has had any direct or indirect financial interest in, any Contract, transaction or business dealing of any nature involving the Company other than with respect to the grant or purchase of Interests in
the Company or except in connection with employment with Company. 
 (d) to the Knowledge of the Company, no Affiliate of the Company has any
claim or right against the Company, except for salary, vacation pay, expense reimbursement or similar claims arising from such Affiliate’s employment with the Company. 
 2.29 Interim Operations. Since December 31, 2006: 
 (a) The Company has operated in the Ordinary Course of Business, and there has not been any occurrence, event, incident, action, failure to act or transaction outside the Ordinary Course of Business; 
 (b) The Company has not (i) declared, accrued, set aside or paid any dividend or made any other distribution in respect of any partnership interests
(other than distributions to Partners, in accordance with past 

  

 -24- 

 
practice, in respect of the taxes payable upon their allocable share of the Company’s income) or (ii) repurchased, redeemed or otherwise reacquired
any partnership interests or other securities, or split, combined or reclassified any of its partnership interests or issued or authorized the issuance of any other securities in respect of, in lieu of or in substitution for partnership interests,
or repurchased or otherwise acquired, directly or indirectly, any partnership interests; 
 (c) The Company has not sold or otherwise issued
(or granted any warrants, options or other rights to purchase) any partnership interests or any other Equity Interest in the Company; 
 (d)
The Company has not amended its Certificate of Limited Partnership or Limited Partnership Agreement and has not effected or been a party to any acquisition transaction, recapitalization, reorganization, reclassification (by split or otherwise) of
partnership interests or similar transaction (other than the acquisition transaction with Buyer set forth herein); 
 (e) There has not been
any material damage, destruction or other casualty loss with respect to any of the Company’s assets; 
 (f) Company has not materially
violated any Legal Requirement applicable to Company; 
 (g) None of the Company or any Partner has entered into any Contract (other than
with Buyer and its Affiliates) regarding any sale or acquisition of the Company (whether by merger, partnership interest acquisition or otherwise) or all or a significant portion of its assets, or any license to its Intellectual Property Rights
outside the Ordinary Course of Business or any exclusive license to its Intellectual Property Rights, nor has Company entered into any Contract with respect to any acquisition by Company of any Person or assets that would materially affect or relate
to the Company’s business; 
 (h) There has not been, except as required by any change in GAAP, any material change by Company in its
accounting principles, practices or methods, in its Tax practices or principles or in the practices or standards used to maintain Company’s books, accounts or business records; 
 (i) Company has not violated, entered into, terminated or modified any of its Company Contracts or Governmental Approvals, and no Governmental Authority
or other Person has amended, accelerated, terminated or modified any such Company Contracts or Governmental Approvals; 
 (j) To
Company’s Knowledge, no Proceeding has been commenced against Company, and Company has not commenced any Proceeding against any other Person other than for the routine collection of Accounts Receivable in the Ordinary Course of Business;

 (k) Company has not (i) failed to maintain its assets in good repair, order and condition, reasonable wear and tear excepted,
(ii) accelerated the collection of any Accounts Receivable or (iii) made any sale of any such Accounts Receivable or any accrual of liabilities, written off any Accounts Receivable which are individually or in the aggregate material or
portions thereof as uncollectible or established an extraordinary reserve with respect thereto; 
 (l) Company has not sold, leased,
transferred or assigned any material asset, other than in the Ordinary Course of Business; 
 (m) Company has not assigned, nor granted any
license or sublicense of any rights under or with respect to, any of its Intellectual Property Rights or granted any license with respect to any such right (other than non-exclusive licenses to customers of the Company in the Ordinary Course of
Business); 
 (n) Company has not made any material gifts or sold, transferred or exchanged any material property on a non-arm’s length
basis; 
  

 -25- 

 (o) Company has not mortgaged, pledged or subjected any of its assets to any Encumbrance; 
 (p) Company has not forgiven any material debt or otherwise released or waived any material right or claim nor discharged any material lien nor paid any
obligation or Liability other than in the Ordinary Course of Business; 
 (q) To the Knowledge of Company, Company has not suffered any
material loss of or harm to any relationship with, any customer or other third Person material to the Company’s business; 
 (r) The
Company has not otherwise become subject to any Liability in an individual or aggregate amount greater than $1,000 not otherwise reflected on the most recent Interim Balance Sheet; 
 (s) Company has not taken, or failed to take, any other action that would or could reasonably be expected to have a Material Adverse Effect; and

 (t) Company has not entered into any Contract or otherwise agreed, in writing or otherwise, to take any of the actions that are described
above or that would be reasonably likely to lead to the occurrence of any of the events or conditions described above. 
 2.30 Finders and
Brokers; Fees. Except as set forth on Section 2.30 of the Company Disclosure Letter, neither the Company nor any person acting on behalf of the Company has negotiated with any finder, broker or any similar person in connection
with the Acquisition. Except as set forth on Section 2.30 of the Company Disclosure Letter, the Company has not entered into a Contract that provides that a fee shall be paid to any Person if the Acquisition is consummated and has not
otherwise incurred any Liability for any brokerage fees, commissions or finder’s fees with respect to this Agreement or the Acquisition. 
 2.31 Full Disclosure. Neither this Agreement (including all schedules and exhibits hereto) nor the other Transaction Agreements (including all schedules and exhibits thereto) contain any untrue statement of material fact or
omits to state any fact necessary to make any of the representations, warranties or statements contained herein or therein not misleading. 
 ARTICLE III 
 REPRESENTATIONS AND WARRANTIES OF THE GENERAL PARTNER 
 The General Partner represents and warrants to Buyer (except, with respect to any particular section or subsection of this ARTICLE III, to the
extent specifically described in the corresponding section or subsection of the General Partner Disclosure Letter delivered to the Buyer at the time of execution hereof (the “General Partner Disclosure Letter”)) that the statements
contained in this ARTICLE III are true and correct as of the date hereof and as of the Closing Date. 
 3.1 Organization, Good
Standing, Qualification.
 (a) The General Partner is a limited liability company duly formed and validly existing, and is in good
standing, under the laws of the State of Texas, and is duly qualified to conduct business and is in good standing in each jurisdiction in which the failure to be so qualified and in good standing would or could reasonably be expected to have a
Material Adverse Effect. The General Partner has all requisite power and authority to own and operate its properties and assets, to execute and deliver this Agreement and the other Transaction Agreements contemplated to be executed and delivered by
it, to carry out the provisions hereof and thereof, and to carry on its business as currently conducted and as presently proposed to be conducted. 
 (b) Section 3.1(b) of the General Partner Disclosure Letter accurately sets forth (i) the names of the members of the General Partner’s board of managers, (ii) the names of the members of each committee of the
General Partner’s board of managers and (iii) the names and titles of the General Partner’s officers. 
  

 -26- 

 (c) Neither the General Partner nor the Partners have ever approved, or commenced any proceeding, or made
any election contemplating, the dissolution or liquidation of the General Partner or the winding up or cessation of the General Partner’s business or affairs. 
 (d) Other than the partnership interests of the Company, the General Partner does not currently own and has never owned, beneficially or otherwise, any shares or other securities of, or any other direct or any other
indirect interest of any nature in, any Entity. 
 3.2 Articles of Organization and Amended and Restated Regulations;
Records.
 (a) The General Partner has delivered or otherwise made available to Buyer accurate and complete copies of: 
 (i) the General Partner’s Articles of Organization and Amended and Restated Regulations, including all amendments thereto, as presently in effect;

 (ii) the membership interest records of the General Partner ; and 
 (iii) the minutes and other records of the meetings and other actions (including any actions taken by written consent or otherwise without a meeting)
relating to the General Partner of the Partners, the General Partner’s board of managers and all committees of the General Partner’s board of managers. 
 (b) The General Partner has never conducted any business under or otherwise used, for any purpose or in any jurisdiction, any fictitious name, assumed name, trade name or other name, other than name “Radlinx
Management Company, LLC.” 
 (c) There has not been any uncured violation of (i) any of the provisions of the General
Partner’s Articles of Organization or Amended and Restated Regulations or (ii) any resolutions adopted by the Partners related to the General Partner, the General Partner’s board of managers, or any committee of the board of managers
of the General Partner’s within the last five (5) years, and no event has occurred, and no condition or circumstance exists, that (with or without notice or lapse of time) constitutes or is reasonably likely to result directly or
indirectly in such a violation. 
 (d) The books of account, membership interest records, minute books and other records of the General
Partner are accurate, up to date and complete in all material respects. All of the records of the General Partner are in the actual possession or control of the General Partner. The General Partner has been administered and the General Partner
limited liability company records maintained as required by Legal Requirements to maintain the separate legal existence of the General Partner. 
 3.3 Capitalization.
 (a) As of the date of the Agreement, the authorized membership interests of the General Partner consist
of 1,000 units, of which 1,000 units are issued and outstanding. No other Interests are authorized or issued and outstanding. Section 3.3 of the General Partner Disclosure Letter sets forth a true and complete list of the record holders
of such Interests listing the type, amount and percentage total of such Interests held by each such holder. All issued and outstanding Interests have been issued in compliance with all applicable securities laws and other applicable Legal
Requirements. 
 (b) The General Partner has not granted any purchaser or other recipient of its membership interests or other securities the
right to require the General Partner to register any securities under the Securities Act or to qualify for any exemption thereunder. 
  

 -27- 

 (c) Except as set forth on Section 3.3 of the General Partner Disclosure Letter, there is no:

 (i) outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire any membership interests or
other securities of the General Partner; 
 (ii) outstanding security, instrument or obligation that is or may become convertible into or
exchangeable for any membership interests or other securities of the General Partner; 
 (iii) Contract under which the General Partner is
or may become obligated to sell or otherwise issue any of its membership interests or any other securities; 
 (iv) condition or
circumstance that will directly or indirectly give rise to or provide a reasonable basis for the assertion of a claim by any Person to the effect that such Person is entitled to acquire or receive from the General Partner any membership interests or
other securities of the General Partner; or 
 (v) other Equity Interest existing with respect to the General Partner. 
 (d) The General Partner has never repurchased, redeemed or otherwise reacquired (or agreed, committed or offered (in writing or otherwise) to repurchase,
redeem or otherwise reacquire) any membership interests or other securities. 
 3.4 Authority; Binding Nature of Agreements. The
execution, delivery and performance by the General Partner of this Agreement and such Transaction Agreements to which it is contemplated to be a party have been duly authorized by all necessary member action on the part of the General Partner, its
board of managers and the Partners. This Agreement and the other Transaction Agreements constitute (assuming such agreements constitute legal, valid and binding obligations of Buyer to the extent it is executing such agreements), or upon execution
and delivery will constitute (assuming such agreements constitute legal, valid and binding obligations of Buyer to the extent it is executing such agreements), the legal, valid and binding obligations of the General Partner, enforceable against the
General Partner in accordance with their respective terms, subject only to bankruptcy, insolvency, reorganization and similar Legal Requirements. 
 3.5 Tax Matters.
 (a) The General Partner has prepared and timely filed all required Tax Returns relating to any and all
Taxes concerning or attributable to the General Partner or its operations and such Tax Returns are true and correct and have been completed in accordance with applicable law. 
 (b) The General Partner has timely paid all Taxes required to be paid and timely paid or withheld with respect to its employees and other third parties
(and timely paid over any withheld amounts to the appropriate Governmental Authority) all income taxes, Federal Insurance Contribution Act and Federal Unemployment Tax Act amounts and other Taxes required to be withheld. 
 (c) The General Partner has not been delinquent in the payment of any Tax, nor is there any Tax deficiency outstanding, assessed or proposed against the
General Partner, nor has the General Partner executed any outstanding waiver of any statute of limitations on or extension of the period for the assessment or collection of any Tax. 
 (d) No audit or other examination of any Tax Return of the General Partner is presently in progress, nor has the General Partner been notified of any
request for such an audit or other examination. No adjustment relating to any Tax Return filed by the General Partner has been proposed by any Governmental Authority to the General Partner or any representative thereof. No claim has ever been made
by a Governmental Authority in a jurisdiction where the General Partner files Tax Returns that the General Partner is or may be subject to taxation by that jurisdiction. 
 (e) The General Partner has no liabilities for unpaid Taxes as of the respective date of the General Partner Interim Financial Statements which have not been accrued or reserved on the balance sheet included 

  

 -28- 

 
in the General Partner Interim Financial Statements, whether asserted or unasserted, contingent or otherwise, nor has the General Partner incurred any
liability for Taxes since the date of such General Partner Interim Financial Statements other than in the Ordinary Course of Business. 
 (f)
The General Partner has made available to Buyer or its legal counsel or accountants copies of all Tax Returns for the General Partner filed for all periods since inception. 
 (g) There are (and immediately following the Closing there will be) no Encumbrances on the assets of the General Partner relating to or attributable to
Taxes other than Permitted Encumbrances. There is no basis for the assertion of any claim relating or attributable to Taxes which, if adversely determined, would result in any Encumbrance for Taxes on the assets of the General Partner. 

(h) The General Partner has (a) never been a party to any Tax sharing, indemnification or allocation agreement or arrangement, nor does the
General Partner owe any amount under any such agreement or arrangement (b) no liability for the Taxes of any other person as a transferee or successor, by contract, or otherwise or (c) never been a party to any joint venture, partnership
or other agreement that could be treated as a partnership for Tax purposes (except, in the case of each of (a), (b) and (c), as a result of the General Partner’s ownership of a general partnership interest in the Company). 

(i) The General Partner has not engaged in a reportable transaction under Treas. Reg. § 1.6011-4(b), including any transaction that is the
same as or substantially similar to one of the types of transactions that the Internal Revenue Service has determined to be a tax avoidance transaction and identified by notice, regulation, or other form of published guidance as a listed
transaction, as set forth in Treas. Reg. § 1.6011-4(b)(2). 
 (j) The General Partner has been an entity treated as a partnership
for U.S. federal income tax purposes at all times since its inception. 
 (k) General Partner was formed for the sole purpose of owning a
general partnership interest in the Company, and has conducted no activities other than such ownership. 
 ARTICLE IV 
 REPRESENTATIONS AND WARRANTIES OF BLOCKER CORP. 
 Blocker Corp. represents and warrants to Buyer that (except, with respect to any particular section or subsection of this ARTICLE IV, to the extent specifically described in the corresponding section or subsection of the Blocker
Corp. Disclosure Letter delivered to Buyer at the time of execution hereof (the “Blocker Corp. Disclosure Letter”) the statements contained in this ARTICLE IV are true and correct as of the date hereof and as of the Closing
Date. 
 4.1 Organization, Good Standing, Qualification.
 (a) Blocker Corp. is a corporation duly formed and validly existing, and is in good standing, under the laws of the State of Delaware, and is duly qualified to conduct business and is in good standing in each
jurisdiction in which the failure to be so qualified and in good standing would or could reasonably be expected to have a Material Adverse Effect. Blocker Corp. has all requisite power and authority to own and operate its properties and assets, to
execute and deliver this Agreement and the other Transaction Agreements contemplated to be executed and delivered by it, to carry out the provisions hereof and thereof, and to carry on its business as currently conducted and as presently proposed to
be conducted. 
 (b) Section 4.1(b) of the Blocker Corp. Disclosure Letter accurately sets forth (i) the names of the
members of Blocker Corp.’s board of directors, (ii) the names of the members of each committee of the Blocker Corp.’s board of directors and (iii) the names and titles of Blocker Corp.’s officers. 
  

 -29- 

 (c) Neither Blocker Corp. nor its board of directors or stockholders have ever approved, or commenced any
proceeding, or made any election contemplating, the dissolution or liquidation of Blocker Corp. or the winding up or cessation of Blocker Corp.’s business or affairs. 
 (d) Other than its partnership interests in the Company and its membership interests in the General Partner, Blocker Corp. does not current own and has
never owned, beneficially or otherwise, any shares or other securities of, or any other direct or any other indirect interest of any nature in, any Entity. 
 4.2 Certificate of Incorporation; Records.
 (a) Blocker Corp. has delivered or otherwise made
available to Buyer accurate and complete copies of: 
 (i) Blocker Corp.’s Certificate of Incorporation and By-Laws, including all
amendments thereto, as presently in effect; 
 (ii) the stock records of Blocker Corp.; and 
 (iii) the minutes and other records of the meetings and other actions (including any actions taken by written consent or otherwise without a meeting) of
the stockholders, the board of directors and all committees of Blocker Corp.’s board of directors. 
 (b) Blocker Corp. has never
conducted any business under or otherwise used, for any purpose or in any jurisdiction, any fictitious name, assumed name, trade name or other name, other than the name “Healthlinx, Inc.” 
 (c) There has not been any uncured violation of (i) any of the provisions of Blocker Corp.’s Certificate of Incorporation or By-Laws or
(ii) any resolutions adopted by Blocker Corp.’s board of directors, or any committee of the board of directors of Blocker Corp. within the last five (5) years, and no event has occurred, and no condition or circumstance exists, that
(with or without notice or lapse of time) constitutes or is reasonably likely to result directly or indirectly in such a violation. 
 (d)
The books of account, stock records, minute books and other records of Blocker Corp. are accurate, up to date and complete in all material respects. All of the records of Blocker Corp. are in the actual possession or control of Blocker Corp. Blocker
Corp. has been administered and the company records maintained as required by Legal Requirements to maintain the separate corporate existence of Blocker Corp. 
 4.3 Capitalization.
 (a) As of the date of the Agreement, the authorized capital stock of Blocker
Corp. consists of 1,000 authorized shares of common stock, all of which are issued and outstanding. DWHP owns all of the Shares of record and beneficially, and no other Interests are authorized or issued and outstanding. Section 4.3 of
the Blocker Corp. Disclosure Letter sets forth a true and complete list of the record holders of such Interests listing the type, amount and percentage total of such Interests held by each such holder. All issued and outstanding Interests, and have
been issued in compliance with all applicable securities laws and other applicable Legal Requirements. 
 (b) Blocker Corp. has not granted
any purchaser or other recipient of its securities the right to require Blocker Corp. to register any securities under the Securities Act or to qualify for any exemption thereunder. 
 (c) Except as set forth on Section 4.3 of the Blocker Corp. Disclosure Letter, there is no: 
 (i) outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire any capital stock or other securities of
Blocker Corp.; 
  

 -30- 

 (ii) outstanding security, instrument or obligation that is or may become convertible into or
exchangeable for any capital stock or other securities of Blocker Corp.; 
 (iii) Contract under which Blocker Corp. is or may become
obligated to sell or otherwise issue any of its capital stock or any other securities; 
 (iv) condition or circumstance that will directly
or indirectly give rise to or provide a reasonable basis for the assertion of a claim by any Person to the effect that such Person is entitled to acquire or receive from Blocker Corp. any capital stock or other securities of the General Partner; or

 (v) other Equity Interest existing with respect to Blocker Corp. 
 (d) Blocker Corp. has never repurchased, redeemed or otherwise reacquired (or agreed, committed or offered (in writing or otherwise) to repurchase,
redeem or otherwise reacquire) any capital stock interests or other securities. 
 4.4 Authority; Binding Nature of
Agreements. The execution, delivery and performance by Blocker Corp. of this Agreement and such Transaction Agreements to which it is contemplated to be a party have been duly authorized by all necessary action on the part of Blocker Corp.,
its board of directors and shareholders. This Agreement and the other Transaction Agreements constitute (assuming such agreements constitute legal, valid and binding obligations of Buyer to the extent it is executing such agreements), or upon
execution and delivery will constitute (assuming such agreements constitute legal, valid and binding obligations of Buyer to the extent it is executing such agreements), the legal, valid and binding obligations of Blocker Corp., enforceable against
Blocker Corp. in accordance with their respective terms, subject only to bankruptcy, insolvency, reorganization and similar Legal Requirements. 
 4.5 Tax Matters.
 (a) Blocker Corp. has prepared and timely filed all Tax Returns relating to any and all Taxes concerning or
attributable to Blocker Corp. or its operations as required on or before the date of this Agreement and such Tax Returns are true and correct in all material respects and have been completed in accordance with applicable law. 
 (b) Blocker Corp. has timely paid all Taxes it is required to pay and timely paid or withheld with respect to its employees and other third parties, if
any (and timely paid over any withheld amounts to the appropriate Governmental Authority) all income Taxes, Federal Insurance Contribution Act and Federal Unemployment Tax Act amounts and other Taxes required to be withheld. 
 (c) Blocker Corp. has not been delinquent in the payment of any Tax, nor is there any Tax deficiency outstanding, assessed or proposed against Blocker
Corp., nor has Blocker Corp. executed any outstanding waiver of any statute of limitations on or extension of the period for the assessment or collection of any Tax. 
 (d) No audit or other examination of any Tax Return of Blocker Corp. is presently in progress, nor has Blocker Corp. been notified of any request for such an audit or other examination. No adjustment relating to any
Tax Return filed by Blocker Corp. has been proposed by any Governmental Authority to Blocker Corp. or any representative thereof. No claim has ever been made by a Governmental Authority in a jurisdiction where Blocker Corp. does not file Tax Returns
that it is or may be subject to taxation by that jurisdiction. 
 (e) Blocker Corp. has no liabilities for unpaid Taxes which have not been
disclosed in Section 4.5 of the Blocker Corp. Disclosure Letter, whether asserted or unasserted, contingent or otherwise, and Blocker Corp. has not incurred any liability for Taxes since the date of such financial statements other than in the
Ordinary Course of Business. 
  

 -31- 

 (f) Blocker Corp. has made available to Buyer or its legal counsel or accountants copies of all Tax
Returns for Blocker Corp. filed for all periods since its inception. 
 (g) There are (and immediately following the Effective Time there
will be) no Encumbrances on the assets of Blocker Corp. relating to or attributable to Taxes other than Permitted Encumbrances. There is no basis for the assertion of any claim relating or attributable to Taxes which, if adversely determined, would
result in any Encumbrance for Taxes on the assets of Blocker Corp. 
 (h) Blocker Corp. is not, and has not been at any time, a “United
States Real Property Holding Corporation” within the meaning of Section 897(c)(2) of the Code. 
 (i) Blocker Corp. has
(a) never been a member of an affiliated group (within the meaning of Code § 1504(a)) filing a consolidated U.S. federal income Tax Return, (b) never been a party to any Tax sharing, indemnification or allocation agreement or
arrangement, nor does Blocker Corp. owe any amount under any such agreement or arrangement (c) no liability for the Taxes of any person under Treas. Reg. § 1.1502-6 (or any similar provision of state, local or non-U.S. law, including
any arrangement for group or consortium relief or similar arrangement), as a transferee or successor, by contract, or otherwise and (d) never been a party to any joint venture, partnership or other agreement that could be treated as a
partnership for Tax purposes (except, in the case of each of (b), (c) and (d), as a result of its ownership of a membership interest in the General Partner or a limited partnership interest in the Company). 
 (j) Blocker Corp. has not constituted either a “distributing corporation” or a “controlled corporation” in a distribution of stock
intended to qualify for tax-free treatment under Section 355 of the Code. 
 (k) Blocker Corp. has not engaged in a reportable
transaction under Treas. Reg. § 1.6011-4(b), including any transaction that is the same as or substantially similar to one of the types of transactions that the Internal Revenue Service has determined to be a tax avoidance transaction and
identified by notice, regulation, or other form of published guidance as a listed transaction, as set forth in Treas. Reg. § 1.6011-4(b)(2). 
 (l) Blocker Corp. uses the accrual method of accounting for income Tax purposes. 
 (m) Blocker Corp. will
not be required to include any income or gain or exclude any deduction or loss from Taxable income as a result of (a) any change in method of accounting under Section 481 of the Code, (b) closing agreement under Section 7121 of
the Code (or in the case of each of (a) and (b) under any similar provision of applicable law), (c) installment sale or open transaction disposition or (d) prepaid amount. 
 (n) There is no contract, agreement, plan or arrangement to which Blocker Corp. is a party, including, without limitation, the provisions of this
Agreement, covering any employee or former employee of Blocker Corp. or other person, which, individually or collectively (and alone or in conjunction with subsequent events), could give rise to the payment of any amount that would not be deductible
pursuant to Sections 280G, 404 or 162(m) of the Code or any similar provision of applicable law. 
 (o) Blocker Corp. was formed for the
sole purpose of owning a general partnership interest in the General Partner and a limited partnership interest in the Company, and has conducted no activities other than such ownership. 
 4.6 Absence of Undisclosed Liabilities. Blocker Corp. has no Liabilities except (i) franchise Taxes relating to its existence as a
corporation and (ii) Taxes relating to its allocable share of the Company’s income. 
  

 -32- 

 ARTICLE V 
 REPRESENTATIONS AND WARRANTIES OF PARTNERS 
 Each Partner severally represents and warrants to Buyer that
the statements contained in this ARTICLE V are true and correct as of the date hereof and as of the Closing Date. 
 5.1 Ownership
of Equity. Such Partner is the sole legal and beneficial owner of all of the outstanding Interests and Shares, as the case may be, set forth opposite such Partner’s name on Schedule 1.1(c) as of the Closing Date; and such
Interests and Shares are to be sold pursuant to this Agreement. None of such Interests or Shares is subject to any Encumbrances or to any rights of first refusal of any kind, except those set forth on Schedule 5.1 or applicable federal
or state securities laws, and no rights to purchase such Interests or Shares, as the case may be, have been granted by any such Partner, by the General Partner or by Blocker Corp. to any other Person. Such Partner has the sole right to transfer such
Interests or Shares, as the case may be, to Buyer. Such Interests or Shares, as the case may be, constitute all of the Interests or Shares, as the case may be, owned, beneficially or legally by such Partner, and such Partner has no other rights to
acquire Interests or Shares. Upon the Closing, Buyer will receive good title to such Interests or Shares, as the case may be, subject to no Encumbrances retained, granted or permitted by such Partner, the General Partner, the Blocker Corp. or the
Company. If such Partner has purchased or otherwise acquired any Interests subject to repurchase by the Company or the General Partner, as the case may be, such Partner has timely filed all elections and notices under Section 83(b) of the Code
with respect to such Interests. Schedule 1.1(c) contains accurate wire transfer instructions for such Partner. 
 5.2 Tax
Matters. Such Partner has had an opportunity to review with its own tax advisors the tax consequences of the Acquisition and the transactions contemplated by this Agreement. Such Partner understands that it must rely solely on its advisors
and not on any statements or representations made by Buyer, the Company, the General Partner or any of their agents. Such Partner understands that it (and not Buyer or the Company) shall be responsible for its own tax liability that may arise as a
result of the Acquisition. 
 5.3 Absence of Claims by the Partners. Except for (i) compensation and expense reimbursements
less than $10,000 in the aggregate earned by employees of the Company in the Ordinary Course of Business and (ii) payments required to be made under continuing agreements noted as such on Section 2.28 of the Company Disclosure
Letter, no Partner has any present claim against the Company, the General Partner or the Blocker Corp. or has Knowledge of the basis for any future claim against the Company, the General Partner or the Blocker Corp whether contingent or
unconditional, fixed or variable, under any contract or on any other legal basis whatsoever, whether in such Partner’s capacity as a Partner or otherwise. 
 5.4 Authority. Such Partner has the legal capacity to enter into, as applicable, this Agreement and the agreements contemplated by this Agreement to which such Partner is a party and to consummate the
transactions contemplated hereby and thereby. No further action is required on the part of Partner to authorize this Agreement and the agreements contemplated by this Agreement to which such Partner is a party and the transactions contemplated
hereby and thereby. This Agreement and the agreements contemplated by this Agreement to which such Partner is a party have been duly executed and delivered by such Partner and, assuming the due authorization, execution and delivery by the other
parties thereto, constitute the valid and binding obligations of such Partner, enforceable in accordance with their terms, except as such enforceability may be limited by principles of public policy and subject to the laws of general application
relating to bankruptcy, insolvency and the relief of debtors and to rules of law governing specific performance, injunctive relief or other equitable remedies. 
 5.5 No Conflict. The execution and delivery by such Partner of this Agreement and the agreements contemplated by this Agreement to which such Partner is a party and the consummation of the transactions
contemplated hereby and thereby will not conflict with (i) any mortgage, indenture, lease, contract or other agreement or instrument, permit, concession, franchise or license to which such Partner or any of its properties or assets are subject
(a “Partner’s Conflict”) or (ii) any judgment, order, decree, statute, law, ordinance, rule or regulation applicable to such Partner or its properties or assets. 
 5.6 Consents. No consent, waiver, approval, order or authorization of, or registration, declaration or filing with, any Governmental Entity
or any third party, including a party to any agreement with such Partner (so as not to trigger any Partners Conflict), is required by or with respect to such Partner in connection with the execution and delivery of this Agreement and the agreements
contemplated by this Agreement to which such Partner is a party or the consummation of the transactions contemplated hereby or thereby except for such consents, waivers, approvals, orders, authorizations, registrations, declarations and filings as
may be required under applicable laws thereby. 
  

 -33- 

 ARTICLE VI 
 REPRESENTATIONS AND WARRANTIES OF BUYER 
 Buyer represents and warrants to the Company as follows, as of the
date hereof and the Closing, to and for the benefit of the Company and the Partners: 
 6.1 Organization, Standing and
Power. Buyer is a corporation duly organized, validly existing and in good standing under the laws of Delaware. Buyer has the corporate power to enter into and perform this Agreement and the other Transaction Agreements to which it is a
party, and Buyer is duly qualified to do business and is in good standing in each jurisdiction in which the failure to be so qualified and in good standing would or could reasonably be expected to have a Material Adverse Effect on Buyer’s
ability to enter into this Agreement and the other Transaction Documents and consummate the transactions contemplated hereby and thereby. Buyer is not in violation of any of the provisions of its certificate of incorporation or bylaws in a manner
which would or could reasonably be expected to have a material adverse effect on Buyer’s ability to enter into this Agreement and the other Transaction Documents and consummate the transactions contemplated hereby and thereby. 
 6.2 Authority; Binding Nature of Agreements. The execution, delivery and performance by Buyer of this Agreement and such Transaction
Agreements to which it is a party have been duly authorized by all necessary corporate action on the part of Buyer. This Agreement and such other Transaction Agreements constitute (assuming such agreements constitute legal, valid and binding
obligations of Company and the Partners), or upon execution and delivery will constitute (assuming such agreements constitute legal, valid and binding obligations of Company and the Partners), the legal, valid and binding obligations of Buyer,
enforceable against Buyer in accordance with its terms, subject only to bankruptcy, insolvency, reorganization and similar Legal Requirements. 
 6.3 Non-Contravention; Consents. The execution, delivery and performance of this Agreement and the other Transaction Agreements and the consummation of the Acquisition will not, directly or indirectly (with or without notice or
lapse of time): (i) contravene or result in a violation of any provisions of the Buyer’s Certificate of Incorporation or Bylaws; or (ii) contravene, conflict with or result in a violation of, any Order to which the Buyer or any assets
owned by the Buyer are subject. 
 6.4. Finders and Brokers; Fees. Neither the Buyer nor any person acting on its behalf has
negotiated with any finder, broker or any similar person in connection with the Acquisition. The Buyer has not entered into a Contract that provides that a fee shall be paid to any Person if the Acquisition is consummated and has not otherwise
incurred any Liability for any brokerage fees, commissions or finder’s fees with respect to this Agreement or the Acquisition. 
 ARTICLE
VII 
 ADDITIONAL AGREEMENTS 
 7.1 Public Announcements. Except as otherwise required by Legal Requirements, (i) neither the Company, the General Partner, the Blocker Corp. nor any Partner shall issue or cause the publication of any press release or
other public announcement with respect to the transactions contemplated hereby without the prior written consent of Buyer and (ii) Buyer shall not issue or cause the publication of any press release or other public announcement with respect to
the transactions contemplated hereby without prior consultation with the Partner Representative. 
 7.2 Key Personnel. GL and MB
shall each be considered a key employee of the Company (the “Key Personnel”) and, contemporaneously with the execution and delivery of this Agreement, have entered into a service and non-competition agreement (the
“Employment Agreements”) satisfactory to Buyer. The Employment Agreements will be signed simultaneously with this Agreement, and will become effective as of the Closing. 
  

 -34- 

 7.3 Closing Balance Sheet. The Company has prepared and delivered to Buyer an estimated
unaudited combined balance sheet of the Company and General Partner as of the business day immediately preceding the Closing Date (the “Closing Balance Sheet”), which Closing Balance Sheet is prepared on estimates derived from and
made in accordance with the books and records of the Company and General Partner, and the Closing Balance Sheet shall, taking into account such estimates, fairly present in all material respects the financial condition of the Company and General
Partner as of the date thereof. The Company shall provide to Buyer any information and back-up materials (including bank account information and an accounts payable schedule) reasonably requested by Buyer with respect thereto. The Closing Balance
Sheet shall be accompanied by a statement (the “Statement”) setting forth the Closing Date Net Working Capital, the Accounts Receivable and the Working Capital Threshold, which Statement shall include a reasonably detailed summary
of the calculations made to arrive at such amounts. The Statement and the amounts reflected thereon shall be based upon the amounts reflected on the Closing Balance Sheet (or otherwise calculated in the case of the Working Capital Threshold), and
shall accurately present in all respects the Closing Date Net Working Capital, the Accounts Receivable and the Working Capital Threshold. 
 7.4 Employee Plans. If requested by Buyer, Company shall, immediately prior to the Closing, terminate any one or more of the Plans. In the event Buyer requests that any of the Plans be terminated, Company shall adopt resolutions
and shall take all other actions necessary to effect the termination of any such Plans, to be effective no later than the Closing, and shall provide to Buyer executed resolutions by the board of managers of the Company authorizing the termination of
any such Plans. 
 7.5 Company Closing Deliverables. The Company has delivered or caused to be delivered at Closing to Buyer, in
form and substance reasonably acceptable to Buyer, the following items: 
 (a) A duly executed opinion of Company’s outside corporate
counsel, substantially in the form attached hereto as Exhibit B; 
 (b) The signed written resignations of the officers and
directors of the Company, the General Partner and the Blocker Corp. in office immediately prior to the Closing Date, effective contingent upon the consummation of the Acquisition; 
 (c) A certificate from (i) the Secretary of State of the State of Texas as to the Company’s and the General Partner’s good standing and
(ii) the Secretary of State of the State of Delaware as to the Blocker Corp’s good standing, in each case dated at a date which is as close as reasonably practicable in advance of the Closing Date, but in no event more than five
(5) days prior to the Closing Date; 
 (d) The Financial Statements described in Section 2.10(a); 
 (e) Signature cards for the bank accounts of Company listed on Section 2.13 of the Company Disclosure Letter that Buyer may use to transfer
authority of those accounts to designees of Buyer’s choosing; 
 (f) A properly executed statement, in a form and substance reasonably
acceptable to Buyer, for purposes of satisfying Buyer’s obligations under Treas. Reg. § 1.1445-2(c)(3), and a notice to the Internal Revenue Service that complies with the requirements of Treas. Reg. § 1.897-2(h)(2);

 (g) A pay-off letter in respect of each outstanding instrument representing Indebtedness of the Company and lien release documents
relating thereto, in each case reasonably satisfactory to Buyer, which will become effective upon payment of the amounts specified in the pay-off letter 
  

 -35- 

 (h) An amendment to the lease agreement related to Company property located at 747 Plaza Blvd, Coppell,
Texas 75019 providing for, among other things, a right in the Buyer to terminate upon sixty (60) days prior written notice; 
  

	 	(i)	Duly executed Extension Agreements; and 

  

	 	(j)	Such other items as may be provided for herein. 

 7.6
Tax Matters.
 (a) Responsibility for Certain Taxes. Notwithstanding anything to the contrary in this Agreement, in addition to
any other remedy provided by this Agreement, the Buyer Indemnified Parties (including, after the Closing, the Blocker Corp., the General Partner and the Company) shall be indemnified and held harmless against any and all liability, obligation or
commitment, whether or not accrued, assessed or currently due and payable, as well as related Damages, for any and all Taxes imposed on the Blocker Corp., the General Partner, the Company or their respective operations with respect to any Tax period
(or portion thereof) ending on or before the Closing Date (a “Pre-Closing Tax Period”). The indemnification obligation set forth in the preceding sentence shall be the sole responsibility of DWHP with respect to Taxes imposed on the
Blocker Corp., and the sole responsibility of the Partners with respect to Taxes imposed on the General Partner or the Company, but with respect to the General Partner or the Company only to the extent secured by the Escrow Amount. In the case of
any taxable period that includes (but does not end on) the Closing Date (each, a “Straddle Period”), (i) the real, personal and intangible property Taxes (“Property Taxes”) imposed upon the Blocker Corp., the
General Partner, the Company or their respective operations that are allocable to the Pre-Closing Tax Period shall be equal to the amount of such Property Taxes for the entire Straddle Period multiplied by a fraction, the numerator of which is the
number of days during the Straddle Period that are in the Pre-Closing Tax Period and the denominator of which is the number of days in the Straddle Period and (ii) the Taxes (other than Property Taxes) imposed upon the Blocker Corp., the
General Partner, the Company or their respective operations that are allocable to the Pre-Closing Tax Period shall be computed as if such taxable period ended on the Closing Date, provided that exemptions, allowances or deductions that are
calculated on an annual basis (including depreciation and amortization deductions), other than with respect to property placed in service after the Closing, shall be allocated between the period ending on the Closing Date and the period after the
Closing Date in proportion to the number of days in each period. Any cash refunds or credits of Taxes paid by Blocker Corp., or by DWHP on behalf of Blocker Corp., shall be for the account of DWHP, and to the extent received by Buyer or Blocker
Corp. shall be offset against DWHP’s indemnification obligation pursuant to this Section 7.6(a) or, to the extent not required for that purpose, paid to DWHP. 
 (b) Tax Returns. Buyer shall be responsible for the preparation and filing of any Tax Return of or with respect to the Blocker Corp., the General Partner, the Company or their respective operations that is
required to be filed after the Closing Date, other than any such Tax Return for income taxes, franchise taxes imposed in lieu of income taxes or similar taxes with respect to a Pre-Closing Tax Period (an “Income Tax Return”). Each
such Tax Return shall be true and correct and completed in accordance with all Legal Requirements in all material respects. At least thirty (30) days prior to the due date for filing (including extensions), Buyer shall provide any such Tax
Return relating to a Pre-Closing Tax Period or a Straddle Period to DWHP, if it is a Tax Return of or with respect to the Blocker Corp or its operations, or to the Partners, if it is a Tax Return of or with respect to the General Partner, the
Company, or their respective operations, for review, and each such Tax Return shall be revised to reflect the Partner’s reasonable comments that are received at least five (5) days prior to the due date for filing (including extensions).
The Partners shall be responsible for the preparation and filing of any Tax Return of or with respect to the General Partner, the Company or their respective operations, and DWHP shall be responsible for the preparation and filing of any Tax Return
of or with respect to the Blocker Corp. or its operations, in each case if such Tax Return is required to be filed on or before the Closing Date or is an Income Tax Return. Each such Tax Return shall be true and correct and completed
in accordance with applicable law and consistent with past practice in all material respects. At least thirty (30) days prior to the due date for filing (including extensions), the Partners shall provide each such Tax Return to Buyer for
review, and each such Tax Return shall be revised to reflect Buyer’s reasonable comments that are received at least five (5) days prior to the due date for filing (including extensions). 
  

 -36- 

 (c) Tax Contests. The Partners shall control and bear the cost of the conduct of any audit, claim,
dispute or controversy (“Tax Contest”) relating to any Tax imposed on the General Partner, the Company or their respective operations for which the Partners are responsible pursuant to Section 7.6(a). DWHP shall control
and bear the cost of the conduct of any Tax Contest relating to any Tax imposed on the Blocker Corp. or its operations for which DWHP is responsible pursuant to Section 7.6(a). Buyer shall have the right to participate at its own expense
in any Tax Contest referred to in the two preceding sentences, and the Partners shall provide Buyer with copies of all correspondence and filings relating to such Tax Contests. Buyer shall control all other Tax Contests relating to the Blocker
Corp., the General Partner, the Company or their respective operations. The Partners shall not (i) take any position on any amended Tax Return relating to the Blocker Corp., the General Partner, the Company or their respective operations
(including any Income Tax Return) that is inconsistent with the provisions of this Agreement or (ii) settle or compromise any Tax Contest relating to the Blocker Corp., RGMC, the Company or their respective operations (including any Tax Contest
with respect to any Income Tax Return), in each case that would be inconsistent with the provisions of this Agreement. 
 (d) Tax Sharing
Agreements. Any Tax sharing, indemnification or allocation agreement or arrangement to which the Blocker Corp., the General Partner, or the Company is a party or by which any of them is bound shall be terminated effective as of the Closing, and
none of the Blocker Corp., the General Partner, or the Company shall have any liability pursuant to any such agreement. 
 (e) Interim Tax
Covenants. From the Execution Date until the earlier of the Closing Date or the termination of this Agreement pursuant to ARTICLE IX, with respect to the Blocker Corp., the General Partner, and the Company, none of the Partners shall make
or change any material Tax election, adopt or change any Tax accounting method, enter into any closing agreement, settle or compromise any Tax claim or assessment, file any amended Tax Return or other material Tax Return, consent to the extension or
waiver of the limitation period applicable to any Tax claim or assessment. 
 (f) Cooperation. The parties to this Agreement shall
provide assistance to each other as reasonably requested in preparing and filing Tax Returns and responding to Tax Contests, provide reasonably detailed notice of any Tax Contest sufficient to apprise the other party of the nature of the claim, make
available to each other as reasonably requested all relevant information, records, and documents, including workpapers, relating to Taxes of or with respect to the Blocker Corp., the General Partner, the Company or their respective operation, and
retain any books and records that could reasonably be expected to be necessary or useful in connection with any preparation by any other party of any Tax Return, or for any Tax Contest. The Partners shall contact Buyer prior to the disposition of
any books and records described in this Section 7.6(f) and allow Buyer to obtain such books and records within thirty (30) days of such notice. 
 (g) Survival; Conflicts. The indemnity obligations set forth in this Section 7.6 and the representations and warranties contained in Sections 2.19 and 3.5 hereof shall terminate
on the second anniversary date of the Closing and the representations and warranties contained in Section 4.5 (Tax Matters) shall terminate on the date of the expiration of the applicable statute of limitations with respect to Tax
liabilities in question (giving effect to any waiver, mitigation or extension thereof). 
 ARTICLE VIII 
 INDEMNIFICATION 
 8.1 Survival of
Representations, Warranties and Covenants.
 (a) All representations and warranties of the Company, the General Partner, the Blocker Corp.
and the Partners contained in this Agreement shall (i) survive the Closing and any investigation at any time made and the consummation of the Acquisition and (ii) terminate and expire at the end of two (2) years following Closing
except for any claims as to which written notice identifying such claim and the basis thereof with reasonable specificity shall have been delivered pursuant to the applicable provisions of this Agreement on or prior to such date. Notwithstanding the
foregoing (i) the representations and warranties in Section 4.5 shall terminate on the date of 
  

 -37- 

 expiration of the applicable statute of limitations and (ii) in the case of liability for fraud, the representations
and warranties that are the subject of such fraud shall not terminate until the expiration of the applicable statute of limitations. The representations and warranties of the Company, the General Partner, the Blocker Corp. and the Partners contained
in this Agreement (and any right to indemnification for breach thereof or other right to indemnification hereunder) shall not be affected by any investigation, verification or examination by Buyer or by any Representative or employee of Buyer or by
the knowledge of the Buyer or the knowledge of any such Representative or employee of any facts with respect to the accuracy or inaccuracy of any such representation or warranty. 
 (b) Covenants. The covenants and agreements of the parties shall survive the Closing and any investigation at any time made and the consummation
of the Acquisition until fully performed, unless limited by their terms or purposes. 
 (c) Effect of Expiration. On expiration or
termination, the representations, warranties and covenants described in subsections (a) and (b) above shall be of no further force or effect, except with respect to any claim for indemnification hereunder as to which written notice
identifying such claim and the basis thereof with reasonable specificity shall have been delivered pursuant to the applicable provisions of this Agreement on or prior to such expiration or termination. 
 8.2 Indemnification.
 (a) From and
after the Closing Date and until the expiration of the period set forth in Section 8.1(a) or (b) (the “Indemnification Expiration”), the Partners (the “Company Indemnifying Parties”) shall
severally and pro rata in accordance with their Consideration Percentage of the Escrow Amount, indemnify, defend and hold harmless Buyer and its Representatives and employees (the “Buyer Indemnified Parties”) from and against any
and all Damages incurred by Buyer or its Representatives, whether or not involving a third party claim, including reasonable attorneys’ fees, arising out of, relating to or resulting from (a) any breach or inaccuracy of a representation or
warranty of the Company, the General Partner, the Blocker Corp. or a Partner contained in this Agreement or in any other Transaction Agreement or in any certificate, instrument, document or agreement delivered by the Company, the General Partner,
the Blocker Corp. or a Partner pursuant to or in connection therewith (including, without limitation, the Closing Balance Sheet) and (b) any breach of a covenant of the Company, the General Partner, the Blocker Corp. or a Partner contained in
this Agreement or in any other Transaction Agreement. On expiration or termination of the underlying representations, warranties and covenants, the obligations of Company Indemnifying Parties in this Section 8.2(a) shall be of no further
force or effect with respect to any such expired or terminated representation, warranty or covenant, except with respect to any claim for indemnification hereunder as to which written notice identifying such claim and the basis thereof with
reasonable specificity shall have been delivered pursuant to the applicable provisions of this Agreement on or prior to such expiration or termination. 
 (b) In the event that Buyer determines in good faith from time to time that it or any Buyer Indemnified Parties is entitled to payment under the indemnities set forth in this Agreement or is otherwise entitled to
set-off any payment hereunder, it shall deliver a written notice of claim (a “Claim”) to such effect to the Partner Representative and to the Escrow Agent. The notice of a Claim shall set forth in reasonable detail the basis for the
claimed indemnity and, if determinable, the amount of Damages related thereto (the “Projected Indemnity Amount”). Resolution of such Claim shall be as set forth in the Escrow Agreement. 
 (c) The Escrow Fund shall be reduced from time to time by any amount, without duplication, (i) that has been determined by a court of competent
jurisdiction to be owing by a Partner to Buyer or a Buyer Indemnified Party, (ii) set forth on a written notice delivered to the Escrow Agent by the Partner Representative directing that such amount be deducted from the Escrow Fund and paid to
Buyer or a Buyer Indemnified Party, (iii) related to a Claim or Projected Indemnity Amount to which the Partner Representative has not, within twenty (20) days after receipt of notice of a Claim or the determination of such Projected
Indemnity Amount, disputed in writing pursuant to Section 8.2(g) below or (iv) that is distributed to the Partners pursuant to Sections 8.2(d), 8.2(e) and 8.2(f) below. 
  

 -38- 

 (d) Promptly after the date that is twelve (12) months after the Closing Date (such twelve month
date, the “Initial Distribution Date”), Buyer will notify the Partner Representative and the Escrow Agent in writing of the aggregate Projected Indemnity Amount as of the Initial Distribution Date. As promptly as practicable
following delivery of such notice (but in no event sooner than twenty (20) days after delivery of such notice), an amount (the “Initial Distribution Amount”) equal to (i) $2.65 million, minus (ii) amounts theretofore
paid from the Escrow Fund pursuant to Section 8.2(c), minus (iii) an amount equal to such aggregate Projected Indemnity Amount as of the Initial Distribution Date, shall be transferred and delivered by the Escrow Agent to the
Partners in accordance with their Consideration Percentage and the written payment instructions for each Partner delivered to the Escrow Agent by the Partner Representative. 
 (e) Promptly after the date that is twenty-four (24) months after the Closing Date (such twenty-four month date, the “Second Distribution
Date”), Buyer will notify the Partner Representative and the Escrow Agent in writing of the aggregate Projected Indemnity Amount as of the Second Distribution Date. As promptly as practicable following delivery of such notice (but in no
event sooner than twenty (20) days after delivery of such notice), an amount (the “Second Distribution Amount”) equal to (i) the remainder of the Escrow Fund (as the same may be reduced from time to time pursuant to this
Agreement) as of such date minus (ii) an amount equal to such aggregate Projected Indemnity Amount as of the Second Distribution Date shall be transferred and delivered by the Escrow Agent to the Partners in accordance with their Consideration
Percentage and the written payment instructions for each Partner delivered to the Escrow Agent by the Partner Representative. 
 (f) Promptly
after the final resolution of any outstanding claim following the Second Distribution Date, notice of which was delivered in accordance with Section 8.2(b), Buyer will notify the Partner Representative and the Escrow Agent in writing of
the remaining aggregate Projected Indemnity Amount as of such date. As promptly as practicable following delivery of such notice, an amount (the “Subsequent Distribution Amount”) equal to (i) the Remaining Amount (as the same
may be reduced from time to time pursuant to this Agreement) as of such date minus (ii) an amount equal to the Projected Indemnity Amount as of such date, shall be transferred and delivered by the Escrow Agent to the Partners in accordance with
their Consideration Percentage and the written payment instructions for each Partner delivered to the Escrow Agent by the Partner Representative. The “Remaining Amount” as of any date shall mean the amount equal to (A) the
remainder of the Escrow Fund (as the same may be reduced from time to time pursuant to this Agreement) minus (B) the sum of (1) the Initial Distribution Amount, (2) the Second Distribution Amount (if theretofore paid) and (3) the
aggregate amount transferred and delivered by the Escrow Agent to the Partners prior to such date pursuant to this Section 8.2. 
 (g) Dispute Resolution. In the event that the Partner Representative disputes any Claim or the Buyer’s determination of the Projected Indemnity Amount, the Partner Representative shall notify Buyer and the Escrow Agent in
writing within twenty (20) days after receipt of notice of a Claim or the determination of such Projected Indemnity Amount of such dispute and the Partner Representative and Buyer shall attempt in good faith to resolve such dispute within
thirty (30) days of such notification by the Partner Representative to Buyer. If the Partner Representative and the Buyer should so agree, a written notice setting forth such agreement shall be prepared and signed by the Partner Representative
and Buyer and delivered to the Escrow Agent. If the Partner Representative does not notify Buyer and the Escrow Agent in writing within the twenty (20) day period after delivery by the Buyer of the notice of Claim, such failure to so object
shall be an irrevocable acknowledgment by the Partner Representative that the Buyer Indemnified Parties are entitled to the full amount of the claim for Damages set forth in such notice and the Escrow Agent is authorized to pay to Buyer the full
amount of such claim out of the Escrow Fund to payment of such Damages. If such dispute is not so resolved within such 30-day period, then the matter shall be resolved in accordance with the provisions of the Escrow Agreement. 
 8.3 Indemnification Basket. In seeking indemnification for Damages under this ARTICLE VIII, the Buyer Indemnified Parties shall make
no Claim against the Escrow Fund for Damages unless and until the cumulative aggregate of such Claims exceeds $150,000 (the “Basket Amount”), after which the Buyer Indemnified Parties shall be entitled to seek indemnification for
all such Claims, provided, however, that Claims in respect of any breach of the representations and warranties set forth in Section 2.15 and Section 4.5, the obligations of the Partners under Section 1.8 and the
obligations of DWHP under Section 7.6 shall not be subject to the Basket Amount limitation, and such Claims shall not count toward satisfaction of the Basket Amount for purposes of other Claims for recovery of Damages. Buyer’s sole
remedy in respect of Claims for indemnification, except as otherwise set forth herein, shall be limited to the Escrow Fund. 
  

 -39- 

 8.4 Procedures for Indemnification for Third Party Claims. In the event Buyer becomes aware
of a third-party claim which Buyer reasonably believes may result in a demand for recovery of Damages, Buyer shall notify the Partner Representative and the Escrow Agent of such claim, and the Partner Representative shall be entitled on behalf of
the Partners, at their expense, to participate in, but not to determine or conduct, the defense of such claim. Buyer shall have the right in its sole discretion to conduct the defense of and settle any such claim; provided, however, that except with
the consent of the Partner Representative, no settlement of any such claim with third-party claimants shall be determinative of the amount of Damages relating to such matter. In the event that the Partner Representative has consented to any such
settlement, the Partners shall have no power or authority to object under any provision of this ARTICLE VIII to the amount of any claim by Buyer with respect to such settlement. 
 8.5 Partner Representative.
 (a) Each
of the Partners hereby appoints Gregory A. Lowenstein, as its agent and attorney-in-fact, as the Partner Representative for and on behalf of the Partners, to give and receive notices and communications, to authorize the payment of Damages from the
Escrow Fund, to object to any claim set forth in an Officers Certificate, to agree to, negotiate, enter into settlements and compromises of, and comply with orders of courts with respect to such claims, and to take all other actions that are either
(i) necessary or appropriate in the judgment of the Partner Representative for the accomplishment of the foregoing or (ii) specifically mandated by the terms of this Agreement. Such agency may be changed by the Partners from time to time
upon not less than thirty (30) days prior written notice to the Partner Representative and the Company. Upon any change in the Partner Representative, such successor Partner Representative shall promptly provide the Buyer with a signature
specimen. No bond shall be required of the Partner Representative, and the Partner Representative shall not receive compensation for its services. Notices or communications to or from the Partner Representative shall constitute notice to or from the
Partners. 
 (b) The Partner Representative shall not be liable for any act done or omitted hereunder as the Partner Representative while
acting in good faith and in the exercise of reasonable judgment. The Partners shall indemnify the Partner Representative and hold the Partner Representative harmless against any loss, liability or expense incurred without negligence or bad faith on
the part of the Partner Representative and arising out of or in connection with the acceptance or administration of the Partner Representative’s duties hereunder, including the reasonable fees and expenses of any legal counsel retained by the
Partner Representative. 
 (c) A decision, act, consent or instruction of the Partner Representative pursuant to this Agreement shall
constitute a decision of the Partners and shall be final, binding and conclusive upon the Partners, and Buyer Indemnified Parties may rely upon any such decision, act, consent or instruction of the Partner Representative as being the decision, act,
consent or instruction of the Partners. In addition, the Partner Representative may agree to the amendment, extension or waiver of this Agreement pursuant to Section 10.6 hereof. The Buyer Indemnified Parties are hereby relieved from any
liability to any Person for any acts done by them in accordance with such decision, act, consent or instruction of the Partner Representative. 
 8.6 Limitation of Liability. In no event shall the maximum liability of the Company Indemnifying Parties under this ARTICLE VIII (exclusive of any liability for indemnification for fraud or for breaches or inaccuracies of
any of the representations and warranties in Section 4.5) exceed, in the aggregate, the balance of the Escrow Fund as of the date of such Claim. Except for Claims made with respect to Damages related to a breach or inaccuracy of any of
the representations and warranties in Section 4.5 or in the case of any liability for fraud, the Escrow Fund represents the sole source of recovery of any claims made by Buyer Indemnified Parties pursuant to this ARTICLE VIII.

  

 -40- 

 ARTICLE IX 
 RELEASE 
 9.1 PARTNER RELEASE; ACKNOWLEDGEMENT. EFFECTIVE AS OF THE CLOSING, EACH PARTNER DOES
FOR ITSELF, HIMSELF OR HERSELF, AND ITS, HIS OR HER RESPECTIVE AFFILIATES, PARTNERS, HEIRS, BENEFICIARIES, SUCCESSORS AND ASSIGNS (THE “RELEASING PARTIES”), IF ANY, RELEASE AND ABSOLUTELY FOREVER DISCHARGE THE COMPANY AND THE
GENERAL PARTNER AND EACH OF THEIR RESPECTIVE MEMBERS, OFFICERS, DIRECTORS, PARTNERS, AFFILIATES, EMPLOYEES AND AGENTS (EACH, A “RELEASED PARTY”) FROM AND AGAINST ALL RELEASED MATTERS. “RELEASED MATTERS” MEANS ANY
AND ALL CLAIMS, DEMANDS, DAMAGES, DEBTS, LIABILITIES, OBLIGATIONS, COSTS, EXPENSES (INCLUDING ATTORNEYS’ AND ACCOUNTANTS’ FEES AND EXPENSES), ACTIONS AND CAUSES OF ACTION OF ANY NATURE WHATSOEVER, WHETHER NOW KNOWN OR UNKNOWN, SUSPECTED OR
UNSUSPECTED, THAT SUCH PARTNER NOW HAS, OR AT ANY TIME PREVIOUSLY HAD, OR SHALL OR MAY HAVE IN THE FUTURE, AS A PARTNER, MEMBER, OFFICER, DIRECTOR, CONTRACTOR, CONSULTANT OR EMPLOYEE OF THE COMPANY OR THE GENERAL PARTNER, ARISING BY VIRTUE OF OR IN
ANY MATTER RELATED TO ANY ACTIONS OR INACTIONS WITH RESPECT TO THE COMPANY AND THE GENERAL PARTNER OR THEIR RESPECTIVE AFFAIRS ON OR BEFORE THE CLOSING DATE; PROVIDED THAT RELEASED MATTERS SHALL NOT INCLUDE ANY RIGHT OF THE RELEASING PARTIES
UNDER THIS AGREEMENT OR THE TRANSACTION DOCUMENTS OR INCLUDE ANY OF THE MATTERS NOTED IN SECTION 5.3. IT IS THE INTENTION OF THE PARTNERS IN EXECUTING THIS RELEASE, AND IN GIVING AND RECEIVING THE CONSIDERATION CALLED FOR HEREIN, THAT
THE RELEASE CONTAINED IN THIS SECTION 9.1 SHALL BE EFFECTIVE AS A FULL AND FINAL ACCORD AND SATISFACTION AND GENERAL RELEASE OF AND FROM ALL RELEASED MATTERS AND THE FINAL RESOLUTION BY SUCH PARTNER AND THE RELEASED PARTIES OF ALL
RELEASED MATTERS. NOTWITHSTANDING ANYTHING HEREIN OR OTHERWISE TO THE CONTRARY, THE RELEASE CONTAINED IN THIS SECTION 9.1 WILL NOT BE EFFECTIVE SO AS TO BENEFIT A PARTICULAR RELEASED PARTY IN CONNECTION WITH ANY MATTER OR EVENT THAT
WOULD OTHERWISE CONSTITUTE A RELEASED MATTER, BUT INVOLVED FRAUD, WILLFUL CONCEALMENT, OR THE BREACH OF ANY APPLICABLE LAW ON THE PART OF SUCH RELEASED PARTY. EACH PARTNER HEREBY REPRESENTS TO THE COMPANY AND THE GENERAL PARTNER THAT SUCH PARTNER
HAS NOT VOLUNTARILY OR INVOLUNTARILY ASSIGNED OR TRANSFERRED OR PURPORTED TO ASSIGN OR TRANSFER TO ANY PERSON ANY RELEASED MATTERS AND THAT NO PERSON OTHER THAN SUCH PARTNER HAS ANY INTEREST IN ANY RELEASED MATTER BY LAW OR CONTRACT BY VIRTUE OF ANY
ACTION OR INACTION BY SUCH PARTNER. THE INVALIDITY OR UNENFORCEABILITY OF ANY PART OF THIS SECTION 9.1 SHALL NOT AFFECT THE VALIDITY OR ENFORCEABILITY OF THE REMAINDER OF THIS SECTION 9.1, WHICH SHALL REMAIN IN FULL FORCE AND
EFFECT. 
 ARTICLE X 
 GENERAL
PROVISIONS 
 10.1 Notices. All notices and other communications hereunder shall be in writing and shall be deemed given if
delivered personally or by commercial delivery service, or mailed by registered or certified mail (return receipt requested; provided that in the case of delivery by registered or certified mail, such notices shall be deemed given three
(3) days after they are so mailed) or sent via facsimile (with confirmation of receipt) to the parties at the following address (or at such other address for a party as shall be specified by like notice) (notice to the Partner Representative
shall be deemed to be notice to all Company Indemnifying Parties for all purposes): 
  

 -41- 

	 	(a)	if to Buyer, or following Closing, the Company, to: 

 Nighthawk Radiology Holdings, Inc. 
 250 Northwest Boulevard, Suite 202 
 Coeur d’Alene, Idaho 83814 
 Telephone
No.: (866) 400-4295 
 Facsimile No.: (208) 292-2825 
 Attention: General Counsel 
 with a copy to: 
 Wilson Sonsini Goodrich & Rosati, P.C. 
 701 Fifth Avenue, Suite 5100 
 Seattle, Washington 98104-7036 
 Attention: Mark J. Handfelt 
 Facsimile
No.: (206) 883-2699 
 Telephone No.: (206) 883-2547 
  

	 	(b)	if to any Partner, c/o the Partner Representative at the following address: 

 Gregory A. Lowenstein 
 1108 Calais Drive 
 Southlake, TX 76092 
 Facsimile No.:
(972) 929-1313 
 with a copy to: 
 Hallett & Perrin 
 2001 Bryan Street, Suite 3900 
 Dallas, Texas 75201 
 Attention: Bruce H.
Hallett 
 Facsimile No.: 214-922-4170 
 Telephone No.: 214-922-4120 
 10.2 Interpretation and Construction of Transaction Agreements. 
 (a) Unless the context shall otherwise require, any pronoun herein or in another Transaction Agreement shall include the corresponding masculine,
feminine, and neuter forms, and words using the singular or plural number also shall include the plural or singular number, respectively. The words “include,” “includes” and “including” herein or in another Transaction
Agreement shall be deemed to be followed by the phrase “without limitation” and the word “or” shall include the meaning “either or both.” All references herein or in another Transaction Agreement to sections, exhibits,
and schedules shall be deemed to be references to sections of, and exhibits and schedules to, the agreement in which such references are made unless the context shall otherwise require. The table of contents and the headings of the sections herein
and in the other Transaction Agreements are inserted for convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement or such other Transaction Agreement, as the case may be. Unless
the context shall otherwise require, any reference herein or in another Transaction Agreement to any agreement or other instrument or statute or regulation is to such agreement, instrument, statute or regulation as amended and supplemented from time
to time (and, in the case of a statute or regulation, to any successor provision). 
 (b) The parties acknowledge that each party has
participated in the drafting of this Agreement and the other Transaction Agreements, and that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or
interpretation of this Agreement or any of the other Transaction Agreements. 
  

 -42- 

 (c) Any reference in a Transaction Agreement to a “day” or a number of “days”
(without the explicit qualification of “business”) shall be interpreted as a reference to a calendar day or number of calendar days. If any action or notice is to be taken or given on or by a particular calendar day, and such calendar day
is not a Business Day, then such action or notice shall be deferred until, or may be taken or given on, the next Business Day. 
 (d) The
phrases “the date of this Agreement”, “the date hereof”, and terms of similar import, unless the context otherwise requires, shall be deemed to refer to the Execution Date. 
 10.3 Specific Performance. Each party agrees that irreparable harm, for which there may be no adequate remedy at law and for which the
ascertainment of Damages would be difficult, would occur in the event any of the provisions of this Agreement were not performed in accordance with its specific terms or were otherwise breached. Each party accordingly agrees that the other parties
shall be entitled to specifically enforce this Agreement and to obtain an injunction or injunctions to prevent breaches of the provisions of this Agreement or any other Transaction Agreement and to enforce specifically the terms and provisions
hereof or thereof, in each instance without being required to post bond or other security and in addition to, and without having to prove the adequacy of, other remedies at law. 
 10.4 Counterparts; Delivery. This Agreement may be executed in one or more counterparts and delivered by facsimile or PDF, all of which shall
be considered one and the same agreement, shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other parties, it being understood that all parties need not sign the same counterpart, and
upon such delivery any facsimile or PDF signature will be deemed to have the same effect as if the original signature had been delivered to the other party. 
 10.5 Entire Agreement. This Agreement, the other Transaction Agreements, and the documents and instruments and other agreements specifically referred to herein or delivered pursuant hereto, including the
exhibits and the schedules hereto and thereto, (a) constitute the entire agreement among the parties with respect to the subject matter hereof and (b) supersede all prior agreements and understandings, both written and oral, among the
parties with respect to the subject matter hereof. 
 10.6 Amendment; Waiver; Requirement of Writing. This Agreement and each of
the other Transaction Agreements cannot be amended or changed nor any performance, term, or condition waived in whole or in part except by a writing signed by the party against whom enforcement of the amendment, change or waiver is sought. Any term
or condition of this Agreement and each of the other Transaction Agreements may be waived at any time by the party hereto entitled to the benefit thereof, and any such term or condition may be modified at any time by an agreement in writing executed
by each of the parties hereto entitled to the benefit thereof. No delay or failure on the part of any party in exercising any rights hereunder, and no partial or single exercise thereof, will constitute a waiver of such rights or of any other rights
hereunder. 
 10.7 [Intentionally Reserved].
 10.8 No Third-Party Beneficiaries. Except with respect to the consideration to be provided hereunder nothing in this Agreement or the other Transaction Agreements will be construed as giving any person,
other than the parties and their successors and permitted assigns, any right, remedy, or claim under or in respect of this Agreement or the other Transaction Agreements or any provision hereof or thereof. 
 10.9 Disclaimer of Agency. Except for any provisions herein or in the Transaction Agreements expressly authorizing one party to act for
another, neither this Agreement nor any Transaction Agreement shall constitute any party as a legal representative or agent of the other party, nor shall a party have the right or authority to assume, create, or incur any Liability of any kind,
expressed or implied, against or in the name or on behalf of the other party or any of its Affiliates. 
 10.10 Relationship of the
Parties. Nothing contained in this Agreement or the Transaction Agreements is intended to, or shall be deemed to, create a partnership or joint venture relationship among the parties hereto or thereto or any of their Affiliates for any
purpose, including tax purposes. 
  

 -43- 

 10.11 Assignment. Unless otherwise set forth in another Transaction Agreement (with respect
to such agreement only), this Agreement and the other Transaction Agreements and the rights and obligations of each party hereunder or thereunder shall be binding upon, and inure to the benefit of, the parties hereto and their respective successors
and permitted assigns. 
 10.12 Severability. In the event that any provision of this Agreement, or the application thereof,
becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect, and the application of such provision to other persons or circumstances will be
interpreted so as reasonably to effect the intent of the parties hereto. The parties further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible,
the economic, business and other purposes of such void or unenforceable provision. 
 10.13 Remedies Cumulative. Except as
otherwise provided herein, any and all remedies herein expressly conferred upon a party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity, upon such party, and the exercise by a party of any
one remedy will not preclude the exercise of any other remedy. 
 10.14 Governing Law and Venue; Certain Costs.
 (a) This Agreement and the other Transaction Agreements will be construed and interpreted in accordance with and governed by the law of the State of
Delaware without regard to the choice-of-law provisions thereof. 
 (b) Each of the parties hereto irrevocably and unconditionally submits,
for itself and its property, to the exclusive jurisdiction of (i) any Washington State court sitting in the County of King and (ii) the United States District Court for the Western District of Washington, in any suit, action or proceeding
arising out of or relating to this Agreement or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such suit, action or proceeding brought by
it or any of its Affiliates shall be heard and determined in such courts, provided, however, in the event Buyer makes any allegation of fraud against any Partner(s) after the date that is two (2) years from the Closing, each of the parties
hereto irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of (i) any Texas State court sitting in the County of Dallas and (ii) the United States District Court for the Northern District of
Texas, in any suit, action or proceeding arising out of or relating to such allegation or for recognition or enforcement of any judgment related thereto. 
 (c) Each party to this Agreement hereby irrevocably and unconditionally waives (and agrees not to plead or claim), to the fullest extent it may legally and effectively do so, any objection which it may now or
hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement in (i) any Washington State court sitting in the County of King, (ii) the United States District Court for the Western
District of Washington and, for purposes of the proviso clause contained in Section 10.14(b) only, (A) any Texas State court sitting in the County of Dallas and (B) the United States District Court for the Northern
District of Texas. Each party hereby irrevocably waives, to the fullest extent permitted by Law, the defense of an inconvenient forum to the maintenance of such suit, action or proceeding in any such court and further waives the right to object,
with respect to such suit, action or proceeding, that any such court does not have jurisdiction over such party. 
 (d) EACH PARTY HERETO
HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT. EACH PARTY HERETO
(i) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (ii) ACKNOWLEDGES THAT IT
AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT, BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS PARAGRAPH. 
  

 -44- 

 (e) Each party to this Agreement irrevocably consents to service of process by U.S. registered mail to
such Person’s respective address set forth in Section 12.1. Nothing in this Agreement will affect the right of any party to this Agreement to serve process in any other manner permitted by Law. 
 (f) In the event of any suit, action or proceeding hereunder involving an allegation of fraud made against any Partner(s) after the date that is two
(2) years from the Closing, the prevailing party shall be entitled to an award of reasonable attorney’s fees and court costs. 
 [SIGNATURE PAGE FOLLOWS] 
  

 -45- 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf by it or by an officer or
representative thereunto duly authorized, all as of the date first written above. 
  

			
	BUYER
	NIGHTHAWK RADIOLOGY HOLDINGS, INC.
		
	By:	 	 /s/ Tim Mayleben

	Name:	 	  

	Title:	 	Executive Vice President & COO
	
	COMPANY
	THE RADLINX GROUP, LTD.
	
	By: Radlinx Group Management Company, LLC its General Partner
		
	By:	 	 /s/ Gregory A. Lowenstein

	Name:	 	Gregory A. Lowenstein
	Title:	 	Manager
	
	GENERAL PARTNER
	RADLINX MANAGEMENT COMPANY, LLC
		
	By:	 	 /s/ Gregory A. Lowenstein

	Name:	 	Gregory A. Lowenstein
	Title:	 	Manager
	
	PARTNER REPRESENTATIVE
	GREGORY A. LOWENSTEIN
		
	By:	 	 /s/ Gregory A. Lowenstein

	Name:	 	Gregory A. Lowenstein
	
	BLOCKER CORP.
	HEALTHLINX, INC.
		
	By:	 	 /s/ Justin Pettit

	Name:	 	Justin Pettit
	Title:	 	Secretary

 [STOCK AND PARTNERSHIP INTEREST PURCHASE AGREEMENT] 

			
	PARTNER:
	DW HEALTHCARE PARTNERS, L.P.
	
	By: DW Healthcare Management, LLC (its General Partner)
		
	By:	 	 /s/ Andrew C. Carragher

	Name:	 	Andrew C. Carragher
	Title:	 	Managing Member
	
	PARTNER:
	GREGORY A. LOWENSTEIN
		
	Name:	 	 /s/ Gregory A. Lowenstein

	
	PARTNER:
	MARK J. BAKKEN
		
	Name:	 	 /s/ Gregory A. Lowenstein

 [STOCK AND PARTNERSHIP INTEREST PURCHASE AGREEMENT] 

			
	SERIES B HOLDER:
	M. WAYNE SOMERS
		
	Name:	 	 /s/ M. Wayne Somers

	
	SERIES B HOLDER:
	MARK PANTENBURG
		
	Name:	 	 /s/ Mark Pantenburg

	
	SERIES B HOLDER:
	CALVIN B. HALL
		
	Name:	 	 Calvin B. Hall

 [STOCK AND PARTNERSHIP INTEREST PURCHASE AGREEMENT] 

 EXHIBIT A 
 DEFINED TERMS 
 “Accounts Receivable” shall have the meaning set forth in
Section 2.12(a). 
 “Acquisition” shall have the meaning set forth in the recitals hereto. 
 “Affiliate” shall mean, with respect to (a) any Person (including the Company), (i) any member of the immediate family (including spouse,
brother, sister, descendant, ancestor or in-law) of such Person, (ii) any officer, director or partner of such Person, (iii) any corporation, partnership, trust or other Entity in which any such Person or any such family partner of such
Person has a five percent (5%) or greater interest or is a director, officer, partner or trustee or (iv) any Person that controls, or is controlled by, or is under common control with, such Person and (b) the Company. 
 “Agreement” shall have the meaning set forth in the preamble hereto. 
 “Basket Amount” shall have the meaning set forth in Section 8.3. 
 “Blocker
Corp.” shall have the meaning set forth in the preamble hereto. 
 “Blocker Corp. Stock” shall have the meaning set forth in the
preamble hereto. 
 “Business Day” shall mean any day other than (i) a Saturday or a Sunday or (ii) a day on which federally
chartered banking and savings and loan institutions are authorized or required by law to be closed in the United States. 
 “Business
Revenue” shall mean revenue accrued by the Buyer or the Company in connection with the provision of professional teleradiology services of the type offered by the Company as of the Closing Date. For clarity, Business Revenue shall not
include revenue accrued in connection with the provision of services related to (i) coronary computed tomography angiography or (ii) technology and workflow solutions. 
 “Buyer” shall have the meaning set forth in the preamble hereto. 
 “Buyer Indemnified
Parties” shall have the meaning set forth in Section 8.2(a). 
 “Cash” shall mean the amount of cash and cash
equivalents set forth on the Closing Balance Sheet. 
 “Certificate of Limited Partnership” shall mean the Company’s Certificate of
Limited Partnership. 
 “Change in Control Payments” means the aggregate amount of all change of control, bonus, termination, severance or
other similar payments that are payable by the Company to any Person as a result of or in connection with the Acquisition or any of the other transactions contemplated by this Agreement (alone or in combination with any other event), whether
accrued, incurred or paid prior to, at or after the Closing. 
 “Claim” shall have the meaning set forth in Section 8.2(b).

 “Closing” shall have the meaning set forth in Section 1.6(a). 
 “Closing Balance Sheet” shall have the meaning set forth in Section 7.3. 
 “Closing
Date” shall have the meaning set forth in Section 1.6(a). 
 “Closing Date Current Liabilities” shall mean the amount
of current liabilities set forth on the Closing Balance Sheet. 
  

 “Closing Date Net Working Capital” shall mean an amount equal to (A) the amount of total current
assets of the Company minus (B) the amount of total current liabilities (other than Indebtedness) of the Company, in the case of each of clauses (A) and (B) as indicated on the Closing Balance Sheet (it being understood that
notwithstanding anything herein to the contrary, all Change in Control Payments and Transaction Expenses of the Company, in each case to the extent not paid (or agreed to be paid by the Partners) prior to the date of the Closing Balance Sheet, will
be set forth on the Closing Balance Sheet and deemed to be current liabilities of the Company in determining Closing Date Net Working Capital). 
 “Closing Payment” shall have the meaning set forth in Section 1.3(a). 
 “Code” shall mean the
Internal Revenue Code of 1986, as amended. 
 “Collected AR” shall mean the total amount collected by Buyer or the Company on or prior to
the Cut-Off Date of Accounts Receivable set forth on the Closing Balance Sheet (it being understood that amounts received by the Company from account debtors prior to the Cut-Off Date shall be applied to the oldest Accounts Receivable from such
account debtor as of the date of payment). 
 “Company” shall have the meaning set forth in the preamble hereto. 
 “Company Contracts” shall have the meaning set forth in Section 2.21(a). 
 “Company Disclosure Letter” shall have the meaning set forth in the introductory paragraph to ARTICLE II. 
 “Company Indemnifying Parties” shall have the meaning set forth in Section 8.2(a). 
 “Company Intellectual
Property” shall mean (i) all Company Registered Intellectual Property Rights and (ii) any other Intellectual Property Rights owned, used, controlled, authorized for use or held by Company. 
 “Company Registered Intellectual Property Rights” shall mean all Registered Intellectual Property Rights at any time owned by, filed in the name of or
applied for by Company. 
 “Company Technology” shall mean all electronic data processing, information, record keeping, communications,
telecommunications and other computing systems and Technology owned, used, controlled, authorized for use or held by Company. 
 “Confidential
Information” shall mean all Trade Secrets and other confidential or proprietary information of a Person that such Person desires remain secret or confidential, including information derived from reports, investigations, research, work in
progress, codes, marketing and sales programs, financial projections, cost summaries, pricing formulas, contract analyses, financial information, projections, confidential filings with any state or federal agency, and all other confidential
concepts, methods of doing business, ideas, materials or information prepared or performed for, by or on behalf of such Person by its employees, officers, directors, agents, representatives, or consultants. 
 “Consent” shall mean any (i) approval, authorization, certificate, concession, consent, declaration, grant, exemption, license, permit, variance,
vote or waiver, (ii) registration or filing or (iii) report or notice, including all renewals, amendments and extensions of any of the foregoing and any similar matters. 
 “Consideration Percentage” means with respect to DWHP 38.2%, with respect to MB 28.65%, with respect to GL 28.65%, with respect to MS 1.5% , with respect to MP 1.5% and with respect to CH 1.5%.

 “Contract” shall mean any agreement, contract, promise, understanding, arrangement, commitment or undertaking of any nature (whether
written or oral and whether express or implied), that is currently in effect, and including any amendment, modification, side letter, supplement or other agreement or change with respect to the foregoing that is currently in effect, whether written
or oral. 
  

 -2- 

 “Copyrights” shall mean all copyrights, including rights in and to Software, works of authorship and all
other rights corresponding thereto throughout the world, whether published or unpublished, including rights to prepare, reproduce, perform, display and distribute copyrighted works and copies, compilations and derivative works thereof. 

“Current Leased Premises” shall have the meaning set forth in Section 2.14(f). 
 “Customer Contracts” means any and all Contracts with customers of the Company, including professional services agreements, supply agreements, service
agreements, license agreements, maintenance and development agreements and consulting agreements. 
 “Cut-Off Date” shall have the meaning
set forth in Section 1.3(b). 
 “Damages” shall mean and include any loss, Liability, damage, injury, decline in value, claim,
demand, settlement, judgment, award, fine, penalty, Tax, fee (including any legal fee, accounting fee, expert fee or advisory fee), charge, cost (including any cost of investigation) or expense of any nature. 
 “DWHP” shall have the meaning set forth in the preamble hereto. 
 “Earnout Amount” means twenty-five percent (25%) of the Business Revenue generated from the entities listed on Exhibit C during the one-year period immediately after the Closing Date. 
 “Earnout Payment” shall have the meaning set forth in Section 1.4(a). 
 “Earnout Payment Date” shall have the meaning set forth in Section 1.4(a). 
 “Employment Agreements” shall have the meaning set forth in Section 7.2. 
 “Employee Benefit Plan”
shall have the meaning specified in Section 3(3) of ERISA. 
 “Encumbrance” shall mean any lien, pledge, hypothecation, charge,
mortgage, security interest, encumbrance, trust, equitable interest, claim, preference, right of possession, lease, tenancy, license, encroachment, covenant, Order, proxy, option, right of first refusal, preemptive right, community property
interest, limitation, material impairment, imperfection of title, condition or restriction of any nature (including any restriction on the voting of any security, any restriction on the transfer of any security or other asset, any restriction on the
receipt of any income derived from any asset, any restriction on the use of any asset and any restriction on the possession, exercise or transfer of any other attribute of ownership of any asset), but excluding any encumbrance which has been
released in connection with the transactions contemplated hereby. 
 “Entity” shall mean any corporation (including any non-profit
corporation), general partnership, limited partnership, limited liability partnership, joint venture, estate, trust company (including any limited liability company or joint stock company) or other legal entity. 
 “Environmental Law” shall mean any Legal Requirement or Governmental Approval relating to the protection of the environment (including air, water, soil
and natural resources) or health and safety aspects associated with environmental protection, including with respect to the release of any Hazardous Materials. 
 “Equity” shall have the meaning set forth in Section 1.1(b). 
 “Equity Interest” means (i) the
capital stock of or other equity or ownership interest in an Entity (including partnership or membership interests and limited liability company partnership or membership interests and similar interests and any similar or equivalent rights) and any
document evidencing any of the foregoing, (ii) any securities, shares or rights convertible into or exercisable for, and any preemptive, subscription, acquisition or other outstanding right, option, warrant, conversion right, exercise right,
stock appreciation right, redemption right, 

  

 -3- 

 
repurchase right, phantom security, or Contract of any nature related to the capital stock or other interest described in clause (i) above and
(iii) any beneficial interest related to the capital stock or other interest described in clause (i) above. 
 “ERISA” shall mean
the Employee Retirement Income Security Act of 1974, as amended. 
 “ERISA Affiliate” shall mean each trade or business, whether or not
incorporated, that would be treated as a single employer with Company under Section 4001 of ERISA or Section 414(b), (c), (m) or (o) of the Code. 
 “Escrow Agent” means Wells Fargo Bank, National Association. 
 “Escrow Agreement” means
that certain Escrow Agreement, dated the date hereof, by and among the parties hereto and the Escrow Agent. 
 “Escrow Amount” shall have
the meaning set forth in Section 1.5. 
 “Escrow Fund” shall have the meaning set forth in Section 1.5. 

“Execution Date” shall have the meaning set forth in the preamble hereto. 
 “Extension Agreements” shall mean the Waiver and Amendment Number One to Teleradiology Services Agreement (Daytime Services) by and among Nighthawk Radiology Services, LLC, US Radiology Partners of
Texas, Inc. and the Company, the Waiver and Amendment Number One to Teleradiology Services Agreement (Daytime Services) by and among Nighthawk Radiology Services, LLC, US Radiology Partners of Louisiana, Inc. and the Company, the Waiver and
Amendment Number One to Teleradiology Services Agreement (Daytime Services) by and among Nighthawk Radiology Services, LLC, MidSouth Radiology Partners, LLC and the Company, the Waiver and Amendment Number One to Teleradiology Services Agreement
(After Hours Coverage Agreement) by and among Nighthawk Radiology Services, LLC, US Radiology Partners of Texas, Inc. and the Company and the Waiver and Amendment Number One to Teleradiology Services Agreement (After Hours Coverage Agreement) by and
among Nighthawk Radiology Services, LLC, US Radiology Partners of Louisiana, Inc. and the Company, each of the preceding agreements executed on the same date as this Agreement. 
 “Financial Statements” shall have the meaning set forth in Section 2.10(a). 
 “GAAP” shall mean U.S. generally accepted accounting principles in effect on the date on which they are to be applied pursuant to this Agreement, applied consistently throughout the relevant periods. 
 “GL” shall have the meaning set forth in the preamble hereto. 
 “General Partner” shall have the meaning set forth in the preamble hereto. 
 “General Partner, Ltd.” shall have
the meaning set forth in Section 3.2(b). 
 “General Partnership Agreement” shall mean the Amended and Restated Regulations of
the General Partner dated as of February 28, 2006. 
 “Governmental Approval” shall mean any (i) permit, license, certificate,
concession, approval, consent, ratification, permission, clearance, confirmation, exemption, waiver, franchise, certification, designation, rating, registration, variance, qualification, accreditation or authorization issued, granted, given,
required by or otherwise made available by or under the authority of any Governmental Authority or pursuant to any Legal Requirement or (ii) pending application or request for any of the foregoing in (i) above. 
 “Governmental Authority” shall mean any (i) nation, principality, state, commonwealth, province, territory, county, municipality, district or other
jurisdiction of any nature; (ii) federal, state, local, municipal, foreign or other government; (iii) federal, state, local, municipal, foreign or other court, arbitrator, or judicial or governmental or 

  

 -4- 

 
quasi-judicial or quasi-governmental authority of any nature (including any governmental division, subdivision, department, agency, bureau, branch, office,
commission, council, board, instrumentality, officer, official, representative, organization, unit, body or entity and any court or other tribunal); (iv) multinational organization or body, (v) individual, entity or body entitled to
exercise any executive, legislative, judicial, administrative, regulatory, police, military or taxing authority or power of any nature or (vi) arbitrator or arbitral panel. 
 “GP Interests” shall have the meaning set forth in Section 1.1(b). 
 “Hazardous
Material” shall mean any material, substance or waste listed, defined, designated or classified by or pursuant to Environmental Law as hazardous, toxic, pollutant, contaminant or words of similar meaning or effect, including petroleum or
petroleum products (including crude oil) and any derivative or by-products thereof, natural gas, synthetic gas and any mixtures thereof, radioactive material or any substance that is or contains polychlorinated biphenyls (PCBs), radon gas, urea
formaldehyde, asbestos-containing materials (ACMs) or lead. 
 “HIPAA” shall have the meaning set forth in Section 2.8(e).

 “Indemnification Expiration” shall have the meaning set forth in Section 8.2(a). 
 “Intellectual Property Rights” shall mean any intellectual property rights, including, without limitation, Patents, Copyrights, mask works, moral
rights, Trade Secrets, Trademarks, designs, and Technology, together with (i) all registrations and applications for registrations therefor and (ii) all rights to any of the foregoing (including: (A) all rights received under any
license or other arrangement with respect to the foregoing, (B) all rights or causes of action for infringement or misappropriation (past, present or future) of any of the foregoing and (C) all rights to apply for or register any of the
foregoing), but excluding any commercially available shrink-wrap software licensed by the Company). 
 “Indebtedness” of any Person means
(i) all obligations of such Person for borrowed money or with respect to cash deposits or advances of any kind other than customer pre-payments made pursuant to Contracts in the Ordinary Course of Business, (ii) all obligations of such
Person evidenced by bonds, debentures, notes or similar instruments, (iii) all obligations of such Person upon which interest charges are customarily paid, other than trade credit incurred in the Ordinary Course of Business consistent with past
practice, (iv) all obligations of such Person under conditional sale or other title retention agreements relating to property or assets purchased by such Person, (v) all obligations of such Person issued or assumed as the deferred purchase
price of property or services, other than trade payables in the Ordinary Course of Business paid consistent with past practice, (vi) all indebtedness of others secured by (or for which the holder of such indebtedness has an existing right,
contingent or otherwise, to be secured by) any Encumbrance on property owned or acquired by such Person, whether or not the obligations secured thereby have been assumed, (vii) all guarantees by such Person, (viii) all capital lease
obligations of such Person, (ix) all net obligations of such Person in respect of interest rate protection agreements, foreign currency exchange agreements or other interest or exchange rate hedging arrangements and (x) all obligations of
such Person as an account party in respect of letters of credit and bankers’ acceptances. 
 “Initial Distribution Amount” shall have
the meaning set forth in Section 8.2(d). 
 “Initial Distribution Date” shall have the meaning set forth in
Section 8.2(d). 
 “Interests” shall have the meaning set forth in Section 1.1(b). 
 “Interim Balance Sheet” shall have the meaning set forth in Section 2.10(b). 
 “Interim Financial Statements” shall have the meaning set forth in Section 2.10(a)(ii). 
 “JCAHO” shall have the meaning set forth in Section 2.8(f). 
 “Key Personnel” shall have the meaning
set forth in Section 7.2. 
  

 -5- 

 “Knowledge” shall mean any fact or matter known by a MB, GL or any Series B Holder or which any thereof
could reasonably be expected to have discovered or have become aware of in the course of performing his duties. 
 “Leased Premises” shall
have the meaning set forth in Section 2.16. 
 “Legal Requirement” shall mean any federal, state, local, municipal, foreign or
other law, statute, legislation, constitution, ordinance, code, Order, edict, decree, proclamation, treaty, convention, rule, regulation, permit, ruling, directive, requirement (licensing or otherwise), specification, determination, decision,
opinion or interpretation that is or has been issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by or under the authority of any Governmental Authority. 
 “Liability” shall mean any debt, obligation, duty or liability of any nature (including any unknown, undisclosed, unmatured, unaccrued, unasserted,
contingent, indirect, conditional, implied, vicarious, derivative, joint, several or secondary liability, debt, obligation, or duty), regardless of whether such debt, obligation, duty, or liability would be required to be disclosed on a balance
sheet prepared in accordance with generally accepted accounting principles and regardless of whether such debt, obligation, duty or liability is immediately due and payable. 
 “Limited Partnership Agreement” shall mean the Amended and Restated Limited Partnership Agreement of the Company dated February 28, 2006. 
 “LP Interests” shall have the meaning set forth in Section 1.1(b). 
 “Material Adverse Effect” shall mean, as to any Person, an event, circumstance, fact or condition which has had or which could reasonably be expected to have a material adverse effect on (i) such
Person’s business, condition, assets, liabilities, operations, financial performance, or prospects for continuing the operation of its business as conducted at Closing or (ii) the ability of such Person to enter into this Agreement or the
other Transaction Agreements to which it is a party, to consummate the Acquisition, or to perform its obligations hereunder or under such other Transaction Agreements (excluding any changes resulting from or arising out of general market, economic
or political conditions, provided that such changes do not have a substantially disproportionate impact on such Person) or other changes incident to, or reasonably foreseeable as a result of, the consummation of the transactions contemplated hereby.

 “MB” shall have the meaning set forth in the preamble hereto. 
 “Multiemployer Plan” shall mean a pension benefit plan described in Section 3(37) of ERISA. 
 “Officer’s Certificate” shall have the meaning set forth in Section 8.2(b). 
 “Order” shall mean
any temporary, preliminary or permanent order, judgment, injunction, edict, decree, ruling, pronouncement, determination, decision, opinion, verdict, sentence, stipulation, subpoena, writ, award or similar action that is or has been issued, made,
entered, rendered or otherwise put into effect by or under the authority of any court, administrative agency or other Governmental Authority or any arbitrator or arbitration panel. 
 “Ordinary Course of Business” shall, as to any Person, describe any action taken by a party if (i) such action is consistent with such Person’s past practices and is taken in the ordinary
course of such Person’s normal day-to-day operations and (ii) such action is not required to be authorized by such Person’s equity owners, board of directors or any committee thereof and does not require any other separate or special
authorization of any nature. 
 “Partner” and “Partners” shall have the meaning set forth in the preamble hereto.

 “Partner Proceeding” shall have the meaning set forth in Section 2.7. 
 “Partner’s Conflict” shall have the meaning set forth in Section 5.5. 
  

 -6- 

 “Patents” shall mean all United States and foreign patents and utility models and applications therefor
and all reissues, divisions, re-examinations, renewals, extensions, provisionals, continuations and continuations-in-part thereof, and equivalent or similar rights anywhere in the world in inventions and discoveries. 
 “Pension Plan” shall mean an employee benefit plan, fund, program, contract or arrangement that is subject to Section 412 of the Code,
Section 302 of ERISA or Title IV of ERISA or any Multiemployer Plan. 
 “Permitted Encumbrances” shall mean (a) Encumbrances
for taxes, assessments and other governmental charges not yet due and payable, (b) Encumbrances for taxes, assessments and other governmental charges that are being contested in good faith by appropriate Proceedings promptly instituted and
diligently conducted and for which reasonable reserves have been established, or (c) statutory, mechanics’, laborers’ and material men’s liens arising in the Ordinary Course of Business for sums not yet due. 
 “Permitted Indebtedness” shall mean accounts payable incurred in the Ordinary Course of Business. 
 “Person” shall mean any individual, Entity or Government Authority. 
 “Plans” shall have the meaning as set forth in Section 2.18(a). 
 “Pre-Closing Tax
Period” shall have the meaning set forth in Section 7.6(a). 
 “Prior Leased Premises” shall have the meaning set forth
in Section 2.14(f). 
 “Proceeding” shall mean any action, suit, litigation, arbitration, proceeding (including any civil,
criminal, administrative, investigative or appellate proceeding), prosecution, contest, hearing, inquiry, inquest, audit, examination or investigation that is, has been or may in the future be commenced, brought, conducted or heard at law or in
equity or before any Governmental Authority. 
 “Projected Indemnity Amount” shall have the meaning set forth in Section 8.2(b).

 “Property Taxes” shall have the meaning set forth in Section 7.6(a). 
 “PTO” shall have the meaning set forth in Section 2.15(g). 
 “Purchase Price” shall have the meaning set forth in Section 1.2. 
 “Ram,
Ltd.” shall have the meaning set forth in Section 2.2(b). 
 “Real Property” shall mean, as to any Person, all real
property owned or leased by such Person and all structures, buildings, building systems (including roof, HVAC, electrical, plumbing, sprinkler and fire safety systems), irrigation systems, fixtures and other improvements, together with the systems
and facilities servicing such structures, located thereon. 
 “Registered Intellectual Property Rights” shall mean all United States,
international and foreign (i) Patents, including applications therefor, (ii) registered Trademarks, applications to register Trademarks, including intent-to-use applications, or other registrations or applications related to Trademarks,
(iii) Copyright registrations and applications to register Copyrights; (iv) mask work registrations and applications to register mask works, and (v) any other Intellectual Property Rights that are the subject of an application,
certificate, filing, registration or other document issued by, filed with, or recorded by, any state, government or other public legal authority at any time on or before Closing. 
 “Released Matters” shall have the meaning set forth in Section 9.1. 
 “Released
Party” shall have the meaning set forth in Section 9.1. 
  

 -7- 

 “Releasing Parties” shall have the meaning set forth in Section 9.1. 
 “Remaining Amount” shall have the meaning set forth in Section 8.2(f). 
 “Representatives” shall mean, as to any Person, officers, directors, attorneys, accountants, advisors, Partners, subsidiaries and parent entities of such Person. 
 “RGMC” shall have the meaning set forth in the preamble hereto. 
 “Second Distribution Amount” shall have the meaning set forth in Section 8.2(e). 
 “Second Distribution
Date” shall have the meaning set forth in Section 8.2(e). 
 “Securities Act” shall mean the Securities Act of 1933, as
amended. 
 “Shares” shall have the meaning set forth in Section 1.1(a). 
 “Statement” shall have the meaning set forth in Section 7.3. 
 “Straddle Period” shall have the meaning set forth in Section 7.6(a). 
 “Subsequent
Distribution Amount” shall have the meaning set forth in Section 8.2(f). 
 “Subsidiary” shall mean, with respect to
any Entity, another Entity (i) of which more than fifty percent (50%) of the securities or other ownership interests having by their terms ordinary voting power to elect a majority of the board of directors, or other body performing
similar functions, of such other Entity is directly or indirectly owned or controlled by such Entity, (ii) which such Entity otherwise directly or indirectly owns or controls or (iii) which is consolidated in the financial statements of
such Entity. 
 “Supplies” shall have the meaning set forth in Section 2.14(a)(iv). 
 “Tax” (and, with correlative meaning, “Taxes” and “Taxable”) shall mean (i) all taxes, however denominated,
including any interest, penalties or additions to tax that may become payable in respect thereof, imposed by any U.S. federal, territorial, state, local or non-U.S. government or any agency or political subdivision of any such government, which
taxes shall include, without limiting the generality of the foregoing, all income or profits taxes (including but not limited to federal income taxes and state income and franchise taxes), payroll and employee withholding taxes, unemployment
insurance, social security taxes, sales and use taxes, ad valorem taxes, excise taxes, franchise taxes, gross receipts taxes, business license taxes, occupation taxes, real and personal property taxes, stamp taxes, environmental taxes, transfer
taxes, workers’ compensation, Pension Benefit Guaranty Corporation premiums and other governmental charges, customs fees, duties and similar obligations, and other obligations of the same or of a similar nature to any of the foregoing, which
Company or any of its subsidiaries is required to pay, withhold or collect, (ii) any liability for the payment of any amounts of the type described in clause (i) as a result of being a partner of an affiliated, consolidated, combined or
unitary group for any period, and (iii) any liability for the payment of any amounts of the type described in clauses (i) or (ii) as a result of any express or implied obligation to indemnify any other person or as a result of any
obligations under any agreements or arrangements with any other person with respect to such amounts and including any liability for taxes of a predecessor or transferor entity. 
 “Tax Contest” shall have the meaning set forth in Section 7.6(c). 
 “Tax
Return” shall mean all reports, estimates, declarations of estimated tax, information statements and returns (whether original or amended) relating to, or required to be filed in connection with, any Tax, including information returns or
reports with respect to backup withholding and other payments to third parties. 
 “Technology” shall mean any know-how, confidential or
proprietary information, name, data, discovery, formula, idea, method, process, procedure, other invention, record of invention, model, research, software, technique, technology, test information, market survey, website, or information or material
of a like nature, whether patentable or unpatentable and whether or not reduced to practice. 
  

 -8- 

 “Trade Secrets” shall mean all trade secrets under applicable law and other rights in know-how and
confidential or proprietary information, processing, manufacturing or marketing information, including new developments, inventions, processes, procedures, techniques, ideas or other proprietary information that provides advantages over competitors
who do not know or use it and documentation thereof (including related papers, blueprints, drawings, chemical compositions, formulae, diaries, notebooks, specifications, designs, methods of manufacture and data processing software and compilations
of information) and all claims and rights related thereto. 
 “Trademarks” shall mean any and all U.S. and foreign trademarks, service
marks, logos, trade names, corporate names, and Internet domain names and addresses, and all goodwill associated therewith throughout the world. 
 “Transaction Agreements” shall mean the Escrow Agreement and the Employment Agreements. 
 “Transaction Expenses”
shall mean attorneys’ fees, accounting fees and similar third party costs and expenses incurred in connection with the transactions contemplated hereby. 
 “Working Capital Shortfall” shall have the meaning set forth in Section 1.3(b). 
 “Working Capital
Threshold” shall mean $868,000. 
  

 -9- 

 EXHIBIT B 
 FORM OF OPINION OF OUTSIDE COUNSEL 
  

 EXHIBIT C 
 LIST OF ENTITIES

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}]]